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Chapter 1 
Introduction
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Background
Ischemic stroke
Stroke is the leading cause of serious, long-term disability and an important cause of 
death in developed countries. Although the age-standardized incidence, prevalence, 
mortality rates and disability have declined the last decades, the global burden of stroke 
has continued to increase due to population growth and ageing. 1, 2
The general aim of this thesis is to contribute to the reduction of the burden of disease 
by increasing our knowledge on the pathophysiology of atherosclerosis by means of ad-
vanced imaging of atherosclerosis in vivo.
Ischemic stroke is defined as a clinical syndrome of a sudden, focal or global neurological 
deficit, presumably of vascular origin, with intracranial haemorrhage excluded by imag-
ing. It is confined to an area of the brain perfused by a specific artery, and according to 
the classic definition lasts longer than 24 hours or leads to death. In a transient ischemic 
attack (TIA) symptoms are reversible and last less than 24 hours.3
Whereas ischemic stroke can be caused by cardiac thrombo-emboli, small vessel disease 
or rare disorders like vasculitis or dissection, atherosclerotic disease - leading to throm-
bo-embolism or local occlusions - is by far the most important cause, counting for approx-
imately 50% of ischemic strokes.3
Atherosclerosis
Atherosclerosis is a chronic immuno-inflammatory, fibro-proliferative disease of large 
and medium-sized arteries. It is characterized by a local thickening of the arterial wall due 
to a slow build-up of cholesterol, lipids, calcium and debris. This wall thickening is called 
an atherosclerotic plaque.4, 5 Endothelial cells, leukocytes, macrophages and intimal 
smooth muscle cells play key roles in the pathogenesis of atherosclerotic plaque forma-
tion.6, 7
Different risk factors appear to accelerate this disease process driven by atherogenic li-
poproteins.2 Our limited ability to predict clinical disease based on cardiovascular risk 
factor profiles indicate that other factors like genetic susceptibility play a role. Moreover, 
susceptibility to atherosclerosis differs among arterial segments, with predilection for 
bends and bifurcations.8 This implies that local hemodynamic conditions and resulting 
shear stress play a role in its development.9-11
Atherosclerotic plaque formation itself could be seen as a process of vascular aging. Al-
though plaque burden can increase with significant reduction or obstruction of the vessel 
luminal diameter, it more often increases without compromising luminal diameter, be-
cause of outward remodelling.12, 13 What makes atherosclerosis a challenging disorder is 
that it, after long periods of indolent growth, suddenly becomes complicated by plaque 
rupture with superimposed thrombosis and subsequent embolism and devastating con-
sequences, such as stroke and myocardial infarction. Histology studies found about 75% 
of fatal coronary thrombi to be precipitated by plaque rupture.7
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Ruptured plaques are histologically characterized by large lipid-rich cores, thin fibrous 
caps containing few smooth muscle cells and many macrophages, angiogenesis (in-
traplaque haemorrhage), adventitial inflammation, and outward remodelling.7, 14-16 Rup-
ture-prone plaques, or so-called ‘vulnerable plaques’, have certain patho-anatomical fea-
tures, that could be detected in vivo by imaging. 
Treatment and prevention of ischemic stroke
Management of ischemic stroke in the acute phase consists of surveillance on a stroke 
unit with optimization of vital functions, intravenous thrombolytics in patients present-
ing within 4,5 hours after onset of symptoms and endovascular thrombectomy in cas-
es with a visible intracranial arterial occlusion on vessel imaging. The risk of recurrent 
stroke after a TIA or ischemic stroke is high.17, 18 Secondary prevention is therefore very 
important. Medical treatment consists of platelet aggregation inhibitors (for example 
acetylsalicylic acid, dipyridamole) or coumarine derivatives (in cases of increased risk for 
cardiac embolism). Further, treatment of cardiovascular risk factors, such as diabetes, 
hypertension, hypercholesterolemia, and refraining from smoking, reduces the risk of 
recurrent events.2, 19 In the secondary prevention of ischemic stroke, it is also important 
to focus on the causative factor. Imaging of the carotid arteries is therefore part of the 
work-up of every ischemic stroke patient. 
Until now, the degree of stenosis of the carotid artery, caused by atherosclerosis, has 
been the only imaging-based risk factor for stroke that is used in clinical decision making. 
Large randomized clinical trials (the North American Symptomatic Carotid Endarterecto-
my Trial – NASCET, and the European Carotid Surgery Trial – ECST) have established the 
imaging criteria for surgical treatment of the carotid artery in stroke patients. Carotid 
endarterectomy (CEA) is considered indicated in symptomatic patients with high-grade 
stenosis (>70%) and in a selection of patients with moderate stenosis (50-69%) to reduce 
the risk of recurrent ischemic stroke.20-23 However, since most persons with a high-grade 
carotid stenosis are asymptomatic, and only a minority of symptomatic patients has such 
a high-grade stenosis, this clinical decision model has considerable shortcomings. Plaque 
burden and numerous plaque-specific features are not yet taken into account in clinical 
decision making.
Ideally, we would be able to prevent (recurrent) ischemic strokes by early detection of 
atherosclerotic disease and intervention in the process of plaque development towards 
a vulnerable plaque and plaque rupture. Although epidemiological, histological and ani-
mal studies have helped to define mechanisms of atherosclerosis, a convincing model of 
plaque rupture, applicable in daily clinical practise, still does not exist. Current imaging 
techniques are promising tools for increasing our understanding of atherosclerosis pro-
gression in humans by providing a window to the human atherosclerotic process in vivo.24
Atherosclerosis imaging biomarkers
In the last decades, research has focused on increasing our knowledge of the pathophys-
iology of atherosclerosis by imaging atherosclerotic disease in vivo in different vessel 
beds. Atherosclerotic plaque in the carotid artery is mainly subject of investigation, since 
it is a large artery which is easily accessible for different imaging modalities, and the per-
formance of plaque imaging techniques can be validated by histology because of the 
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availability of carotid endarterectomy (CEA) specimens. Moreover, serial in vivo imaging 
of the carotid artery allows the investigation of disease progression and the develop-
ment of vulnerable plaques as well as the assessment of their determinants. 
Advanced non-invasive or minimally invasive imaging techniques, such as duplex ultra-
sound (DUS), magnetic resonance imaging (MRI) and computed tomography angiogra-
phy (CTA) enable carotid stenosis grading as well as visualisation of wall pathology. These 
techniques could provide imaging biomarkers of early and advanced atherosclerotic dis-
ease.24 
Biomarkers are characteristics that are objectively measured as indicators of normal bi-
ological processes, pathological changes, or responses to therapeutic intervention.25 An 
imaging biomarker is defined as an (anatomical or functional) feature detectable with 
an imaging technique that can indicate the presence or state of a disease. Except for 
detection of disease, imaging biomarkers can be used to predict risk of disease, classify 
the extent of disease, and grade its aggressiveness and prognosis. Although qualitative 
imaging features (either present or not present) can be used, accurate quantitative imag-
ing biomarkers add valuable information as they enable monitoring of disease evolution 
and treatment response. Effective use of imaging biomarkers requires technological ro-
bustness, non-invasiveness, broad availability, standardization and validation. Standard-
ization concerns data acquisition parameters and post-processing techniques to ensure 
reproducibility. Requirements for validation of imaging biomarkers, like sensitivity, spec-
ificity, precision and reproducibility) are high, especially when used in drug development 
trials. Biomarker s and changes in its values should correlate strongly with biological ef-
fects (histological validation) and clinical endpoints.26
Ultrasound was the first modality to replace digital subtraction angiography (DSA) for 
stenosis grading of the extracranial carotid artery in clinical practise. Measurement of 
the combined thickness of the intima and media layer (carotid intima-media thickness 
(cIMT)) as assessed with B-mode ultrasound, has been thoroughly investigated and is 
associated with cardiovascular events.27, 28 The composition of atherosclerotic carotid 
plaques can also be evaluated with ultrasound. Echolucency of carotid plaques has been 
associated with unstable plaque and echolucent plaques have been associated with sub-
sequent cerebrovascular events.29
Magnetic Resonance Imaging (MRI) has emerged as a valuable non-invasive technique 
to evaluate different carotid plaque features as imaging biomarkers of plaque burden, 
plaque composition and plaque activity. Its accuracy has been validated against histology 
with a high reproducibility.30 Certain plaque features were found to stimulate plaque pro-
gression and instability.31-34 Prospective MRI studies found thinned/ruptured fibrous caps, 
the presence of intraplaque haemorrhage, larger maximum percentage of LRNC and larg-
er maximum wall thickness to be strongly correlated with occurrence of cerebrovascular 
events.35-39 Carotid plaque composition can be accurately quantified by MRI.40 Serial MRI 
plaque imaging has been upcoming in clinical trials of pharmaceutical compounds to bet-
ter understand the pathogenesis of atherosclerosis.31, 41
CT imaging is widely used in the acute clinical work-up of stroke patients. First of all, CT of 
the brain is necessary to differentiate between haemorrhagic stroke and ischemic stroke 
in the acute setting, since both diseases require a completely different therapy. CT angi-
ography is increasingly used for visualization of the intracranial and extracranial arteries, 
classically to assess carotid artery stenosis to indicate surgical intervention, but recently 
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also to diagnose possible acute occlusion of intracranial arteries, in order to initiate end-
ovascular thrombectomy.42 Multidetector CTA (MDCTA) allows fast and reliable evalu-
ation of steno-occlusive disease of both intracranial and extracranial arteries, is readily 
available and can nowadays be performed using a relatively low radiation dose (1-5 mSv). 
CT angiography is therefore a potential imaging technique for the assessment of athero-
sclerotic plaque biomarkers. The technique has already been found to enable evaluation 
of lumen as well as plaque surface morphology43, 44 and to enable quantification of plaque 
volume and plaque components, in good correlation with histology.45-47
We need better understanding of the development of carotid atherosclerosis and factors 
associated with plaque rupture and ischemic stroke. 
The work in this thesis therefore focusses on:
• Quantification of imaging biomarkers of carotid atherosclerotic disease with CTA.
• The investigation of the role of carotid atherosclerotic plaque surface (i.e. ulceration) 
as an imaging biomarker of plaque vulnerability.  
• The study of plaque development and its determinants using serial CTA imaging.
Quantitative imaging biomarkers of 
carotid atherosclerosis using CTA
 
To investigate the pathophysiology and development of atherosclerosis, accurate and 
robust measures of severity of stenosis, plaque burden and plaque features are neces-
sary. Several technical imaging aspects should be taken into account, since they highly 
influence quantitative luminal and plaque measures. These considerations are explained 
in Chapter 2.1.
DSA has been the gold standard for grading carotid artery stenosis according to the NAS-
CET and ECST criteria. The inherent risk of the invasive nature of angiography has led 
to the introduction of less invasive diagnostic tools. Multi-detector CT Angiography has 
replaced the more invasive technique of DSA for the measurement of carotid stenosis 
in lots of clinical practises. Generally, 3D software is used to create multiplanar reforma-
tions (MPRs) and/or curved planar reformations (CPRs) in oblique planes parallel to the 
carotid lumen to seek the point of maximum stenosis, and the smallest diameter in the 
cross-sectional plane perpendicular to the central lumen line at that level is measured 
and compared to the reference diameter in the healthy distal internal carotid artery. In 
order to facilitate and automate this procedure, extensive efforts have been put in the 
development of (semi)-automated lumen segmentation methods and luminal stenosis 
assessment.48, 49 The state-of-the-art CTA techniques to assess carotid artery stenosis are 
reviewed in detail in Chapter 2.1. 
Assessment and quantification of plaque volume and plaque composition with MDCT an-
giography has been validated in in vitro an in vivo studies, using histology as gold stand-
ard.45, 46, 50 To obtain plaque volume measures, plaque boundaries should be defined to 
segment 3D plaque volume. This has been done manually, which is a very labour-intensive 
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task. Algorithms have been developed that combine (semi-)automatically obtained seg-
mentations of the outer vessel wall and the lumen to create plaque segmentation. Plaque 
components within this segmented plaque are then specified and further segmented 
based on distinctive ranges of Hounsfield Units, distinguishing lipid, fibrous tissue and 
calcifications.46, 50 In Chapter 2.1 an in-depth overview on qualitative and (semi-automat-
ed) quantitative plaque assessment using CTA is provided. 
Chapter 2.2 focusses on the performance of a (semi-)automated algorithm for plaque 
volume and plaque component measurements against manually derived measurements. 
Carotid atherosclerotic plaque ulceration
Atherosclerotic carotid plaque ulceration is primarily diagnosed with conventional angi-
ography and describes the extension of contrast media beyond the vascular lumen into 
the surrounding plaque.51 MDCTA is also effective in the detection of carotid plaque ulcer-
ation, with a sensitivity and specificity of 94% and 99% respectively,52 and is – due to its 3D 
data-acquisition and reconstruction- even superior to 2D DSA in detecting ulcerations.53
Atherosclerotic carotid plaque ulceration is considered to be a marker of previ-
ous plaque rupture,51, 54 probably representing the heavily ruptured plaques, in 
which part of the LRNC is detached with downstream embolization. Further, it 
is an important predictor of ischemic stroke besides degree of stenosis.55, 56 Non- 
lacunar stroke is thought to be most often caused by thromboembolism, whereas lacu-
nar ischemic stroke would be caused by small vessel disease.3 To evaluate the vulnerable 
plaque hypothesis we investigated the association between atherosclerotic plaque ulcer-
ation in the symptomatic artery and non-lacunar stroke, in comparison to lacunar stroke, 
in a large stroke population using MDCTA (Chapter 3.1). 
In addition to its association with plaque rupture and ischemic stroke, carotid plaque 
ulcerations are likely to form an additional focal source of thromboembolism due to flow 
disturbances, causing recurrent ischemic events.57, 58 The natural evolution of plaque rup-
tures and surface irregularities is not known. So far, knowledge on evolution after plaque 
rupture is based on histological analysis of coronary arteries in autopsy studies or carotid 
plaque specimens obtained from CEA. In CEA specimens for example, a strong negative 
association between time since stroke and prevalence of ruptured plaques was found 
which indicates a process of plaque healing.59 These cross-sectional studies provide in-
direct evidence for temporal changes after plaque rupture. Serial imaging is the optimal 
method to study plaque surface morphology changes in vivo. MDCTA is able to identify 
and classify plaque ulcerations with an excellent interobserver agreement.43 Therefore I 
used MDCTA to explore the natural history of ulcerated carotid plaques, by assessing the 
temporal changes in plaque surface morphology on serial scans in patients with TIA or 
stroke (Chapter 3.2).
According to the vulnerable plaque hypothesis, certain plaque characteristics render 
an atherosclerotic plaque prone to plaque rupture. Histological studies found plaque 
ruptures to be associated with large necrotic cores, inflammation and thin, fragile fi-
brous caps.15 In addition, in severely stenosed carotid arteries, plaque ulceration on 
DSA has been associated with the presence of fibrous cap rupture, intraplaque haem-
orrhage, large lipid core and less fibrous tissue in carotid endarterectomy specimens.51 
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Imaging studies can investigate this hypothesis by evaluating both plaque composition 
and plaque ulceration in cross-sectional and serial studies. In an MR study, LRNC propor-
tion of carotid plaques in arteries with a stenosis of 50-79% was found to be the strongest 
predictor of surface disruption.33 Chapter 3.3 presents the study that analysed the relation 
of plaque volume and plaque component proportions with plaque ulceration in a group 
of consecutive patients with AF, TIA or minor ischemic stroke, as assessed with MDCTA.
Serial carotid plaque imaging and determinants 
of atherosclerotic plaque changes
 
Serial quantitative imaging generates the opportunity to study temporal plaque changes 
in vivo, which provides insight into plaque development and its determinants, and could 
enable also the monitoring of treatment effects and prediction of plaque progression. 
The Agatson score, a coronary artery calcification (CAC) measure, is a CT-derived imaging 
biomarker for coronary atherosclerosis burden, used in clinical decision making in cardi-
ology. In accordance with this CAC score, carotid calcification has been used as a surro-
gate marker for carotid atherosclerosis in studies on risk prediction.60, 61 Although some 
cross-sectional studies on asymptomatic subjects have demonstrated a relation between 
cardiovascular risk factors and presence or volume of calcification,62-64 the natural history 
of carotid calcification in symptomatic patients has not been evaluated yet. Therefore, I 
investigated the growth pattern of calcifications in carotid arteries and the determinants 
of change using serial MDCTA imaging in patients with recent TIA or ischemic stroke 
(Chapter 4.1).
The clinical significance of carotid calcification, however, is not as clear as it is in the cor-
onary arteries. Some studies suggest that carotid calcification burden is associated with 
increased stroke risk,61, 65, 66 whereas others found a relatively high calcification content 
of carotid plaques to be associated with plaque stabilization.67-70 The relative proportion 
of calcification within a carotid plaque seems to be important for risk evaluation.71 This 
requires calcification volume measurements to be related to the total plaque volume.
Besides calcifications, other plaque characteristics assessed with plaque imaging have 
been associated with plaque instability and an increased risk of ischemic stroke, LRNC 
being an important feature.33 Quantitative MDCTA plaque imaging enables the inves-
tigation of certain relative plaque components in comparison to total plaque volume. 
Furthermore, it enables the study of temporal changes in atherosclerotic disease and 
their determinants. In order to find out whether MDCTA and (semi-)automatically derived 
plaque segmentation can be used to quantify atherosclerotic plaque measures in vivo 
and track temporal plaque changes I first performed a pilot study in patients with TIA 
or ischemic stroke who underwent serial MDCT angiographies (Chapter 4.2). In this pilot 
study, the carotid bifurcations of baseline and follow-up scans were registered using a 
semi-automated registration method. In this analysis a maximum coverage of the carot-
id plaque was evaluated. To improve the inclusion of baseline-follow-up pairs of carotid 
bifurcations and to enable comparison with results from the literature, the arteries in a 
larger group of patients were registered based on number of axial slices above and under 
the carotid bifurcation, according to methods used in serial MRI studies. In this study I 
investigated the determinants of plaque growth and plaque changes (Chapter 4.3).
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Background
Stroke is the second leading cause of mortality in the Western world after coronary heart 
disease. Although stroke death rate declined 44% in the last decade, the burden of dis-
ease remains high.1 Of all strokes, 87% are ischemic, 10% are intra cerebral hemorrhage 
and 3% are subarachnoid hemorrhage strokes.1 About 50% of the ischemic strokes are due 
to atherosclerotic disease, which is preferentially located in the carotid artery.2
Till now, the degree of luminal narrowing of the carotid arteries, caused by atheroscle-
rosis, has been the only image-based risk factor for (recurrent) stroke that is used in 
therapeutic decision making. Large, randomized clinical trials (the North American Symp-
tomatic Carotid Endarterectomy Trial (NASCET) and the European Carotid Surgery Trial 
(ECST)) have established the imaging criteria for surgical treatment in symptomatic pa-
tients. Carotid endarterectomy (CEA) is indicated for symptomatic patients with high-
grade stenosis (>70%) and in selected patients with recent symptoms and moderate 
stenosis (50-69%).3-5 In asymptomatic carotid artery stenosis, a modest benefit of CEA 
is described in selected patient groups (relatively young male patients) who had a se-
vere stenosis.6-8 However, most patients with a stenosis >70% are asymptomatic and most 
symptomatic patients have a carotid stenosis <70%, which suggest that other factors play 
an important role in the pathophysiological cascade of ischemic stroke. Especially in the 
group of patients with moderate carotid stenosis, it is of clinical importance to improve 
risk prediction.
The last decades, extensive research has been performed to increase our knowledge of 
the pathophysiology of atherosclerosis. Apart from luminal narrowing of the carotid ar-
tery resulting in blood flow compromise, rupture of the atherosclerotic plaque and sub-
sequent thrombo-embolism is thought to result in ischemic events. Post-mortem histo-
logical studies of coronary and carotid arteries have found that certain atherosclerotic 
plaque characteristics increase the vulnerability of the plaque to rupture. Inflammation is 
the hallmark of vulnerability and plaques with active inflammation may be identified by 
extensive macrophage infiltration. Plaques with a thin cap of <100 mm and a lipid core ac-
counting for >40% of total plaque volume are also considered highly vulnerable. Plaques 
with a fissured or ruptured cap are prone to thrombosis and thrombo-embolization.9 Ca-
rotid plaque ulcerations on digital subtraction angiography (DSA) have been associated 
with plaque rupture 10 and with an increased risk of acute recurrent ischemic events.11, 
12 Advanced invasive and non-invasive imaging technologies enable the visualization of 
these atherosclerotic plaque characteristics in vivo.
DSA has long been the modality of choice for imaging carotid arteries, since it accurately 
visualizes the vascular lumen and its contours. However, DSA has several disadvantages; 
it is invasive, laborious, time intensive, and expensive. Moreover, DSA requires skilled 
operators and is therefore less readily available. More importantly, cerebrovascular DSA 
has a non-negligible morbidity and mortality, with a complication rate of 0.4-12.2% for 
neurological deficits.13, 14 These drawbacks and the increasing interest in the arterial vessel 
wall have driven the use of other, less invasive modalities for imaging the carotid arteries.
Nowadays, non-invasive imaging techniques like duplex ultrasound (DUS), magnetic res-
onance imaging (MRI) and computed tomography (CT) not only enable grading of carotid 
stenosis but also provide a window to the atherosclerotic process in vivo.15 They also 
allow for the quantification of plaque measures like plaque burden and plaque composi-
tion.
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Using serial imaging, the early natural development of the atherosclerotic plaque can 
now be studied in vivo. Furthermore, it provides a tool to monitor changes in atheroscle-
rotic plaque in response to secondary preventive therapies. The development of new 
pharmaceutical therapies is a slow and costly process, since the most reliable way to 
measure their clinical impact is to study its effect on clinical endpoints. The use of imaging 
biomarkers of atherosclerotic disease could speed up this process and reduce the num-
ber of subjects studied. For an effective use, imaging biomarkers should be derived in a 
robust, non-invasive way and the imaging modality should be broadly available.16 Further, 
standardized image acquisition parameters and post-processing methods are required 
and the imaging biomarkers should be carefully validated and highly reproducible. The 
changes in an imaging biomarker should be correlated to the biological effect and the 
clinical endpoints.16 Quantification, and especially automated quantification, of the de-
gree of stenosis and atherosclerotic plaque measures is therefore important in the devel-
opment of reliable surrogate endpoints for atherosclerosis.
Computed tomography angiography (CTA) is a potential imaging modality for monitoring 
atherosclerosis in vivo. It is a readily available and fast imaging technique causing minimal 
inconvenience for the patient. Although CTA involves potentially harmful ionizing radia-
tion, the effective dose during a diagnostic CTA is relatively low (1-5 mSv).17 The increased 
acquisition speed of multi-detector CT angiography (MDCTA) reduces motion artifacts. 
Current multi-detector row CTA enables fast vascular imaging from the aortic arch to the 
intracranial vessels. This enables simultaneous investigation of other vascular territories, 
which makes that MDCTA can compete with other non-invasive imaging techniques and 
is increasingly used in the clinical evaluation of stroke patients. In this chapter, the state-
of-the-art CTA technique used to evaluate carotid artery stenosis and atherosclerotic 
plaque is described.
Luminal imaging using CTA
Technical aspects
In the early 1990s spiral CT was introduced, which enabled a volumetric data acquisition 
through continuous X-ray source rotation and simultaneous continuous table movement. 
Using this technique non-invasive imaging of blood vessels became widely available. The 
steady increase of the longitudinal coverage of the X-ray detectors, i.e. the number of 
slices, even further improved the feasibility of luminography.
Contrast material is necessary for the visualization of the lumen. Stenosis measurement 
relies upon the contrast difference between the lumen and its environment. Several tech-
nical factors should be taken into account when imaging vessel lumen using MDCTA.
The contrast difference between lumen and surrounding tissue is varying and depends 
mainly on the amount of lumen attenuation which is artificially increased by contrast 
material. The attenuation caused by contrast material can vary depending on patient-re-
lated factors like cardiac output and weight, and on scan parameters and contrast pro-
tocol-specific factors. Peak tube voltage (kVp) influences the difference in HU values be-
tween different tissues. The lumen contrast density increases as tube voltage decreases. 
The lumen enhancement pattern is determined by the injection volume, the injection 
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rate, and the iodine concentration in the contrast material.18 Timing of contrast bolus 
arrival should be such that a maximum contrast density is achieved in the carotid artery 
with a concomitant low contrast density in the neighboring jugular vein. Use of a saline 
bolus chaser reduces the amount of contrast material needed by 20-40% and reduces the 
extent of perivenous artifacts due to high contrast density in the jugular vein.18 Synchro-
nization between passage of the contrast bolus and data acquisition can be achieved by 
real time bolus tracking at the 
level of the ascending aorta. 
Moreover, a craniocaudal scan 
direction also reduces contrast 
material-related perivenous ar-
tifacts.19 The contrast injection 
protocol for carotid artery im-
aging is generally standardized 
with a fixed contrast volume of 
80-125 mL (iodine concentration 
of >300 mg/mL), and a saline bo-
lus chaser of 40 mL, both at an 
injection rate of 2-4 mL/sec. The 
disadvantage of intravenous 
contrast in CT angiography re-
mains that its application is lim-
ited in patients with renal insuffi-
ciency and hyperthyroidism.
Because of the limited spatial 
resolution of the CT scanner par-
tial volume averaging occurs, 
leading to the so-called bloom-
ing artifact. This is easily appre-
ciated at the boundary of the 
enhanced lumen and the vessel 
wall where differences in densi-
ty are large. In subtle cases this 
is reflected in a blurred interface 
between structures as well. Par-
tial volume averaging may influ-
ence the appreciation of the real 
luminal dimensions and there-
fore the accuracy of the steno-
sis measurements. The extent 
of blooming also depends on 
the convolution kernel chosen 
in the filtered-back projection 
algorithm. Sharp convolution kernels increase the contrast of small dense structures as 
the blurring is reduced, whereas smooth kernels lead to averaging of contrast differenc-
es. The signal-to-noise-ratio on the other hand improves when applying a smooth kernel 
because the image noise is reduced.
Figure 1. Influence of window-level setting and convolution ker-
nels on the evaluation of lumen and plaque
Four axial MDCT images through the carotid bifurcation ob-
tained with a smooth (a+c) or a sharp (b+d) kernel and with a 
larger (W1000 L200; a+b) or smaller (W400 L100; c+d) window 
width setting. A large window width (a+b) gives a better differ-
entiation between lumen and neighboring calcifications, which 
mostly appear brighter. A smaller window width (c+d) enables 
visualization of the small density differences inside the non-calci-
fied part of the plaque. A sharper reconstruction kernel (b+d) in-
creases the contrast between the small dense calcifications and 
the surrounding structures, whereas a smoother kernel (a+c) 
leads to averaging of contrast differences, which gives a smooth-
er appearance to the structures.
29
chapter 2.1
The appearance of the lumen- 
wall interface is influenced by 
adjustment of the window-level 
setting. Each lumen contrast 
opacification has been shown 
to theoretically have its own 
optimal window-level setting 
for which lumen measurements 
are most accurate.20 When calci-
fications border the lumen, the 
two hyperdense structures may 
be difficult to differentiate from 
each other, impeding accurate 
lumen measurement. Normal-
ly, in CTA a large window width 
(500-1000 HU) is used, which 
can be adjusted by the reader 
dependent on the lumen atten-
uation and the presence of calci-
fications near the lumen in order 
to improve the visual differenti-
ation between dense structures. 
Figure 1 illustrates the influence 
of window-level setting and con-
volution kernels on the evalua-
tion of the lumen.
In MDCTA images a challenge is 
formed by the artifacts from ex-
tra luminal dense structures like 
dental material, bone, and ath-
erosclerotic calcifications which 
might obscure a clear visualiza-
tion of the lumen. Correct head 
positioning with a slight tilt of 
the head and an upright position 
of the chin reduces the effect of 
beam hardening artifacts from 
dental material at the level of 
the carotid bifurcation, the pre-
dilection place for atheroscle-
rotic disease in the carotid artery 
(Figure 2). As described, convo-
lution kernels and window-level 
settings highly influence the appearance of high density calcifications. In addition, with a 
fixed window-level setting, calcification volumes appear smaller in higher kVp-settings.21
From the cross-sectional source images, 2D or 3D image reconstructions can be created 
which aid in the identification and measurement of the maximal stenosis. Multiplanar re-
constructions (MPR) and curved planar reconstructions (CPR) provide 2D images of any 
predefined plane and enable accurate stenosis measurement. For creating a longitudinal 
Figure 2. Influence of artifacts on MDCTA imaging
a) Axial image at a level above the carotid bifurcation showing 
motion artifacts due to swallowing. The tissue boundaries are 
heavily blurred. b) The dependent part of the jugular vein is 
filled with high density contrast material, which causes streaks 
of low attenuation, artificially introducing a low contrast area in 
the neighboring carotid artery and hampering visualization of 
its wall. c) Dental material can cause enormous streak artifacts 
(images on the left), impeding correct judgment of surrounding 
structures. A slight upward tilt of the chin moves these artifacts 
away from the region of interest and allows a normal visualiza-
tion of the larger part of the carotid bifurcation (as shown on 
the right).
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view of the artery, CPR has the advantage over MPR that it corrects for vessel curvature 
outside of the plane. Shaded surface display (SSD), volume rendering (VR) and maximum 
intensity projection (MIP) are all 3D techniques with their own strengths and weakness-
es. In SSD all pixels with densities below a certain threshold are excluded and the remain-
ing data are viewed as if their surfaces are illuminated by a point source. VR utilizes the 
image intensities directly, by assigning opacity and color coding, to create 3D reconstruc-
tions. Both techniques are less useful for carotid artery stenosis measurements. MIPs are 
created by projection of the maximum intensity pixels from a 3D data set on a predefined 
2D plane and give a simple overview of the vessel and its stenosis. However, this tech-
nique is limited in arteries with atherosclerotic calcifications, since calcifications in the 
vessel wall can easily cover the contrasted lumen causing overestimation of the degree 
of luminal stenosis. In addition, bony structure like the spine, thyroid cartilage, cricoid 
and hyoid might interfere with a clear overview of the artery in 3D post-processing tech-
niques (Figure 3).
New techniques have been investigated that might solve the problem of artifacts from 
bone and calcifications on images. Matched mask bone elimination (MMBE) is a tech-
nique for the automated removal of bone pixels from CTA data sets. Preceding to the CT 
angiography a nonenhanced data set is acquired on which the bone pixels are identified. 
The corresponding pixels on the registered CT angiography are assigned an arbitrarily low 
value and MIP images free from overprojecting bone can then be obtained.22, 23 Whereas 
for MMBE, acquisition and registration of two separate datasets is necessary, in dual-en-
ergy CT (DECT) two image data sets can be simultaneously acquired with different tube 
voltages (for example 80 and 140 kVp). Tissues can be differentiated by analysis of their 
attenuation differences depending on the tube voltage. The attenuation difference is es-
Figure 3. Different post processing techniques in MDCTA images of a moderately stenosed carotid artery
a) Axial slices through the common carotid artery (lower image), the level of the carotid bifurcation (middle) 
and a level above the bifurcation (upper image). b) Multiplanar reformat (MPR) in the sagittal plane visualizing 
the atherosclerotic plaque around the bifurcation. c) Maximum intensity projection (MIP, 8.8 mm) in the same 
plane. Over projection of calcifications hampers a clear visualization of the lumen. d) Volume rendering (VR) 
shows a 3D reconstruction of the carotid artery. e) Shaded surface display (SSD) of the same carotid bifurca-
tion. Both last techniques suffer from over projection of calcifications.
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pecially large in materials with a high atomic number, such as iodine. Bone and calcifica-
tions, which show a smaller attenuation difference, can therefore be differentiated from 
iodine in the carotid lumen. As a result, calcifications can be removed from the contrast 
filled lumen, enabling quantification of carotid stenosis in heavily calcified arteries.24 How-
ever, because in both techniques an additional rim around the calcified pixels is removed 
due to blooming artifacts, overestimation of the grade of stenosis can still be introduced.
Stenosis Measurement
The accuracy of the stenosis measurement is important, seen its role in clinical decision 
making about carotid endarterectomy. Traditionally, the stenosis in the carotid artery 
was assessed using intra-arterial digital subtraction angiography (DSA), which is still con-
sidered the gold standard. The degree of stenosis was defined as the residual lumen at 
the stenosis as a percentage of the normal lumen in the distal internal carotid artery (ac-
cording to the NASCET criteria) or as the residual lumen as a percentage of the estimated 
original diameter of the artery at the level of the stenosis (according to the ECST criteria). 
In the large symptomatic carotid surgery trials, conventional DSA was performed in two 
or three projections (lateral, postero-anterior, and/or oblique) which were investigated 
for the most severe stenosis. Whereas rotational DSA, using multiple planes, showed to 
provide a benefit in detecting the smallest diameter in a stenosed artery compared to 
conventional DSA,25 the association between the severity of stenosis and stroke risk and 
therefore the indication for surgical intervention remained based on conventional DSA.
The volumetric CTA datasets allow for MPRs and MIPs in any plane and therewith provide 
much more information on the lumen and its morphology than conventional DSA. The 
residual lumen is almost never circular and DSA performed in a limited number of projec-
Figure 4. Assessment of carotid stenosis with DSA and MDCT angiography
a) Digital subtraction angiography (DSA) of a right carotid artery shows a 50% stenosis at the level of the bi-
furcation. b) A maximum intensity projection (MIP, 6 mm) of MDCTA images of the same artery. MIP has the 
disadvantage of overprojection of calcifications over the lumen, causing overestimation of stenosis measure-
ment. c) A multiplanar reformatted image (MPR, 1 mm) in the same plane as the MIP in (b); the problem of 
overprojection does not occur here. Using MPR reconstruction of 3D data the point of maximum stenosis can 
be found easier compared to using DSA.
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tions does not always reveal the narrowest lumen. Analysis of 3D information therefore 
may provide a more realistic way to assess the true maximum stenosis. 
In case CTA replaces DSA in clinical decision making, stenosis measurements on CTA 
should be performed in a comparable way i.e. measuring the diameter of the remaining 
lumen at the level of the maximal stenosis and of the normal lumen distal to the stenosis. 
This can be done in several ways using different post-processing techniques. Although 
with MIP reconstructions images comparable to those in DSA can be obtained, this tech-
nique is limited in calcified plaques and it is recommended not to use MIP images for ste-
nosis measurements in arteries with calcifications (Figure 4). Generally, one uses 3D soft-
ware to create MPRs and/or CPRs in oblique planes parallel to the carotid lumen to seek 
the point of maximum stenosis and measures the smallest diameter in the cross-sectional 
plane perpendicular to the central lumen line at that level. Figure 5 shows this method 
of stenosis measurement using 3D software. The reference diameter is measured in the 
same way at a level above the carotid bulb where the lumen walls run parallel to each 
other (i.e. the healthy distal carotid artery).
When using the ECST criteria to assess the degree of 
stenosis, CTA directly enables visualization of the outer 
vessel wall, whereas on DSA the vessel diameter has to 
be estimated by delineating the projected lumen con-
tour. Therewith, CTA takes into account the changes in 
vessel diameter caused by vascular remodeling, whereas 
this phenomenon is ignored when measured on DSA. This 
might cause differences in ECST stenosis measurements 
between CTA and DSA.
Diagnostic accuracy
Several diagnostic studies have been performed which 
compared single slice CTA with DSA in the assessment of 
carotid stenosis. From a meta-analysis of studies published 
between 1990 and 2003, single slice CTA has been shown 
to have a pooled sensitivity of 85% and a pooled specificity 
of 93% for detection of a 70-99% stenosis. Sensitivity and 
specificity for detection of an occlusion were 97% and 99%, 
respectively.26 Another systemic review reported a pooled 
sensitivity of 95% and a specificity of 98% for the detection 
Figure 5. Stenosis measurement in MDCT angiography using 3D software
Multiplanar reformatted images are created in planes parallel and perpen-
dicular to the lumen axis; the smallest lumen diameter in the cross-sec-
tional plane can then be measured using calipers. A) A sagittal view of 
the carotid bifurcation. The blue and red lines correspond to the planes 
that are depicted in B and C, respectively. A large atherosclerotic plaque 
is visible at the origin of the internal carotid artery, causing a high-grade 
stenosis. B) The cross-sectional image perpendicular to the central lumen 
line at the level of the smallest vessel diameter. The residual lumen has 
an oval shape. C) The view perpendicular to those in A and B. In this plane 
the stenosis is not very prominent. 
33
chapter 2.1
of a 70-99% stenosis.27 The latter study also found that CTA was sensitive (95%), but slightly 
less specific (92%) in depicting stenosis >30%. In 2006, Wardlaw and colleagues performed a 
meta-analysis comparing non-invasive imaging techniques with intra-arterial angiography. 
They found only 11 studies on CTA, published between 1980 and 2004, that explicitly met 
the Standards for Reporting of Diagnostic Accuracy (STARD) criteria 28 and they reported a 
sensitivity of 77% and a specificity of 95% for diagnosing 70-99% stenosis using CTA.29 The au-
thors warned for the methodological shortcomings of many studies evaluating diagnostic 
imaging. They concluded that the existing data might support the cautious use of non-inva-
sive imaging to diagnose 70-99% stenosis, but that more data are needed from carefully de-
signed trials to determine true sensitivity and specificity of non-invasive imaging techniques 
in routine clinical practice, especially for 50-69% stenosis, or when used in combination.29 In 
2009, Chappell and colleagues performed an individual patient data meta-analysis to find 
clinically significant estimates of the accuracy of non-invasive imaging in diagnosing severe 
and moderate symptomatic artery stenosis.30 They also concluded that existing primary 
studies provide limited data and that the literature overestimates the accuracy of noninva-
sive imaging techniques. The small CTA dataset included in this analysis revealed a sensitivity 
and specificity of 65% and 56% for detection of 70-99% stenosis, respectively.30
A difficulty in the evaluation of the accuracy of stenosis measurement using non-inva-
sive imaging techniques is that both acquisition and post-processing procedures evolve 
rapidly. Although multidetector CTA is now widespread and is expected to improve di-
agnostic accuracy, this has barely been tested. Only one study compared MDCTA with 
DSA and found MDCTA to have a high specificity and a high negative predictive value for 
significant carotid disease.31 Since DSA is not routinely used anymore in clinical practice, 
the assessment of new non-invasive imaging techniques against DSA cannot be justified 
ethically anymore. Therefore there is an increasing need for practical, reliable methods 
for evaluating new technologies, for example by standardized comparison with other 
non-invasive tests or test phantoms.
Both aforementioned systemic reviews26, 27 did not provide enough evidence to draw 
robust conclusions about the diagnostic accuracy of the different post-processing tech-
niques, although stenosis assessment using axial slices and MIPs seemed to be better 
than when using VR and SSD.27 Most studies did not report on the exact –combinations 
of- reformatting techniques used, which hampers a solid meta-analysis. More recent 
studies comparing the post-processing techniques in MDCTA revealed that stenosis mea-
surements on axial source images are highly reproducible and accurate and that the addi-
tional use of MPRs or other reconstructions is not necessary, but might aid in finding the 
location of the maximum stenosis.32-34
(Semi)-automated quantification of luminal measures
Manual lumen segmentation and stenosis quantification is laborious and suffers from in-
ter and intra observer variability. Consequently much work has been performed on the 
development of (semi)-automated lumen quantification. The majority of publications 
with respect to lumen quantification focus on the segmentation of the lumen while the 
assessment of the severity of luminal stenosis is addressed by few.
Lumen segmentation methods have been reviewed and grouped according to the math-
ematical framework used 35 or categorized with respect to (1) the way vessel geometry 
and appearance are modeled, (2) the image features which are used for vessel extraction 
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and (3) the methodology used in 
vessel extraction.36
Some of the published methods 
have been tailored to or evalu-
ated on carotid CTA images.37-40 
Reported values vary highly. 
However the comparison of 
these methods is hampered by 
the fact that they all use differ-
ent imaging data and evaluation 
measures, like Dice similarity 
coefficient, mean surface dis-
tances, or visual inspection. In 
addition, most studies were per-
formed on small and selected 
data sets. Figure 6 illustrates a 
3D lumen segmentation of a ca-
rotid bifurcation.
To facilitate an objective com-
parison of carotid artery seg-
mentation and stenosis quanti-
fication algorithms, the Carotid 
Bifurcation Algorithm Evaluation 
Framework was set up in 2009 
(http://cls2009.bigr.nl/).41 This 
framework consists of a publically available image database, annotated data for training 
and evaluation and standardized evaluation measures. Till date 9 algorithms have been 
evaluated by the framework, of which only one is fully automatic, whereas the others 
require three initialization points. The three best performing methods evaluated by the 
framework have dice similarity coefficients of 0.92, 0.88 and 0.90, mean surface distanc-
es of 0.18, 0.54 and 0.17 mm and Hausdorff distances of 1.5, 4.4 and 1.7 mm, respectively.41 
Figure 7 shows three examples of lumen segmentations with three different dice values.
These three best performing methods are based on three different approaches, i.e. graph 
cut, level set and active surface algorithms.41
In the graph cut framework voxels are assigned to vessel lumen or background by consid-
ering all image voxels as nodes in a 3-dimensional graph, and creating an optimal surface 
which separates (cuts) the foreground (lumen) from the background. To compute this 
optimal cut the image gradient can be used.
In the level set framework, the vessel surface is represented implicitly by the zero level 
lines (zero level set) of an embedding function (similar as e.g. sea level in a height map). 
This embedding function is then changed (evolved), implicitly resulting in deformation zero 
level set. This representation has the advantage that the zero level set can change topology 
(Figure 8). The evolution of the embedding function should ensure that the zero level set 
halts at the vessel lumen boundary. This is achieved by defining a speed function derived 
from the image data. Both the initial segmentation and the design of the speed image are 
the key ingredients in the design of a level set-based segmentation method.
Figure 6. 3D-segmentation of the lumen of a carotid artery
An example is shown of a carotid artery lumen segmentation 
using three different segmentation representations. The red 
dots indicate a centerline through the centroids of the vessel 
cross-sections. The yellow ‘circles’ show the lumen contours per-
pendicular to the centerline. The blue surface shows an interpo-
lated surface through the yellow contours.
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Active surfaces are a general-
ization of active contours (also 
called snakes). Using active sur-
faces the segmentation is also 
the result of the evolution of 
an initially segmented surface. 
However changing topology is 
much harder to model in this 
framework. The segmentation is 
modeled as a surface on which 
forces are acting which causes 
the evolution of the segmenta-
tion. This evolution can be con-
strained by properties of the 
used surface representation.
Although considerable research 
has been performed on vessel 
lumen segmentation, only few 
researchers have published on 
automatic vessel stenosis.42-44 
Also, approaches differ widely 
in the evaluation that has been 
performed, both with respect to 
evaluation measures and num-
ber of data sets used.
The evaluation framework dis-
cussed previously also allows 
objective comparison of perfor-
mance in stenosis quantifica-
tion. To date only three steno-
sis grading methods have been 
evaluated using this framework, 
also indicating that this field has 
received less attention.41 Clin-
ically, the minimal diameter is 
often used to calculate the ste-
nosis degree. However, the min-
imal diameter of a non-elliptical 
shape is not uniquely defined 
and is therefore prone to mea-
surement errors and is hard to 
measure automatically. The eval-
uation framework evaluates two 
stenosis measures: an area based measure which compares the area of the lumen at the 
stenosis to the area of a distal vessel part and a measure that compares the minimal 
diameter at the two positions. In the framework, the diameter-based stenosis degree is 
defined by the smallest line that divides the cross-sectional area in two equal parts. Us-
ing automated lumen segmentation the minimal diameter can easily be replaced by the 
lumen cross-sectional area. This is a much more accurate measure for the obstruction of 
Figure 7. (Semi-) automated lumen segmentations of a carotid 
artery of different qualities
Shown are curved multiplanar reformats (CMPR) of a carotid 
artery with a calcified atherosclerotic plaque that causes a high-
grade stenosis. A visual impression is shown of the reference 
standard (yellow line) based on manual annotations by three 
observers and automated lumen segmentations (in red) that 
have different qualities: a) with a bad Dice similarity index (SI) 
of 0.881, b) a moderate Dice SI of 0.884 and c) a good Dice SI 
of 0.945. The Dice similarity indices are calculated on the whole 
volume of which the shown CMPR is just a single plane.
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the blood flow as carotid arteries, especially at the site of atherosclerotic plaque, gener-
ally do not have circular luminal cross-sections and also do not run exactly perpendicular 
to the axial plane of the CT scan. Zhang et al. investigated the use of area measurements 
and found that assessment of area stenosis was highly reproducible and correlated bet-
ter with diameter stenosis on DSA than did diameter stenosis as assessed on CTA.45 The 
average error in assessing carotid artery stenosis of the best stenosis grading method ac-
cording to the evaluation framework is 16.9% for area-based and 17.0% for diameter-based 
measurements.41
Besides stenosis grading, lumen segmentation also enables the extraction of other quan-
titative measures. The extracted lumen model can e.g. be used for Computation Fluid Dy-
namic calculations to assess the shear stress in the atherosclerotic carotid bifurcation46 
and the quantification of geometric parameters such as vessel tortuosity and bifurcation 
angles.47
Plaque imaging using CTA
Technical aspects
Assessment of different atherosclerotic plaque components in CTA relies on the differ-
ences in linear attenuation coefficient expressed in Hounsfield Units (HU) of the plaque 
components. Plaque component differentiation is highly dependent on scan parameters.
Reconstruction of thin slices is very important for plaque evaluation. Thin slices allow for 
datasets with isotropic and higher resolution and therefore enhance the differentiation 
of plaque components. Especially for plaque components of which HU values are close, 
like lipid and fibrous tissue, thin slices are crucial.
Where blooming artifacts from vessel wall calcifications can hamper correct stenosis 
measurements, it also causes a problem in the evaluation of plaque, since it interferes 
with optimal plaque characterization of the non-calcified part of the plaque. The finite 
spatial resolution of CT causes partial volume averaging and therefore blooming arti-
facts. Blooming of calcifications leads to overestimation of calcifications and inability to 
Figure 8. Level set method for lumen segmen-
tation
Using the level set framework a segmentation 
(indicated by the yellow contours) is seen as 
the zero level (grey plane) of an embedding 
function in a higher dimension (blue surface). If 
the embedding function changes as is indicat-
ed by the two blue surfaces which are slightly 
different, the zero level (segmentation) chang-
es. Using this framework a segmentation can 
easily change topology. The segmentation on 
the left has one object (contour) while the seg-
mentation on the right consists of two distinct 
objects.
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evaluate the atherosclerotic regions that border the calcifications. Moreover, the calcifi-
cation volume appears larger when using lower kVp settings.21
For accurate differentiation of plaque components a high signal-to-noise ratio (SNR) is 
necessary. Image noise depends mainly on the product of the tube current and rotation 
time (mAs), the tube voltage and reconstruction kernel. Because the atherosclerotic 
plaque is a relative small structure, a thin slice thickness and a small field-of-view are 
required. These result in a decrease of SNR, which should be compensated by a higher 
radiation exposure.
High intraluminal contrast material density may influence the density measurements in 
the plaque. Ex vivo studies in coronary arteries revealed that intraluminal attenuation 
strongly affects the measured attenuation of the plaque.48 This can be explained by par-
tial volume effects, but also by the entrance of contrast material in the plaque via the 
vaso vasorum. It is unknown yet if this effect is also seen in the larger carotid artery, but it 
underlines the necessity of standardized scan protocols, especially since plaque enhance-
ment in CTA is thought to be associated with increased risk for neurological events.49, 50
Figure 9. Assessment of plaque surface morphology using MDCT angiography
Cross-sectional images (upper panels) perpendicular to the central lumen line and multiplanar reformats (lower 
panels) of carotid bifurcations. a) An atherosclerotic carotid plaque with a smooth surface. b) A plaque at the 
level of the carotid bifurcation with an ulceration (arrowhead). c) An ulcerated plaque with thrombus material 
(arrow head) that protrudes into the lumen. 
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Another technical aspect influencing accurate differentiation of plaque components in 
CTA is the convolution kernel used for reconstruction of the image dataset. The convo-
lution kernels allow for influencing the image characteristics; a smooth algorithm will 
reduce spatial resolution, image noise and image contrast for tiny structures, whereas 
a sharp algorithm has the opposite effect. Plaque characterization and quantification of 
the different plaque components based on measurement of HU densities is thus highly 
influenced by the convolution kernel used. Smooth kernels hamper the correct differenti-
ation between tissues with small differences in density, as is the case for lipid and fibrous 
tissue. In contrast, sharp kernels increase contrast differentiation, but also lead to an 
increase in calcium size and low-intensity rings around calcifications (edge-enhancement 
artifacts), which hamper further plaque interpretation. Intermediate reconstruction ker-
nels turned out to allow optimal plaque interpretation.21
The window-level setting also influences the visualization of the different plaque com-
ponents. Whereas a large window-width is used in luminography to differentiate lumen 
from calcifications that border the lumen, a small window-width is necessary to enhance 
the small differences in HU density inside the non-calcified plaque (Figure 1).
Diagnostic accuracy
Plaque surface morphology
The accuracy of DSA in the detection of plaque ulceration, as compared to macroscopic 
surgical observations, has been found to be low (sensitivity 46% and sensitivity 74%).51 
CTA allows for analysis of the plaque surface (Figure 9) and the differentiation between 
ulcerations and irregularities and has been demonstrated to perform better than DSA.52 
A validation study, comparing single slice CTA with histological specimens reported a sen-
sitivity and specificity of 60% and 74%, respectively.53 However, MDCTA has been found to 
have a high sensitivity and specificity (94% and 99%, respectively) in detecting plaque ul-
cerations compared to surgical observation.54 Assessment of plaque ulceration on MDC-
TA is highly reproducible (k > 0.86).55, 56
Plaque composition
The first validation studies compared 3 mm single slice CT images with histological sec-
tions from carotid endarterectomy specimens and did not show clear-cut results. Where-
as two studies reported that calcifications, lipid and fibrous tissue could be differentiated 
based on density measurements57, 58, another study concluded that single slice CT was not 
sufficiently robust to reliably characterize plaque composition and plaque morphology.53 
The introduction of multidetector CT enabled a more detailed analysis of the atheroscle-
rotic carotid plaque composition and the differentiation of plaque components.
Several validation studies have been performed, in carotid arteries as well as in coronary 
arteries. In coronary studies, intravascular ultrasound (IVUS) is used as a gold standard. 
In carotid studies, the availability of histological carotid plaque specimens from carotid 
endarterectomy enables reliable validation against histology. An additional advantage is 
that the characterization of the separate plaque components can be performed easier 
and in more detail in the larger carotid arteries. In 2005, we performed an ex vivo valida-
tion study, in which CEA specimens were scanned and the images were compared with 
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the histological slices (Figure 10). The CT value of lipid-rich regions differed significantly 
from that of fibrous-rich regions (45±21 HU versus 79±20 HU, p<0.001). An ROC-analysis 
revealed 60 HU as the optimal cut-off point for differentiation between lipid and fibrous 
tissue, with a sensitivity of 89% and a specificity of 93%.21 The study was repeated in vivo, 
in which the CT values for lipid and fibrous-rich tissue were 25 ± 19 HU and 88 ± 18 HU, 
respectively. Again an optimal threshold value of 60 HU was found, with a sensitivity and 
specificity of both 100%.59 Calcifications are easily detected on CT images as high density 
Figure 10. Hounsfield attenuation based differentiation of plaque components – validation against histological 
sections
Column A: axial MDCT images of a carotid artery with atherosclerotic plaque. Column B: MDCT plaque compo-
sition based on HU differences. Column C+D: Corresponding histological sections with Sirius Red (SR) and hae-
matoxylin eosin (HE) staining, respectively. Blue regions in the MDCT plaque composition images correspond 
well with lumen and calcifications on HE stained histological sections (arrows). The red regions correspond well 
with the red collagen-rich regions in the SR stained sections. Yellow regions correspond with the lipid core (i.e. 
lipid, hemorrhage and necrotic debris) (arrowhead) regions on histology (the non-red regions on the SR stained 
sections that are not calcified areas on the HE stained sections). (Reprinted with permission from de Weert TT, 
Ouhlous M, Meijering E, et al (2006) In vivo characterization and quantification of atherosclerotic carotid plaque 
components with multidetector computed tomography and histopathological correlation. Arterioscler Thromb 
Vasc Biol 26 (10):2366-2372)
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structures and equivalent to coronary calcium scoring in electron beam CT, 130 HU is gen-
erally taken as a threshold for differentiating calcifications.
Wintermark and colleagues performed a validation study in which they compared in vivo 
MDCTA images with histological sections for the non-calcified plaque components and 
with ex vivo MDCTA images for the calcifications.56 They found the following scan-pa-
rameter dependent cut-off values, determined as the half way HU attenuation value be-
tween the average HU values of each plaque component: 39.5 HU between lipid-rich and 
connective tissue, 72.0 HU between connective tissue and hemorrhage and 177.1 HU be-
tween hemorrhage and calcifications. They further compared the CT classification with 
the histological classification of type of atherosclerotic plaque and stage of lesion devel-
opment according to the system derived from the AHA classification and found an overall 
agreement of 72.6% (unweighted κ of 67.6%).56 The concordance for calcifications was 
perfect, whereas the reliability of the identification of the non-calcified plaque compo-
nents was limited due to overlap of the values between the soft components. However, 
CTA showed good correlation with histology for larger lipid cores and larger hemorrhag-
es. Further they demonstrated that CTA performed well in measuring fibrous cap thick-
ness (R2 = 0.77, p<0.001).56
Quantification of plaque components
Calcifications in the vessel wall can easily be measured in a quantitative way. Agatston and 
colleagues were the first to quantify coronary calcifications with electron beam CT.60 As 
a default, the threshold to differentiate calcification is ³130 HU in non-contrast CT scans. 
Although the Agatston score as a quantification tool can be used in carotid arteries, oth-
er scoring methods like a volume score are more frequently used.61 However, when CTA 
images are used, the threshold has to be higher in order to automatically differentiate 
calcifications from the bordering luminal contrast. Another possibility is to first delineate 
the inner and outer borders of the carotid plaque and subsequently discriminate calcifica-
tions using a HU threshold of 130 HU within the plaque. In this way, 3D volumetric MDCTA 
datasets also allow for quantification of the soft plaque components.
Annotation of the luminal area can be done (semi-)automatically based on thresholds 
that separate the bright, contrast filled lumen from the lower density plaque. Howev-
er, calcifications bordering the lumen might be included in the lumen segmentation and 
therefore manual correction is necessary. Using lumen and outer vessel wall contours, 
the plaque area can be calculated by subtracting lumen area from vessel area.
Validation studies of plaque area measurements with histology as gold standard are ham-
pered by the fact that histologic preparation leads to shrinkage of the specimens. Nev-
ertheless, strong correlations have been found between ex vivo and in vivo MDCTA and 
histology for the assessment of plaque area (r2 = 0.81 and 0.73, respectively).21 Interob-
server reproducibility of plaque area measurements with MDCTA was good (coefficient 
of variation of 10%).59
The CT value thresholds in HU that differentiate between plaque components create 
the opportunity to quantify plaque composition. The aforementioned in vivo validation 
study, comparing MDCTA images with histological specimens, showed that area mea-
surements of calcifications were overestimated by MDCTA, however the correlation with 
histology was good (R2= 0.74). The correlation between MDCTA and histology for fibrous 
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area measurements was also good (R2 = 0.76), but was poor for lipid (R2 = 0.24). Further 
investigation however showed that this correlation improved in mildly calcified plaques 
and non-calcified plaques (R2 = 0.77 and 0.81, respectively). The intraobserver variability 
of area measurements of the different plaque components was low, with a coefficient of 
variation of 8%, 11% and 15% for calcifications, fibrous tissue and lipid respectively.59
Plaque volume and plaque component volumes can be calculated by multiplying area 
measurements with slice increment and the number of slices in the range of interest. In 
an in vivo study in 56 patients, plaque volume and plaque component volumes could be 
assessed in a reproducible way. The difficulty of defining the transition of normal wall 
into atherosclerotic plaque contributes highly to the interobserver variability. Consensus 
about the longitudinal dimension of the plaque improved the reproducibility of plaque 
volumes strongly.62
Figure 11. (Semi-) automated segmentation of lumen and plaque components
(Semi-) automated segmentation of lumen and plaque is performed on axial images within a predefined range. 
Contours of lumen and plaque are generated and can be manually adjusted if necessary. Within the plaque area 
(outer vessel wall contour minus lumen contour) the plaque components are differentiated based on Hounsfield 
Unit thresholds (lipids: <60 HU, fibrous 60-130 HU, calcification >130 HU). The color overlay shows the different 
structures; lumen = red, lipid = yellow, fibrous = green, calcification = white. This figure shows a CPR image of 
a carotid bifurcation on the left and plaque segmentation on axial slices at three levels: a) through the internal 
and external carotid artery, showing a large, mainly non-calcified atherosclerotic plaque in the internal carotid 
artery; b) through the distal common carotid artery just below the bifurcation on which an ulcerated surface is 
visible and c) through the common carotid artery at the level of the smallest vessel diameter. 
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(Semi)automated plaque measurements
Manually assessing lumen and vessel contours is a time-consuming task and is highly in-
fluenced by the window-level setting. Segmentation of the outer vessel wall and subse-
quent automated plaque characterization has received considerably less attention than 
luminal analysis.
The challenge of automated analysis of carotid atherosclerotic plaque lies in the difficulty 
of defining the outer vessel wall. This is a challenging task due to the low and varying 
contrast between the plaque and its surrounding soft tissue. Vukadinovic et al. devel-
oped a semi-automated method to segment the outer vessel wall63, which only required 
clicking initialization points for lumen segmentation and clicking seed points for defining 
the range of interest for plaque segmentation. The method uses a level-set framework 
for vessel lumen segmentation,37 followed by classification of calcium objects using a set 
of image features related to the appearance, shape and size of bright objects in the CTA 
data set. Subsequently, image voxels are identified as lying inside or outside the ves-
sel wall, using a same set of image features. Finally, the outer vessel wall is determined 
by fitting an ellipsoid that utilizes the information from the calcium and inner/outer ves-
sel classification step. After generation of the inner and outer vessel wall contours, the 
plaque components (lipid, fibrous tissues and calcifcations) are automatically differenti-
ated based on the aforementioned HU-thresholds. Figure 11 shows the results of (semi)
automatically generated plaque segmentations.
The method has been trained and tested on manually annotated MDCTA datasets of the 
carotid arteries and validated against manually segmented carotid arteries. The average 
Dice similarity index was 91%, which was comparable to the similarity index between 
two observers.63 Subsequently, the performance of this plaque segmentation method 
in quantifying plaque volume and plaque component volumes was studied by comparing 
measurement error of the automated method using manual contours as a reference stan-
dard with the interobserver variability in manual annotations. The differences between 
the automated method and the manual observers were comparable to the interobserver 
variability.64
Although the method is highly automated some observer interventions are still needed 
and the outer vessel wall segmentations should still be checked manually for erroneous 
inclusion or exclusion of calcifications, and therewith over-segmentation or under-seg-
mentation of the plaque. Taken these manual interventions into account, the intraob-
server and interobserver reproducibility of the semiautomated method is better as com-
pared to the reproducibility of manual annotating, with intraclass correlation coefficients 
of 0.93/0.84 for plaque volume and 0.86-1.00 / 0.76-0.99 for plaque component volumes 
(unpublished data).
Applications of quantitative atherosclerotic measures
MDCTA quantitative plaque measures have been used in several studies to investigate 
atherosclerotic development. Rozie et al. investigated in a cross-sectional study the cor-
relation between cardiovascular risk factors and plaque volume and plaque composition. 
They found that plaque volume and severity of stenosis were just moderately correlated, 
which means that plaque volume could be an additional predictor for ischemic stroke. 
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An increasing plaque volume was associated with increased lipid and calcium proportion 
and a decreased fibrous proportion. Age and smoking were independently related to 
plaque volume. Patients with hypercholesterolemia had a significantly higher contribu-
tion of calcifications and a significantly lower contribution of lipid in the atherosclerotic 
plaque.65 Another study investigated whether plaque features could be correlated with 
the presence of ulcerations, which is thought to be a marker of plaque rupture.10 It was 
demonstrated that degree of stenosis, plaque volume and the proportion of lipid-rich ne-
crotic-core were associated with the presence of carotid plaque ulcerations.66 In another 
cross-sectional study, carotid atherosclerotic plaque features were identified that were 
significantly different in acute carotid stroke patients compared to non-stroke patients 
and on the infarct side compared to the contralateral side in stroke patients. These fea-
tures included increased vessel wall, thinner fibrous caps, greater number of lipid cores 
and their location closer to the lumen. The number of calcium clusters was a protective 
factor.67
Figure 12. Serial quantitative plaque imaging 
Serial plaque imaging in a 67 year old male patient (a+b) and a 62 year old male patient (c). On the left, axial 
MDCTA images and the plaque color overlays of the baseline scan and on the right the corresponding images 
of the follow-up scan. a) Predominantly non-calcified plaque at a level just above the bifurcation. At follow-up 
imaging after 6 years an ulceration is visible (arrow head). b) Images from the same artery at a more distal site. 
a+b) At follow-up a decrease in plaque volume and a change in plaque composition is demonstrated. c) Internal 
carotid artery demonstrating an increase in calcification of the vessel wall at follow-up (after 6 years).
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Numerous studies report on the role of plaque calcifications in plaque stability. The find-
ings are not conclusive. A recent systemic review suggests that clinically symptomatic 
plaques have a lower degree of calcifications than asymptomatic plaques.61 The percent-
age calcification within a plaque of a stenosed artery, rather than the absolute volume 
seems to be associated with plaque stability.68 This underscores why the (automated) 
quantification of the relative contribution of the plaque components might add to the 
improvement of stroke risk prediction.
The MDCTA plaque imaging studies performed so far had a cross-sectional design. The 
ability to quantify atherosclerotic features in vivo creates the potential to further explore 
atherosclerotic plaque development by prospective, serial in vivo imaging of the carotid 
plaque (Figure 12). Currently, a prospective serial MDCTA plaque imaging study is being 
performed, which investigates the temporal changes in plaque burden and plaque com-
position and its determinants in TIA and stroke patients.
Summary and future directions
Currently, MDCTA is a non-invasive imaging technique frequently used in clinical practice 
for the assessment of carotid stenosis grading and is replacing the more invasive tech-
nique of DSA. MDCTA can perfectly be combined with a native CT scan and a perfusion CT 
scan of the brain in the evaluation of stroke patients.
Although plaque imaging is currently only used in research settings, the same MDCTA 
data set might provide further clinically important information on the atherosclerotic 
plaque burden, plaque surface morphology and plaque composition for a more individu-
alized risk prediction. Large, prospective studies demonstrating significant associations 
between CTA-based risk factors and (recurrent) events are yet lacking. Future research 
should focus on the role of plaque measures in stroke risk prediction and on the use of 
MDCTA-based quantified plaque measurements in monitoring efficacy of medical thera-
py. Large –preferably multicenter– studies, should pay attention to the standardization 
of data acquisition and post processing across centers and imaging time points, since sev-
eral technical parameters highly influence quantification of plaque features as is broadly 
depicted in this chapter. More effort should further be put in the development of robust, 
accurate, automated quantification of plaque measures in order to minimize measure-
ment variability.
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Abstract 
The purpose of this study was to validate automated atherosclerotic plaque measure-
ments in carotid arteries from CT angiography (CTA). We present an automated meth-
od (three initialization points are required) to measure plaque components within the 
carotid vessel wall in CTA. Plaque components (calcifications, fibrous tissue, lipids) are 
determined by different ranges of Hounsfield Unit values within the vessel wall. On CTA 
scans of 40 symptomatic patients with atherosclerotic plaque in the carotid artery auto-
matically segmented plaque volume, calcified, fibrous and lipid percentages were 0.97 
± 0.51 cm3, 10 ± 11%, 63 ± 10% and 25 ± 5%; while manual measurements by first observer 
were 0.95 ± 0.60 cm3, 14 ± 16%, 63 ± 13% and 21 ± 9%, respectively and manual measurement 
by second observer were 1.05 ± 0.75 cm3, 11 ± 12%, 61 ± 11% and 27 ± 10%. In 90  datasets, 
significant associations were found between age, gender, hypercholesterolemia, diabe-
tes, smoking and previous cerebrovascular disease and plaque features. For both auto-
mated and manual measurements, significant associations were found between: age and 
calcium and fibrous tissue percentage; gender and plaque volume and lipid percentage; 
diabetes and calcium, smoking and plaque volume; previous cerebrovascular disease and 
plaque volume. Significant associations found only by the automated method were be-
tween age and plaque volume, hypercholesterolemia and plaque volume and diabetes 
and fibrous tissue percentage. Significant association found only by the manual method 
was between previous cerebrovascular disease and percentage of fibrous tissue. Auto-
mated analysis of plaque composition in the carotid arteries is comparable with the man-
ual analysis and has the potential to replace it. 
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Introduction
One of the major causes of death in the western world is atherosclerotic disease, which 
manifests itself as ischemic heart disease and ischemic stroke.1 The amount of atheroscle-
rotic disease in carotid arteries is normally expressed by the severity of luminal narrow-
ing. Risk of (recurrent) stroke is related to the severity of stenosis.2 However, the pres-
ence of a large atherosclerotic plaque is not always associated with luminal narrowing3, 
which demonstrates that luminal narrowing alone is probably not a reliable marker of 
atherosclerosis. In addition, studies on carotid atherosclerotic plaque show that plaque 
morphology and composition are also important in the risk assessment of patients with 
carotid artery stenosis.4-6 
Atherosclerotic plaque volume and composition can be determined with Magnetic Res-
onance Imaging (MRI)7-10 and CT angiography (CTA).11-14 CTA has established itself as an 
accurate modality to assess the presence of atherosclerotic disease and to grade the se-
verity of stenosis.15 Carotid plaques with a thin fibrous  cap and a large lipid core are also 
considered to increase the risk for stroke,16,17 while plaques with high calcium content, 
especially when located superficially, are thought to be associated with a lower risk for 
stroke.18 
Manual measurement of plaque volume and the contribution of the different plaque com-
ponents to the plaque volume in MRI or CTA data is a very labor intensive task. Several 
methods address the segmentation of the outer vessel wall and plaque components in 
both MRI and CTA data in carotid arteries19-24 as well as coronary arteries.25,26 We previous-
ly developed an algorithm to automate the plaque measurements in CTA imaging data 
of the carotid arteries. In this algorithm we combined outer vessel wall segmentation27 
with lumen segmentation.28 Once the outer vessel wall and lumen were segmented, the 
plaque components were segmented using distinctive ranges of Hounsfield Unit (HU) 
values.11 However, with this algorithm the outer vessel wall was automatically segmented 
only in common carotid artery, while atherosclerotic disease is commonly present in both 
the common and internal carotid artery. 
The purpose of this study was to develop and evaluate a method to obtain automat-
ed measurements of plaque  volume and its components at the carotid bifurcation and 
to demonstrate that this method has potential to replace the manual measurements in 
terms of accuracy in plaque volume and plaque component characterization. Further-
more, we investigated whether in group associations studies similar trends can be found 
with automated processing. Hereto, the method validation consists of (1) evaluation of 
the accuracy by comparing differences between method and manual tracings with vari-
ability of manual measurements of different observers and (2) comparison of the associ-
ations between cardiovascular risk factors and plaque features as assessed with manual 
segmentation and automated segmentations.
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Materials and methods
Study population
From November 2002 to December 2005, patients with amaurosis fugax, TIA or minor 
ischemic stroke (Rankin  score ≤3) were consecutively enrolled in the study cohort and 
clinical and research data were derived in a standardized way. Multi-detector CT angiog-
raphy (MDCTA) of the carotid arteries was performed as part of a research protocol, ap-
proved by the Institutional Review Board. All patients gave written informed consent. All 
patients underwent neurological examination on admission and symptoms and risk fac-
tors were reported. Subsequently, all carotid arteries of those patients with symptoms in 
the anterior circulation were evaluated for the presence of atherosclerotic plaque. This 
validation study of the automated plaque segmentation has a retrospective study design. 
The main test set contained the symptomatic carotid artery from 90 randomly selected 
patients (63% male, mean age 67 ± 11 years) from the group of patients with atheroscle-
rotic plaque in the symptomatic carotid artery. The symptomatic carotid artery was the 
artery ipsilateral to the ischemic hemisphere, which was based on clinical symptoms and 
findings on MDCT of the brain. A subset of 40 datasets, which has a similar distribution of 
stenosis degrees as the full set, was used for the interobserver study.
Training set for automated method
The parameter settings for the automated method were previously trained on 40 man-
ually annotated datasets, which are not part of the 90 datasets for which the method 
is evaluated. Furthermore this training was manually annotated by a different observer 
than the two observers who annotated the imaging data reported on this study. Hence, 
a possible bias of the method to one of the observers is prevented.
Scan protocol and image reconstruction
CTA of the carotid arteries was performed on a 16-slice MDCT system (Siemens, Sensation 
16, Erlangen, Germany) with a standardized optimized contrast-enhanced protocol (120 
kVp, 180 mAs, collimation 16 x 0.75 mm, table feed 12 mm/rotation, pitch 1).29 All patients 
received 80 ml contrast material (Iodixanol 320 mg/mL, Visipaque, Amersham Health, 
Little Chalfont, UK), followed by 40 ml saline bolus chaser, each at an injection rate of 
4 mL/s. Synchronization between the passage of contrast material and data acquisition 
was achieved by real-time bolus tracking at the level of the ascending aorta. Image recon-
structions were made with a 120-mm field of view, a matrix size of 512 x 512, a slice thick-
ness of 1.0 mm, an increment of 0.6 mm, and an intermediate reconstruction filter (B46f).
Plaque volume and composition measurements
To define different plaque components by using different HU ranges, it is sufficient to 
have a segmentation of the carotid artery outer vessel wall and the lumen.11 
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Automated Segmentation of the outer vessel wall and lumen 
An automatic method using a three-point initialization was used to segment the outer 
vessel wall of the carotid artery in CTA.27,30 First, the vessel lumen was segmented using 
a level set approach,28 using an initialization point in the common, internal and external 
carotid artery. Subsequently, using a set of image features, calcium objects which are 
part of the vessel wall were detected using a GentleBoost framework.27 Calcium object 
classification is used as a preprocessing step for the outer vessel wall segmentation since 
it is a much easier task than outer vessel segmentation and it can improve the accuracy 
of outer vessel wall segmentation. In the third step probability images were created that 
indicate the likeliness of a voxel lying within or outside the vessel, using the same Gentle-
Boost framework. Each voxel is represented by a set of descriptive features: distance of 
the pixel to the lumen center and a set of contextual features. Contextual features in this 
case are radial image intensity profiles emanating from the lumen center. These profiles 
are extracted from the original image, the image smoothed with 2D Gaussian filters at 
different scales and directional 2D, Gaussian derivatives also at different scales. Based on 
this set of features, a GentleBoost classifier is trained to classify each pixel as being inside 
or outside vessel wall. The classifier provides a confidence measure which reflects the 
likelihood that a pixel lies inside or outside the vessel. Finally, ellipsoids are fitted using 
both the calcium and vessel classification results.
Manual Segmentation of the outer vessel wall and lumen
Images of carotid arteries that contained plaque were analyzed using custom-made quan-
titative image analysis software, developed using MeVisLab (MeVis Research, Bremen, 
Germany). Using this software, regions of interest (ROI) were manually drawn over the 
outer vessel wall contour in consecutive axial MDCTA images (Figure 1). Since the observ-
ers placed the ROI over the outer vessel wall contour, the ROI consisted of both plaque 
and lumen. The window/level setting was fixed at 1200/800 HU for all measurements. To 
assess the border between lumen and atherosclerotic plaque it was necessary to draw a 
second ROI close to the lumen in each image. Normally, the lumen area was then auto-
matically differentiated from atherosclerotic plaque based on the adjusted cut-off value. 
But in those plaques in which calcifications bordered the lumen and the two dense struc-
tures merged with each other, lumen area and calcifications had to be separated by man-
ual drawing. One observer (S.R.) who was blinded to other clinical information, manually 
drew lumen and outer vessel wall  contours. A second observer (M.G.) performed the 
manual segmentations in the interobserver dataset. A third observer (T.W.) performed 
manual annotation of the training set on which our automated method was trained.
Calculation of the volume of plaque and the components
Having the carotid artery vessel wall and lumen segmented, different HU ranges were 
used to define different plaque components. The cut-off point for the distinction be-
tween calcifications and fibrous tissue was set at 130 HU, the value currently used for 
calcium scoring. The cut-off point for the distinction between fibrous tissue and lipid was 
set at 60 HU as determined in previous studies.11 We adjusted the cut-off point for the dis-
tinction between atherosclerotic plaque and vessel lumen for each patient on the basis of 
the full-width-half-maximum principle (mean lumen attenuation plus mean fibrous tissue 
attenuation (≈88 HU) divided by two). The pixels surrounding the vessel lumen, with a 
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density between 130 HU and the adjusted cut-off value, were considered to be fibrous 
tissue. 
The plaque volume and the volume of the plaque components were calculated by multi-
plying the number of pixels of the total atherosclerotic plaque or its components, with 
the pixel size and the slice increment. The proportion of plaque components was calcu-
lated as the ratio of volume of the component to the total plaque volume multiplied by 
100. As an example, in Figure. 1 a cross-sectional slice with outer vessel wall and all three 
plaque components in different colors automatically segmented and manually segment-
ed by two observers is shown.
Cardiovascular risk factors
We obtained clinical measures and information on risk factors and medication during 
the patient’s visit at the outpatient clinic. Subjects were categorized as currently, ever, 
or never smoking. Hypertension was defined as systolic blood pressure over 140 mmHg 
and/or diastolic blood pressure over 90 mmHg during two episodes of at least 15 min of 
continuous noninvasive blood-pressure measurement and/or treatment with antihyper-
tensive medication. Blood pressure-lowering drugs comprised ACE inhibitors, calcium-an-
tagonists, beta-blockers, and diuretics. Hypercholesterolemia was defined as fasting cho-
lesterol over 5.0 mmol/l and/or use of cholesterol-lowering drugs. Diabetes was defined 
as fasting serum glucose levels over 7.9 mmol/l, nonfasting serum glucose levels over 
11.0 mmol/l, or use of antidiabetic medication. Information was collected on previous car-
diovascular events and conditions (myocardial infarction, atrial fibrillation, angina pecto-
ris, chronic heart failure, coronary artery bypass grafting) and previous cerebrovascular 
events.
Statistical analysis
Both for automated and manual measurements (2 observers), plaque and plaque com-
ponent volumes and proportions were presented on 40 datasets with mean (+/- SD). The 
differences between automated and manual measurements and those between the mea-
surements of two observers are presented with mean values and standard deviations. 
Figure 1. Different plaque components on one cross sectional slice segmented by the automated method (left), 
observer S.R. (center) and observer M.G. (right). Red = lumen, Green = fibrous, yellow = lipids, white = calcium
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The differences between the automated and manual measurements (2 observers) on 40 
datasets were plotted against the mean value of the measurements (Bland–Altman plot), 
they were evaluated with paired Student t test and the correlation between the mea-
surements by the two methods was evaluated by Pearson’s correlation coefficient (Rp). 
Bland–Altman plots are plotted in Excel. Limits of agreement are calculated as average 
difference ± 1.96 * standard deviation of the difference.
The differences between automated and manual measurements on 90 datasets (1 ob-
server) are presented with mean values and standard deviations and the correlation was 
evaluated by Rp.
Both for automated and manual measurements (1 observer) we determined the associa-
tions between cardiovascular risk factors and PV and plaque composition on 90 datasets 
using univariable linear regression. Multivariable analysis was not performed for two rea-
sons. Firstly, the focus of the study was to show that automated method can replicate 
the associations between manually measured plaque components and cardiovascular 
risk factors. Second, we did not focus on the assessment of independent associations be-
tween risk factors and plaque characteristics as this was not possible due to limited sam-
ple size. Because the distribution of plaque volume was skewed, we used a log10 trans-
formation prior to statistical analysis. Similarly, for proportion of plaque components we 
used square root (sqrt) transformation.
P values ‹ 0.05 were considered statistically significant. Statistical analyses were per-
formed using SPSS software (version 15.0, Inc., Chicago, Illinois).
Results
Baseline clinical characteristics
The baseline characteristics are presented in Table 1.
Characteristics N=90
Age [years; mean ±SD] 67±11
Male sex [%] 63
Hypertension [%] 84
Hypercholesterolemia [%] 85
Diabetes Mellitus [%] 24
Smoking: current or past [%] 44
Previous cardiac disease [%] 35
Previous cerebrovascular disease [%] 31
Table 1. Demographic and clinical characteristics of 90 patients
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Plaque measurements: comparison to interobserver variability
Table 2 shows lumen, plaque volume, plaque component volumes and plaque component 
proportions assessed by the automated method and by the manual methods (two ob-
servers) in 40 datasets. The differences between the automated and the manual method 
and between the manual measurements of two observers are also shown. The differ-
ences between automated method and both observers were in the same range as the 
differences between observers. The difference between the automated method and first 
observer manual measurements of PV, calcified, fibrous and lipid percentages were 0.02 
± 0.24 cm3, -4 ± 6%, -0 ± 8% and 4 ± 7%, respectively. The differences between automated 
method and second observer manual measurements of PV, calcified, fibrous and lipid 
percentages were -0.09 ± 0.43 cm3, -1 ± 4%, 2 ± 8% and -1 ± 9%. respectively. The differences 
between two observers manual measurements of PV, calcified, fibrous and lipid percent-
ages were 0.11 ± 0.29 cm3, 3 ± 5%, 2 ± 6% and -5 ± 7%, respectively. Similar differences were 
found between automated plaque measurements and manual measurements performed 
on 90 datasets by observer S.R.
Figure 2 shows regression plots and Pearson’s correlation coefficient (Rp) between au-
tomated and manual measurements by both observers of plaque features on 40 data-
sets. For PV, calcium, fibrous and lipid contribution correlation coefficients between au-
tomated and manual measurements of observer S.R. and M.G. were: 0.92 and 0.83; 0.94 
and 0.94; 0.79 and 0.73 and 0.57 and 0.52, respectively. Correlation coefficients between 
automated and manual measurements by observer S.R. on 90 datasets of PV, calcium, 
fibrous and lipid contributions were 0.89, 0.86, 0.77 and 0.55, respectively.
From the Bland–Altman plots, in Figure 3, it can be observed that the difference between 
automated and manual measurements of plaque volume increases when the volume 
increases. Similarly, the difference between automated and manual measurements of 
plaque components proportions increase with the components proportions.
40 datasets μ (A) ± SD
μ (Obs 1) 
± SD
μ (Obs 2) 
± SD
μ (Diff 
(A,Obs1)) 
± SD
μ (Diff 
(A,Obs2))
± SD
μ (Diff 
(Obs1,Obs2))
± SD
Plaque volume [mm3] 965±511 946±595 1052±754 19±235 -87±432 -106±288*
Lumen volume [mm3] 1030±577 1040±562 1052±567 -10±84 -22±73 -12±27*
Calcium volume [mm3] 129±178 155±197 136±174 -26±50* -6±45 19±31*
Fibrous volume [mm3] 591±271 564±302 602±336 26±101 -10±165 -37±112*
Lipid volume [mm3] 244±144 225±215 314±348 18±133 -69±272 -88±190*
Calcium proportion [%] 10±11 14±16 11±12 -4±6* -1±4 3±5*
Fibrous proportion [%] 63±10 63±13 61±11 -0±8 2±8 2±6*
Lipid proportion [%] 25±5 21±9 27±10 4±7* -1±9 -5±7*
μ- mean, A – automated method, Obs1 – first observer, Obs2 – second observer, SD – standard deviation, Diff – 
difference, CoV – coefficient of variation, * - t-test P-value < .05
Table 2. Plaque features measured by automated method and by two observers in 40 datasets with the differ-
ences and coefficients of variation.
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Figure 2. Regression plots showing the comparison between automated and manual measurements in 40 
datasets
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Risk factors associations with plaque features: comparison 
between manual and automated measurements
Table 3 shows the associations between cardiovascular risk factors and automatically as-
sessed and manually assessed plaque volume and plaque component percentages on 90 
datasets. Mostly, similar associations were found with automatically and manually as-
sessed plaque features and cardiovascular risk factors.
Older patients had significantly larger PV measured by the automated method, whereas 
the association with manually assessed PV was not significant (P = 0.065). Male patients 
had significantly higher plaque volume for both automated and manual plaque measure-
ments. Patients with hypercholesterolemia had significantly lower plaque volume when 
measured with the automated method, and not when measured manually. Patients who 
were smokers and patients who had a history of cerebrovascular disease had significantly 
higher plaque volume for both automated and manual plaque measurements. 
For both automated and manual plaque measurements older patients had a significantly 
higher calcium contribution and a significantly lower fibrous contribution. Male patients 
had a significantly higher lipid contribution for both automated and manual plaque mea-
surements. Patients with diabetes had a significantly higher calcium contribution for both 
automated and manual plaque measurements and a significantly lower fibrous contribu-
tion when measured with the automated method and not when measured manually.
Patients with a history of cerebrovascular disease had a significantly lower fibrous contri-
bution when measured manually and not when measured automatically.
Figure 3. Bland-Altman plots of plaque volume and plaque components percentages assessed by automated 
method and manual method by two observers in 40 datasets
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Discussion
In this study we presented a method for automated plaque volume and plaque compo-
sition assessment. Furthermore, we evaluated its accuracy (i) with respect to manual 
tracings, and (ii) its ability to replicate associations between plaque characteristics and 
cardiovascular risk factors.
With respect to segmentation accuracy, we showed that the differences in estimating 
plaque volume and plaque components between our automated method and expert 
observers are in the same range as interobserver variability. The results show some bias 
between the observers and between observers and the method. All automated volume 
measurements values are larger than volumes measured by observer S.R. and smaller 
than the volumes measured by observer M.G. with the exception of calcium volume and 
fibrous contribution. All the volumes and proportion differences between two observers 
were statistically significant, although these differences were small. The statistically signif-
icant difference is a consequence of a persistent, albeit small, oversegmentation of most 
plaque components by observer M.G. compared to observer S.R. The differences between 
automated method and observer S.R. were significant for calcium volume and proportion 
and lipid proportion. None of the differences between automated method and observer 
M.G. were significant. The differences between automated method and observer S.R. were 
larger than the differences between automated method and observer M.G. for more mea-
surements: calcium volume, fibrous volume, calcium proportion and lipid proportion. In a 
previous interobserver study of plaque and plaque components assessment with CTA, in 
which three observers manually annotated 46 CTA datasets,14 the differences of plaque vol-
ume and all plaque components were significant between at least one pair of observers.14 
Pearson’s correlation coefficients between automated and manual measurements of both 
observers for PV and plaque contributions were mostly similar as shown in Figure 2. 
In a second evaluation, we showed that associations between cardiovascular risk factors 
and automated plaque measurements were mostly similar to the associations found with 
manual plaque measurements. Seven associations were significant for both the automat-
ed and manual plaque measurements; one was significant for the automated method and 
almost significant for manual method and three were significant for only one of the meth-
ods. The associations that were found to be significant for both manual and automated 
measurements have also similar correlation coefficient values. 
To our knowledge, this is the first study that compares cardiovascular risk factors associ-
ations with manually and automatically assessed plaque volume and plaque components. 
When comparing our results with results of a previous study in which the association 
between cardiovascular risk factors and manually assessed plaque volume and plaque 
components was evaluated in 57 symptomatic carotid arteries,31 we found more associa-
tions. This can possible be explained by the larger number of datasets that is used in our 
study. In the previous study age and smoking were related to plaque volume, which is 
confirmed in our current study. In the previous study, patients with hypercholesterolemia 
had significantly less lipid and more calcium; these associations were not confirmed. A 
reason for this could be that automated results are the least similar to manual ones in 
case of lipids contribution (Rp = 0.55). Calcium proportion is shown to be underestimated 
by the automated method. 
In previous studies from our institute on CT based plaque assessment, 11, 29, 14 different 
datasets were used than in this paper. The 57 datasets used to relate manually derived 
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plaque measurements to cardiovascular risk factors in31 are a subset of the 90 datasets 
used in this paper. Compared to this work, we thus both extended the dataset, and we 
investigated the influence of automated plaque assessment, in order to try to replace 
laborious manual plaque segmentation.
Manual quantification takes on average around 30 min per carotid artery. This time pe-
riod depends on the lesion length. The automated method takes on average around 6 
min on a single CPU 2GHZ, RAM 24 GB computers. Manual plaque segmentation is not 
applicable in clinical setting, because it is too time-consuming. Automated plaque assess-
ment already is considerably faster and improved implementation and hardware could 
reduce processing time such that it would become acceptable in clinical workflow. Also, 
this automated tool can be used in larger datasets for the investigation of associations 
between plaque volume/composition and risk factors or recurrent ischemic events and 
for longitudinal studies on plaque imaging.
Study limitations
A limitation of our study is that we do not have a definite gold standard. The scarcity of 
histological carotid plaque specimens hampers the validation of automated plaque vol-
ume and composition assessment on a sizeable dataset. We therefore compared results 
from automated plaque segmentation with those from manual plaque segmentation—a 
method previously validated against histology—thus indirectly evaluating the perfor-
mance of our automated method.
A second limitation of our study is that we used CT data from a single vendor, collected 
at a single site. Our automated method might perform less on data from different CT- 
scanners, different sites or using different image protocols. However, the underlying 
method is generic and if required can be tuned to different systems by using new training 
on data. 
A third limitation concerns the plaque segmentation method that uses distinctive rang-
es of Hounsfield Unit (HU) values.11 There is some overlap between the HU of lipid and 
fibrous tissue and no distinction can made between lipid and intraplaque heamorrhage, 
which is thought to be an important feature in plaque vulnerability assessment as well.9
As a final limitation, the comparison of cardiovascular risk factors associations with man-
ually and automatically segmented plaque components does only indicate that the au-
tomated method can be used to find similar associations in a group study. It does not 
provide information on the method applicability on a single subject.
Conclusion
We presented an approach to automatically segment outer vessel wall and plaque of 
carotid artery in CTA and to automatically assess plaque volume and plaque components. 
The results were validated with respect to manual tracings and interobserver variability.
Furthermore, the associations between cardiovascular risk factors and plaque volume 
and plaque component contributions assessed by our automated method and a manual 
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method were compared. We have shown that the difference between our automated 
method and the observers is in the range of the variability of the observers, and hence 
can be applied for automated analysis in large studies.
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Abstract 
Background and Purpose Atherosclerotic carotid plaque ulceration is considered a 
marker of previous plaque rupture and subsequent thromboembolism. It can be accu-
rately detected with multidetector CTA.  We hypothesized that atherosclerotic plaque 
ulceration is associated with non-lacunar ischemic stroke rather than lacunar stroke.  
Methods Prospectively, 750 consecutive patients with  transient ischemic attack or isch-
emic stroke symptoms in the anterior cerebral circulation were evaluated for the pres-
ence of atherosclerotic plaque ulceration in the symptomatic carotid artery with multi-
detector CTA. Patients with stroke due to cardiac embolism or other specific etiologies 
and patients with amaurosis fugax were excluded. Ischemic strokes in the remaining 534 
patients were classified as non-lacunar (n=236) or lacunar (n=298) based on clinical symp-
toms and multidetector CT of the brain. Ulceration was defined as extension of contrast 
material beyond the vascular lumen into the surrounding plaque. 
Results Plaque ulceration in the symptomatic carotid artery was more common in non-la-
cunar strokes (n=47, 20%) as compared to lacunar strokes (n=20, 7%; P<0.001). After ad-
justment for age, gender, cardiovascular risk factors, and degree of stenosis, ulcerations 
were independently associated with non-lacunar stroke compared to lacunar stroke 
(odds ratio, 2.70; 95% confidence interval, 1.43-5.09). 
Conclusions Atherosclerotic carotid plaque ulceration is associated with non-lacunar 
ischemic stroke, independent of the degree of carotid stenosis. These results suggest 
that non-lacunar stroke and lacunar stroke are caused by different pathophysiological 
mechanisms. 
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Introduction
Whereas lacunar strokes are associated with local occlusive disease of the deep perfo-
rating arteries at the base of the brain,1 large deep and non-lacunar ischemic strokes are 
frequently caused by thromboembolism from extracranial arteries or the heart.2 The 
association of atrial fibrillation and carotid stenosis with non-lacunar stroke3 supports 
the assumption that this is attributable to (thrombo-)embolism. Atherosclerotic carotid 
plaque ulceration is considered to be a marker of previous plaque rupture and an influen-
tial predictor of ischemic stroke besides degree of stenosis.4,5 Plaque rupture with sub-
sequent thrombus formation and embolisation of plaque material or thrombus into the 
intracranial circulation may cause non-lacunar stroke. 
Multidetector computed tomography angiography (MDCTA) has been demonstrated to 
be effective in the detection of carotid plaque ulceration, with a sensitivity and specificity 
of 94% and 99% respectively.6 CT angiography is superior to digital subtraction angiogra-
phy in detecting ulcerations of the carotid atherosclerotic plaque.7
In the current study, the association between atherosclerotic plaque ulceration in the 
symptomatic carotid artery and non-lacunar stroke was evaluated by means of MDCTA 
in a large population of patients with ischemic stroke. If non-lacunar stroke is associat-
ed with thromboembolism, then it may also be associated with atherosclerotic plaque 
ulceration in the symptomatic carotid artery. To test this hypothesis, we compared the 
prevalence of plaque ulceration by means of MDCTA between patients with lacunar and 
non-lacunar stroke.
Materials and Methods
Study Population
From a prospective registry of 911 consenting patients with amaurosis fugax, transient 
ischemic attack (TIA) or minor ischemic stroke (Rankin score <4) who underwent MDCTA 
of the carotid arteries, we selected all patients (n=750) with symptoms in the anterior 
circulation. Patients were enrolled from a specialized TIA/stroke outpatient clinic or the 
neurology ward. All patients underwent an interview, neurological examination, electro-
cardiography and laboratory analysis on admission. Medical history and cardiovascular 
risk factors were thereby recorded. On admission, patients underwent MDCT of the brain 
and MDCTA of the carotid arteries in a single session. In 3 patients the carotid arteries 
could not be analyzed because of scan artifacts. Patients with a likely cardiac etiology 
(n=96) or other specific etiology 9n=20) according to the Trial of Org 10172 in Acute Stroke 
Treatment (TOAST) criteria were excluded.8 Subsequently, patients with amaurosis fugax 
(n=79) were excluded. Amaurosis fugax is often associated with nonatherosclerotic, pri-
mary neurological or ophthalmologic orirgin, and it conveys a different cerebrovascular 
prognosis.9 The remaining 534 patients were included in the study.
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Cardiovascular Risk Factors 
Hypercholesterolemia was defined as fasting cholesterol >5.0 mmol/l or treatment with 
cholesterol-lowering medication. Hypertension was defined as a systolic blood pressure 
>140 mmHg or a diastolic blood pressure >90 mmHg, during two episodes of at least 
15 minutes of continuous non-invasive blood pressure measurement or treatment with 
antihypertensive medication. Diabetes was defined as fasting serum glucose levels >7.9 
mmol/l, HbA1c >6.5%, or use of antidiabetic medication. 
MDCT and MDCTA Data Acquisition
Imaging was performed with a 16-slice MDCT scanner (Sensation 16, Siemens) or a 64-slice 
MDCT scanner (Sensation 64, Siemens) with a standardized optimized contrast-enhanced 
protocol (120 kVp, 180 mAs, collimation 16 x 0.75 mm or 64 x 0.6 mm, pitch ≤1).10,11 
The MDCT brain scan ranged from the foramen magnum to the vertex. Image reconstruc-
tions were made with a 220 mm field of view, matrix size 512 x 512, (real in-plane resolu-
tion 0.5 x 0.5 mm), slice thickness 3 to 4.5 mm and with an intermediate reconstruction 
algorithm.
The MDCTA scan ranged from the ascending aorta to the intracranial circulation (2 cm 
above the sella turcica). All patients received 80 ml contrast material (Iodixanol 320 mg/
ml, Visipaque, Amersham Health), followed by a 40 ml saline bolus chaser, both with an 
injection rate of 4 ml/sec. Synchronization between the passage of contrast material and 
data acquisition was achieved by real time bolus tracking at the level of the ascending 
aorta. Image reconstructions were made with a 100 mm field of view, matrix size 512 x 
512 (real in-plane resolution 0.6 x 0.6 mm), slice thickness 1.0 mm, increment 0.6 mm and 
with an intermediate reconstruction algorithm.12 
MDCT and MDCTA Data Analysis
Relevant cerebral infarctions on MDCT of the brain related to the stroke symptoms were 
classified as non-lacunar infarction or lacunar infarction. A non-lacunar infarction was de-
fined as an infarction with involvement of the cerebral cortex or a large deep infarction > 
1.5 cm. A lacunar infarction was defined as an infarction in the deep brain structures (grey 
or white matter) with a size ≤ 1.5 cm. 
The MDCTA images were sent to a stand-alone workstation (Leonardo; Siemens Medi-
cal Solutions) with dedicated 3-dimensional analysis software for further analysis. The 
symptomatic carotid bifurcation was evaluated with multi-planar reformatting software, 
which allows reconstruction of sagittal, coronal, and oblique views from axial sections. 
Two experienced investigators blinded to clinical data and MDCT of the brain analyzed 
the MDCTA images. Discrepancies were solved by consensus.
First, the degree of stenosis in the symptomatic carotid artery was determined according 
to the North American Symptomatic Carotid Endarterectomy Trial criteria13 on multipla-
nar reformatting images perpendicular to the central lumen line. Second, the symptom-
atic carotid artery was evaluated for the presence of occlusion, atherosclerotic plaque 
and atherosclerotic plaque ulceration. Presence of atherosclerotic plaque was defined as 
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thickening of the vessel wall and/or the presence of calcification. Plaque ulceration was 
defined as extension of contrast media beyond the vascular lumen into the surrounding 
plaque. 
Stroke Type and Etiology
All patients were analyzed for ischemic stroke etiology. The presence of a likely cardiac 
etiology or other specific etiology according to the TOAST criteria was determined.8 For 
the purposes of this study, stroke was defined as ischemic stroke or transient ischemic 
attack. Based on clinical symptoms, strokes were classified as non-lacunar stroke of lacu-
nar stroke in consensus by 2 experienced neurologists. In patients with a relevant infarc-
tion on MDCT of the brain, classification was corrected for imaging results. Non-lacunar 
ischemic stroke was defined as either ≥2 of the following symptoms: (1) higher cerebral 
dysfunction (e.g. dysphasia, dyscalculia, visuospatial disorder); (2) homonymous visual 
field defect; and (3) ipsilateral motor or sensory deficit, or higher cerebral dysfunction 
alone or a motor or sensory deficit more restricted than those classified as lacunar (e.g. 
confined to one limb, face, or hand but not the complete arm). Lacunar ischemic stroke 
was defined as a pure motor stroke, pure sensory stroke, sensory-motor stroke, dysar-
thria clumsy hand syndrome, or ataxic hemiparesis without brainstem symptoms.14 
Statistical Analysis
Data are presented as means ± SD, medians with interquartile range, or number of pa-
tients (%). Differences between categorical data were analyzed with a χ2 test or Fisher 
Exact Test when appropriate. Differences between continuous data were analyzed with 
a Mann-Whitney test. 
The association between degree of stenosis and plaque ulceration was evaluated in a 
multivariable logistic model adjusted for age and sex. The association between age, gen-
der, cardiovascular risk factors, degree of stenosis and plaque ulceration with non-lacu-
nar stroke (with lacunar stroke as reference) was first evaluated in a univariable logistic 
regression model. Thereafter, a multivariable logistic regression analysis was performed 
to identify variables independently associated with non-lacunar stroke after adjustment 
for all variables. Patients with a symptomatic occluded carotid artery, in which assess-
ment of atherosclerotic plaque morphology was not possible, were not included in this 
analysis.
A multivariable logistic regression analyses was repeated with non-lacunar infarctions 
(versus lacunar infarctions) on MDCT of the brain to confirm the association of plaque 
ulcerations with clinically defined stroke subtype. Adjustments were made for age and 
gender plus the 6 variables, with the strongest association in the univariable analysis. 
Statistical analyses were performed using SPSS software (version 15.0, SPSS). P<0.05 was 
considered statistically significant.
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Results 
Patients Characteristics 
Excluded patients with a likely cardiac etiology or other specific etiology (n=116) had less 
hypertension (56% versus 71%, P=0.002) and smoked less often (28% versus 39%, P=0.02) 
than patients included in the analysis. In this group, plaque ulceration in the symptomatic 
carotid artery was present in 9 patients (8%). Excluded patients with amaurosis fugax 
(n=79) smoked less often (28% versus 39%, P=0.04) and less often had a previous ischemic 
stroke (5% versus 14%, P=0.02) than included patients. Plaque ulceration in the symptom-
atic carotid artery was present in 7 patients (7%) with amaurosis fugax.  
In the remaining 534 patients, non-lacunar stroke was present in 236 patients and lacu-
nar stroke was present in 298 patients. The mean age of the study population was 62±13 
years and 56% of the patients were male. In 355 (66%) patients the index event was an 
ischemic stroke, whereas 179 (34%) patients had a transient ischemic attack. Patients with 
non-lacunar stroke were significantly older than patients with lacunar stroke (64 versus 
61 years; P=0.003; Table 1). The prevalence of other cardiovascular risk factors was similar 
in the 2 groups.
Table 1. Characteristics of patients with non-lacunar and lacunar ischemic stroke
Non-lacunar Stroke 
n=236 (44%)
Lacunar Stroke 
n=298 (56%)
P-value
Age (years) 64±13 61±13 0.003
Male Sex 128 (54%) 170 (57%) 0.52
Hypercholesterolemia 174 (74%) 215 (72%) 0.68
Hypertension 167 (71%) 212 (71%) 0.92
Diabetes Mellitus 50 (21%) 55 (18%) 0.43
Smoking 82 (35%) 126 (42%) 0.08
Peripheral Arterial Disease 17 (7%) 17 (6%) 0.48
Previous Ischemic Stroke 31 (13%) 42 (14%) 0.75
Previous TIA 36 (15%) 42 (14%) 0.71
Previous Intracerebral Hematoma 4 (2%) 5 (2%) 0.99
History of Ischemic Heart Disease 37 (16%) 42 (14%) 0.61
Data are means±SD or number of patients (%).
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Plaque Surface Morphology in the Symptomatic Carotid Artery
In 362 of the 534 patients (68%), atherosclerotic plaque was observed in the symptomatic 
carotid artery. In 23 patients (4%), the symptomatic carotid artery was occluded and in 
149 patients (28%) the symptomatic carotid artery was normal. Plaque ulcerations were 
observed in 67 symptomatic carotid arteries (13%). The likelihood of plaque ulceration in 
the symptomatic carotid artery was increased with a higher degree of stenosis after ad-
justment for age and gender (OR 1.6; 95% CI, 1.4-1.7).
Risk Factors for Non-lacunar Ischemic Stroke
Occlusions of the symptomatic carotid artery were significantly more prevalent in pa-
tients with non-lacunar stroke as compared to patients with lacunar stroke (8% versus 1%; 
P<0.001; Table 2). Normal symptomatic carotid arteries were significantly less prevalent 
in patients with non-lacunar stroke as compared to patients with lacunar stroke (20% vs 
34%; P<0.001; Table2). 
Stenosis of ≥50% of the symptomatic carotid artery in patients with non-lacunar stroke 
was significantly more prevalent than in patients with lacunar stroke (P<0.001). Plaque 
ulceration in the symptomatic carotid artery was more common in non-lacunar strokes 
(n=47; 20%) as compared to lacunar strokes (n=20;  7%; P<0.001). In patients with plaque 
ulcerations no significant differences in number of ulcerations per plaque, location of the 
ulceration and type of ulceration were observed between patients with non-lacunar and 
lacunar stroke. 
Table 2. MDCTA Plaque characteristics of the symptomatic carotid artery in patients with non-lacunar and lacu-
nar ischemic stroke
Non-lacunar Stroke
n=236 (44%)
Lacunar Stroke
n=298 (56%)
P-value
Atherosclerotic Plaque 169 (72%) 193 (65%) 0.09
Occluded carotid artery 19 (8%) 4 (1%) <0.001
Normal carotid artery 48 (20%) 101 (34%) <0.001
Degree of Stenosis
 0% 121 (56%) 207 (70%) <0.001
 1-29% 38 (18%) 57 (19%) 0.36
 30-49% 18 (8%) 17 (6%) 0.37
 50-69% 22 (10%) 5  (2%) <0.001
 ≥70% 18  (8%) 8  (3%) 0.01
Plaque Ulceration 47 (20%) 20 (7%) <0.001
Data are number of patients (%).
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Risk factors associated with non-lacunar stroke (as opposed to lacunar stroke) in univari-
able and multivariable analysis are provided in Table 3. In univariable analysis age, degree 
of stenosis and plaque ulceration were found to be significantly associated with non-lacu-
nar stroke, whereas smoking was found to be associated with lacunar stroke. Risk factors 
independently associated with non-lacunar stroke in multivariable analysis were degree 
of stenosis (OR, 1.19; 95% CI, 1.07-1.32) and plaque ulceration (OR, 2.70; 95% CI, 1.43-5.09). 
As illustrated by the forest plot in the Figure, multivariable analysis revealed an indepen-
dent association between plaque ulceration and non-lacunar stroke after adjustment for 
age and gender; age, gender and cardiovascular risk factors; degree of stenosis alone and 
age, gender, all cardiovascular risk factors, and degree of stenosis.
Univariable Analysis Multivariable Analysis
Age (per decade) 1.23 (1.08-1.40)* 1.11 (0.96-1.29)
Male 0.84 (0.59-1.20) 0.70 (0.48-1.02)
Hypercholesterolemia 1.02 (0.69-1.51) 0.86 (0.56-1.33)
Hypertension 0.98 (0.66-1.44) 0.75 (0.48-1.15)
Diabetes Mellitus 1.27 (0.82-1.95) 1.24 (0.77-1.98)
Smoking 0.68 (0.47-0.98)* 0.73 (0.49-1.10)
Peripheral Arterial Disease 1.04 (0.49-2.19) 0.81 (0.36-1.87)
Previous Ischemic Stroke 0.89 (0.53-1.49) 0.81 (0.46-1.42)
Previous TIA 1.17 (0.71-1.94) 1.05 (0.61-1.82)
Previous Intracerebral Hematoma 1.09 (0.29-4.09) 1.07 (0.27-4.27)
History of Ischemic Heart Disease 1.23 (0.75-2.00) 1.09 (0.63-1.89)
Degree of Stenosis (per 10%) 1.27 (1.16-1.40)* 1.19 (1.07-1.32)*
Plaque Ulceration 3.79 (2.17-6.61)* 2.70 (1.43-5.09)*
Table 3. Univariable- and multivariable OR for association between non-lacunar stroke (versus ischemic lacunar 
stroke) and cardiovascular risk factors, degree of stenosis, and plaque ulceration
Data are OR (95% CI). In multivariable analyses, adjustments were made for all variables. 
*Significant relation.
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Risk Factors for Non-lacunar Infarction on MDCT of the brain 
An infarction on MDCT of the brain was found in 162 patients (30%), including 82 patients 
with non-lacunar infarction and 80 patients with lacunar infarction. The median time be-
tween the index event and acquisition of the MDCT of the brain was 5 days (interquartile 
range 1-14 days). In patients with non-lacunar infarction as compared to patients with la-
cunar infarction, a higher prevalence of atherosclerotic plaques (n=60; 73% vs n=65; 81%) 
and occlusions (n=10; 12% vs n=1; 1%; P=0.02), was observed in the symptomatic carotid 
artery. Plaque ulceration in the symptomatic carotid artery was more common in non-la-
cunar infarction (n=23; 28%) as compared to lacunar infarction (n=7; 9%; P=0.002). 
Risk factors associated with non-lacunar infarction (as opposed to lacunar infarction) in 
univariable and multivariable analysis are provided in Table 4. Atherosclerotic plaque ul-
ceration was independently associated with non-lacunar infarction in multivariable anal-
ysis (OR 3,88; 95% CI, 1.39-10.84).
Figure. Symptomatic carotid plaque ulceration is independently associated with non-lacunar stroke after cor-
rection for age, sex, cardiovascular risk factors (RF) and degree of stenosis.
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Discussion 
In the current study patients with ischemic cerebrovascular symptoms were classified ac-
cording to presumed stroke etiology. Besides degree of stenosis, atherosclerotic carotid 
plaque ulceration was shown to be independently associated with non-lacunar stroke. 
This relation between plaque ulceration and clinically defined non-lacunar stroke was 
confirmed by an independent association between the presence of atherosclerotic carot-
id plaque ulceration and non-lacunar infarction on MDCT of the brain. 
Etiology of ischemic stroke subtypes
The association of various risk factors with subtypes of ischemic stroke has been stud-
ied extensively.3 Differences in cardiovascular risk factor profile would support a distinct 
arterial pathological process underlying different types of stroke. Previous studies have 
suggested lacunar strokes to be predominantly associated with hypertension and diabe-
tes mellitus.15,16
However, in a review by Jackson et al,3 only a marginal increase was shown in the preva-
lence of hypertension in patients with lacunar stroke as compared to non-lacunar stroke. 
Data are OR (95% CI). In multivariable analyses, adjustments were made for age, gender, hypercholesterolemia, 
hypertension, diabetes mellitus, previous ischemic stroke, degree of stenosis, and plaque ulceration. 
*Significant relation.
Table 4. Univariable- and multivariable OR for association between CT-confirmed non-lacunar infarctions (ver-
sus lacunar infarctions) and cardiovascular risk factors, degree of stenosis, and plaque ulceration
Univariable Analysis Multivariable Analysis
Age (per decade) 0.90 (0.69-1.18) 0.80 (0.60-1.10)
Male 1.16 (0.61-2.20) 0.88 (0.43-1.80)
Hypercholesterolemia 0.70 (0.32-1.53) 0.76 (0.33-1.78)
Hypertension 0.60 (0.28-1.31) 0.45 (0.19-1.09)
Diabetes Mellitus 1.48 (0.72-3.03) 2.04 (0.92-4.55)
Smoking 0.95 (0.50-1.80)
Peripheral Arterial Disease 0.97 (0.35-2.67)
Previous Ischemic Stroke 1.47 (0.64-3.39) 1.44 (0.58-3.60)
Previous TIA 0.99 (0.38-2.58)
Previous Intracerebral Hematoma 1.10 (0.07-17.89)
History of Ischemic Heart Disease 1.11 (0.45-2.75)
Degree of Stenosis (per 10%) 1.23 (1.05-1.44)* 1.18 (0.98-1.43)
Plaque Ulceration 4.83 (1.92-12.12)* 3.88 (1.39-10.48)*
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In the present study, a risk factor-free stroke subtype classification was used and stroke 
subtypes were differentiated based on clinical symptoms and MDCT imaging of the brain. 
In concordance with Jackson et al, no significant difference in cardiovascular risk factors 
was observed between patients with non-lacunar and lacunar ischemic stroke. To fur-
ther elucidate the pathophysiological mechanisms associated with subtypes of ischemic 
stroke, we evaluated the relation between parameters of carotid atherosclerosis as as-
sessed by MDCTA of the symptomatic carotid artery. 
Relation of Carotid Artery Stenosis and Plaque 
Ulceration with Non-lacunar Stroke  
The relation of degree of stenosis and plaque ulceration with any ischemic stroke has 
been previously studied using conventional angiographic studies. Previous studies re-
lating degree of stenosis with specific stroke subtypes have identified an association 
with non-lacunar stroke.3,17,18 Accordingly, in the current study a significant relation was 
observed between the severity of carotid stenosis and presence of non-lacunar stroke. 
Plaque ulceration in the symptomatic carotid artery of patients with ischemic stroke has 
been shown to be independently associated with an increased risk of recurrent ipsilateral 
ischemic stroke in patients using medical treatment in the North American Symptomatic 
Carotid Endarterectomy Trial and European Carotid Surgery Trial (ECST)  study.4,5 Howev-
er, no previous studies have evaluated the association of plaque ulceration with non-la-
cunar stroke in particular. 
Atherosclerotic carotid plaque ulcerations are thought to be a marker of previous plaque 
ruptures.19 After plaque rupture, thrombogenic material is exposed to blood initiating 
platelet aggregation and thrombus formation, ultimately leading to thromboembolism 
or local carotid artery occlusion.20 Emboli from ruptured atherosclerotic carotid plaques 
may occlude the intracranial cerebral arteries, resulting in ischemia of cortical and sub-
cortical brain tissue. Accordingly, Lovett et al21 observed a strong correlation between 
atherosclerotic plaque ulceration in the carotid artery and histological characteristics of 
plaque instability including plaque rupture, intraplaque hemorrhage and large lipid core. 
The results of the present study support this underlying mechanism by revealing an in-
dependent association between plaque ulceration in the symptomatic carotid artery and 
non-lacunar stroke. In addition, current results suggest a different pathophysiological 
mechanism in non-lacunar and lacunar stroke subtypes. 
Clinical and Research Implications
Recent research on atherosclerosis has shifted from severity of stenosis toward parame-
ters of plaque vulnerability. Plaque surface morphology and plaque ulcerations may be a 
reflection of plaque vulnerability. Plaque surface evaluation of the symptomatic carotid 
artery has been recommended in an algorithm for clinical decision making concerning 
carotid endarterecomy.22 That particular algorithm is based on the results of the North 
American Symptomatic Carotid Endarterectomy Trial and ECST data, in which plaque 
surface morphology was evaluated using conventional arterial angiography. However, 
in current clinical practice conventional angiography is increasingly replaced by non-in-
vasive imaging modalities such as MDCTA and MRA. Both techniques provide accurate 
non-invasive evaluation of carotid artery stenosis. In addition, MDCTA provides supple-
mentary information on plaque surface morphology as compared to MRA.7 Accordingly, 
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for individual risk stratification assessment of plaque surface morphology could be based 
on MDCTA rather than conventional angiography. This study further supports the impor-
tance  of etiologic stroke subtype assessment in stroke patients and the evaluation of 
plaque morphology in patients with non-lacunar stroke. Furthermore, future studies eval-
uating the relation between atherosclerotic disease in the carotid bifurcation and clinical 
events or brain tissue damage should take into account the heterogeneity of stroke eti-
ologies.
Study Limitations 
The current study is based on carotid analysis by MDCTA, and findings were not con-
firmed by histological specimens. Thus far, MDCTA  has been validated for detection of 
plaque ulceration in one stuy.6 The good accuracy observed in that particular study re-
mains to be confirmed. The applied stroke subtype classification was based on clinical 
symptoms and corrected for relevant infarctions seen on MDCT of the brain. In patients 
with a transient ischemic attack in whom the diagnosis is often solely based on the pa-
tients’ history, subtype classification may be less accurate. MRI of the brain, especially 
when combined with diffusion-weighted imaging, can better-detect and localize infarcts 
resulting in an improved classification of stroke subtypes. Furthermore, stroke classifica-
tion based on clinical symptoms alone may lead to misclassification of stroke subtype in 
25% of the patients.23 In the current study, the clinical classification of stroke subtypes was 
corrected for relevant infarctions seen on MDCT of the brain. This refinement has likely 
improved the accuracy of stroke subtype classification. However, relevant infarctions on 
MDCT of the brain were absent in 70% of the patients. Accordingly, an overall misclassifi-
cation of stroke subtype may be possible in up to ≈20% of the study population. Of note, 
the current study results were confirmed by a subanalysis in patients with relevant brain 
infarction on MDCT, in which an independent association was found between carotid 
plaque ulceration and non-lacunar infarction. It should be acknowledged that given the 
limited total number of relevant infarctions, this analysis was based on a small number of 
ulceration (23 in non-lacunar infarctions compared to 7 in lacunar infarctions). 
Finally, the present study has a cross-sectional design. Therefore, the prognostic value 
of carotid plaque ulcerations in different stroke subtypes remains to be determined in 
follow-up studies. 
Conclusion 
Atherosclerotic plaque ulceration of the symptomatic carotid artery is strongly related to 
non-lacunar ischemic events as compared to lacunar ischemic events, independently of 
severity of stenosis. This finding was confirmed by an independent association between 
the presence of atherosclerotic carotid plaque ulceration and non-lacunar infarctions on 
MDCT of the brain. These results indeed suggest that non-lacunar ischemic stroke and 
lacunar stroke are caused by different pathophysiological mechanisms. Plaque ulceration 
is an important factor to evaluate in future prognostic and therapeutic studies of patients 
with carotid atherosclerotic disease.
83
chapter 3.1
References
1. Fisher CM. Lacunar strokes and infarcts: A review. Neurology. 1982;32:871-876
2. Warlow C, Sudlow C, Dennis M, et al. Stroke. Lancet. 2003;362:1211–1224
3. Jackson C, Sudlow C. Are Lacunar Strokes Really Different? A Systematic Review of Differences in 
Risk Factor Profiles Between Lacunar and Nonlacunar Infarct. Stroke. 2005;36:891-904
4. Eliasziw M, Streifler JY, Fox AJ, et al. Significance of plaque ulceration in symptomatic patients 
with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial. 
Stroke. 1994;25:304-308
5. Rothwell PM, Gibson R, Warlow CP. Interrelation between plaque surface morphology and de-
gree of stenosis on carotid angiograms and the risk of ischemic stroke in patients with symptom-
atic carotid stenosis. On behalf of the European Carotid Surgery Trialists’ Collaborative Group. 
Stroke. 2000;31:615-621
6. Saba L, Caddeo G, Sanfilippo R, et al. Efficacy and sensitivity of axial scans and different recon-
struction methods in the study of the ulcerated carotid plaque using multidetector-row CT angi-
ography: comparison with surgical results. AJNR Am J Neuroradiol. 2007;28:716-723
7. Randoux B, Marro B, Koskas F, et al. Carotid artery stenosis: prospective comparison of CT, 
three-dimensional gadolinium-enhanced MR, and conventional angiography. Radiology. 
2001;220:179-185
8. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. 
Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treat-
ment. Stroke. 1993;24:35-41
9. Current management of amaurosis fugax. The Amaurosis Fugax Study Group. Stroke. 1990;21:201-
208
10. de Monyé C, Cademartiri F, de Weert TT, et al. Sixteen-detector row CT angiography of carotid 
arteries: comparison of different volumes of contrast material with and without a bolus chaser. 
Radiology. 2005;237:555-562
11. de Monyé C, de Weert TT, Zaalberg W, et al. Optimization of CT angiography of the carotid artery 
with a 16-MDCT scanner: craniocaudal scan direction reduces contrast material-related perive-
nous artifacts. AJR Am J Roentgenol. 2006;186:1737-1745
12. de Weert TT, Ouhlous M, Zondervan PE, et al. In vitro characterization of atherosclerotic carotid 
plaque with multidetector computed tomography and histopathological correlation. Eur Radiol. 
2005;15:1906-1914
13. Rothwell PM, Gibson RJ, Slattery J, et al. Prognostic value and reproducibility of measurements 
of carotid stenosis. A comparison of three methods on 1001 angiograms. European Carotid Sur-
gery Trialists’ Collaborative Group. Stroke. 1994;25:2440-2444
14. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifi-
able subtypes of cerebral infarction. Lancet. 1991;337:1521-1526
15. Murat Sumer M, Erturk O. Ischemic stroke subtypes: risk factors, functional outcome and recur-
rence. Neurol Sci. 2002;22:449-454
16. Grau AJ, Weimar C, Buggle F, et al. Risk factors, outcome, and treatment in subtypes of ischemic 
stroke: the German stroke data bank. Stroke. 2001;32:2559-2566
17. Boiten J, Lodder J. Lacunar infarcts. Pathogenesis and validity of the clinical syndromes. Stroke. 
1991;22:1374-1378
18. Schmal M, Marini C, Carolei A, et al. Different vascular risk factor profiles among cortical infarcts, 
small deep infarcts, and primary intracerebral haemorrhage point to different types of underly-
ing vasculopathy. A study from the L’Aquila Stroke Registry. Cerebrovasc Dis. 1998;8:14-19
19. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126
20. Lammie GA, Sandercock PA, Dennis MS. Recently occluded intracranial and extracranial carotid 
arteries. Relevance of the unstable atherosclerotic plaque. Stroke. 1999;30:1319-1325
Ca
ro
tid
 p
la
qu
e 
ul
ce
ra
tio
n
84
21. Lovett JK, Gallagher PJ, Hands LJ, et al. Histological Correlates of Carotid Plaque Surface Mor-
phology on Lumen Contrast Imaging. Circulation. 2004; 110:2190-2197
22. Rothwell PM. Medical and surgical management of symptomatic carotid stenosis. Int J Stroke. 
2006;1:140-149
23. Mead GE, Lewis SC, Wardlaw JM, et al. How well does the Oxfordshire community stroke project 
classification predict the site and size of the infarct on brain imaging? J Neurol Neurosurg Psychia-
try. 2000;68:558-562
85
chapter 3.1

Chapter 3.2 
Evolution of atherosclerotic carotid 
plaque morphology: Do ulcerated 
plaques heal? A serial Multidetector 
CT Angiography study
M.J. van Gils • P.J. Homburg • S. Rozie • T.T. de Weert •  
D.W.J. Dippel • A. van der Lugt
Cerebrovasc Dis 2011;31:263-270
DOI: 10.1159/000322152
Ca
ro
tid
 p
la
qu
e 
ul
ce
ra
tio
n
88
Abstract
Background Atherosclerotic carotid plaque rupture may lead to thrombo-embolization, 
causing transient ischemic attack or ischemic stroke. Carotid plaque ulceration on angiog-
raphy is associated with plaque rupture. Although healing of ruptured plaques has been 
described in coronary arteries, little is known about the natural development of plaque 
ulcerations in carotid arteries. We therefore explored the evolution of carotid plaque sur-
face morphology with serial multidector CT angiography (MDCTA).
Methods From a registry of patients with transient ischemic attack or minor ischemic 
stroke, we selected 83 patients who had undergone serial MDCTA of the carotid arteries. 
Arteries subjected to revascularization procedures between the two scans were exclud-
ed (n=11). Plaque surface morphology was classified as smooth, irregular or ulcerated on 
both baseline and follow-up MDCTA. Progression (i.e. development of irregularities or 
ulceration) and regression (i.e. disappearance of irregularities or ulceration) in morphol-
ogy were evaluated. 
Results The mean time interval between the MDCTA scans was 21±13 months. At base-
line, 28 (18%) arteries were normal, 124 (80%) contained atherosclerotic plaque and 3 (2%) 
were occluded. Plaque surface morphology was smooth in 86 arteries (55%), irregular 
in 23 (15%) and ulcerated in 15 (10%). At follow-up, surface morphology was unchanged 
in 88% of arteries, had progressed in 8% and regressed in 4%. Most importantly, plaque 
morphology remained unchanged in most ulcerated plaques (10/15; 67%). One ulcerated 
plaque had progressed, whereas 4 had regressed. New ulcerations had developed in 2 
non-ulcerated plaques. 
Conclusion MDCTA allows evaluation of temporal changes in atherosclerotic carotid 
plaque morphology. Plaque surface morphology remained unchanged in most arteries. 
Carotid ulcerations persist for a long time, and may remain a potential source of throm-
boembolism. 
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Introduction
Carotid plaque ulceration is associated with plaque rupture,1 which is an important ele-
ment in the cascade between vulnerable plaque and the occurrence of thromboembolic 
events.2,3 In addition to this, carotid plaque ulcerations may be an additional cause of em-
bolic stroke due to local flow disturbances.4-6 While there is evidence of a healing process 
of plaque ruptures in the coronary arteries which contributes to the degree of luminal 
narrowing,7,8 little is known about the healing process of plaque ruptures in carotid ar-
teries. 
Current knowledge about the evolution of atherosclerotic plaque rupture is mainly based 
on histological analysis of coronary arteries in autopsy studies9,10 or carotid plaque speci-
mens obtained from carotid endarterectomy.11-13 However, for extensive investigation of 
the temporal changes of plaque surface characteristics and their relation with recurrent 
thromboembolic events, longitudinal noninvasive serial imaging studies are required. 
Computed tomography angiography has been demonstrated to be superior to angiog-
raphy in detecting plaque ulcerations14 and multidetector CT angiography (MDCTA) has 
been found to have a high sensitivity and specificity (94% and 99%, respectively) in detect-
ing plaque ulcerations.15 Therefore MDCTA is an appropriate noninvasive imaging tech-
nique for studying plaque ulceration. As MDCTA is able to identify and classify plaque ul-
cerations with a very good interobserver agreement,16 it is also suitable for serial imaging.
To explore the natural history of ulcerated plaques and to assess whether plaque ulcer-
ations heal, we studied the temporal changes in plaque surface morphology on serial 
MDCTA in patients with transient ischemic attack (TIA) or minor ischemic stroke. 
Materials and Methods
Study population
From November 2002 to January 2007, 911 consecutive patients with amaurosis fugax, 
TIA or minor ischemic stroke (Rankin score < 4) who underwent MDCTA of the carotid 
arteries were registered. From November 2002 until December 2004, MDCTA was per-
formed as part of a research protocol approved by the Institutional Review Board. All 
patients gave written informed consent. Onwards of January 2005, MDCTA was per-
formed as part of standard clinical workup. Patients were enrolled from the neurology 
department’s specialized TIA/stroke outpatient clinic or neurology ward and underwent 
neurological examination on admission; symptoms, risk factors and medication use were 
reported. Follow-up MDCTA scans of the carotid arteries were registered. 
For the present study we selected the patients from our registry who had undergone 
more than one MDCTA of the carotid arteries in the period November 2002 to December 
2008 (n=84). One patient was excluded because of poor image quality caused by dental 
artifacts on both MDCTA scans. If more than two MDCTA scans per patient had been per-
formed, the one with the largest lead time before any surgical treatment was evaluated 
in this study. Arteries subjected to revascularization procedures between the two scans 
were excluded (n=11).The present study was approved by the Institutional Review Board.
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Cardiovascular risk factors
Hypercholesterolemia was defined as fasting cholesterol > 5.0 mmol/L or treatment with 
cholesterol-lowering medication. Hypertension was defined as a systolic blood pressure 
> 140 mmHg and/or a diastolic blood pressure >90 mmHg during two episodes of at least 
15 minutes of continuous non-invasive blood pressure measurement, or treatment with 
antihypertensive medication. Diabetes was defined as serum glucose levels > 7.9 mmol/L, 
HbA1c > 6.5%, or use of anti-diabetic medication. Smoking was categorized as either cur-
rent smoking or non-smoking. Information was collected on previous peripheral vascular 
disease (intermittent claudication and/or ankle/arm systolic blood pressure ratio < 0.85; 
or a history of related leg amputation, reconstructive surgery or angioplasty), previous 
ischemic TIA or stroke, and previous cardiovascular disease (myocardial infarction, angi-
na pectoris, coronary artery bypass graft) or otherwise previous cardiac disease (atrium 
fibrillation, chronic heart failure). 
MDCTA data acquisition 
Imaging was performed on a 16-slice multidetector CT scanner (Siemens, Sensation 16, 
Erlangen, Germany) or a 64-slice MDCT scanner (Siemens, Sensation 64) with a standard-
ized, optimized contrast-enhanced protocol (120 kVp, 180 mAs, collimation 16 x 0.75 or 
32 x 2 x 0.6 mm, pitch ≤1).17,18 The scan range extended from the ascending aorta to the 
intracranial circulation. All patients received 80 mL of contrast material (iodixanol 320 
mg/ml, Visipaque, Amersham Health, Little Chalfont, UK), followed by 40 mL saline bolus 
chaser, both at an injection rate of 4 mL/sec. Real-time bolus tracking at the level of the 
ascending aorta was used to synchronize passage of contrast material and data acquisi-
tion. Image reconstructions were made with a 120 mm FOV, a matrix size of 512 x 512, a 
slice thickness of 1.0 mm, a slice increment of 0.6 mm, and intermediate reconstruction 
algorithms (B30 and B46).
Analysis of the atherosclerotic plaque
The MDCTA images were sent to a workstation (Leonardo-Siemens Medical Solutions, 
Forchheim, Germany) equipped with dedicated 3-D analysis software. Multi-planar refor-
matting software was used to evaluate both carotid bifurcations in multiple reformations 
and different planes. Each carotid artery was evaluated for the presence of an atheroscle-
rotic plaque, defined as the presence of thickening of the vessel wall and/or a calcification 
in the wall. Atherosclerotic plaque surface morphology was evaluated and classified as 
smooth, irregular or ulcerated. Plaques were classified as ulcerated if contrast material 
extended into the plaque, being visible in at least two perpendicular planes. The number 
of ulcerations per carotid artery was recorded. Irregularities were described as preste-
notic or poststenotic dilatation and/or irregular plaque-surface morphology without ex-
tension of contrast material into the plaque. Plaques that were not ulcerated or irregular 
were classified as smooth. The interobserver agreement for the presence of plaque ulcer-
ation as described above was found to be good (kappa=1.00; 95% CI 0.86-1.00).16
In addition, plaque density was evaluated as previously described by Saba et al.19 In ath-
erosclerotic carotid plaques, the mean Hounsfield unit attenuation was measured within 
manually drawn regions of interest covering the plaque on three consecutive axial im-
ages at the level of largest plaque burden. Plaque density was classified as soft, mixed 
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or calcified, according to cut-off values derived from a method validated by Schroeder 
et al20: soft plaques with mean density values < 50 HU, intermediate plaques with mean 
density values between 50 and 119 HU and calcified plaques with a mean density value ≥ 
120 HU. 
The number of calcifications in the investigated plaques was manually counted within a 
range of 3 cm above to 3 cm under the bifurcation point. An automated calcium scoring 
tool was used to assess calcium volumes within this same range, using a cut-off value of 
600 HU to differentiate calcifications from contrast material in the lumen.   
Assessment of changes in plaque morphology
The atherosclerotic plaque morphology at baseline and follow-up MDCTA were evaluated 
separately, with a time interval of more than one month between the two assessments. 
Two experienced observers blinded to clinical data analyzed the multi-planar reformation 
images. Discrepancies were resolved by consensus. Additionally, temporal changes in 
morphology between baseline and follow-up MDCTA scans were verified by a consensus 
reading where necessary. Changes in atherosclerotic plaque morphology were consid-
ered as progression if irregularities, ulceration or occlusion had developed. Regression 
was defined as disappearance of ulceration or irregularities. 
Statistics
Where appropriate, data are presented descriptively as numbers and percentages and 
means ± standard deviations. We evaluated the association between cardiovascular risk 
factors and baseline plaque morphology and between cardiovascular risk factors and 
temporal change in plaque morphology. Differences between categorical data and con-
tinuous data were analyzed with a χ2 test and a Mann-Whitney test or a Student t test, re-
spectively. Temporal changes in continuous data on plaque characteristics were analyzed 
with a paired-samples t test.
Results
In total, 83 patients who had undergone a baseline MDCTA as well as a follow-up MDCTA 
evaluation of the carotid arteries were included. The mean time period between the seri-
al scans was 21 ± 13 months. The mean age in the study population was 60 ± 12 years, and 
the majority of patients were male (64%; Table 1). In 75 patients (90%), the indication for 
follow-up MDCTA was recurrent TIA or ischemic stroke; in 39 (47%), the recurrent event 
was attributed to the same vascular distribution as the previous attack, and in 36 (43%) a 
different vascular territory was involved. In eight patients (10%), a follow-up MDCTA was 
performed for pre- and post interventional indications or for neurological symptoms that 
could not be attributed to a specific vascular territory. 
Of the 166 carotid arteries in 83 patients, 11 arteries were excluded, because of treatment by 
carotid endarterectomy (n=3) or because of stent placement (n=8) in the period between 
the baseline and follow-up MDCTA. One-hundred-fifty-five carotid arteries were available 
for analysis of changes in atherosclerotic plaque characteristics on follow-up MDCTA.
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Table 2 shows plaque characteristics of the carotid arteries on baseline and follow-up 
MDCTA scans. At baseline, 28 (18%) carotid arteries were normal, 124 (80%) contained 
atherosclerotic plaque, and 3 arteries were occluded. The majority (n=86, 55%) of vessels 
had a smooth plaque surface, whereas 23 (15%) had irregular plaque surfaces. Fifteen of 
the 155 vessels (10%) had an ulcerated plaque surface; most arteries contained one ulcer-
ation. These ulcerated plaques were present in 15 patients. Most of the plaques (119/124; 
96%) were mixed or calcified plaques, since the majority of carotid plaques (102/124, 82%) 
contained at least some calcifications. The mean HU density of the 124 plaques at baseline 
was 179 ± 147 HU, which increased to 216 ± 187 HU over time (p=0,001). The number of 
calcifications did not significantly change over time (4.9 ± 3.5 at baseline versus 4.6 ± 3.2 
at follow-up, p=0.21), whereas calcium volume increased significantly (44.7 ± 72.1 mm3 at 
baseline versus 62.8 ± 92.2 mm3 at follow-up, p<0.001).
Changes in surface morphology between the baseline and the follow-up MDCTA are pre-
sented in Table 3. On the follow-up MDCTA the surface morphology was unchanged in 137 
(88%) of the carotid arteries, whereas 12 (8%) had progressed and 6 (4%) had regressed. 
The 12 arteries that had progressed were present in 10 patients. The morphology of most 
ulcerated plaques (10 out of 15) had not changed over a mean time period of 20 ± 15 
months, as illustrated by an example in figure 1. A second ulceration evolved in one ulcer-
ated plaque (over 21 months), whereas a new ulceration developed in two non-ulcerated 
Total Patients (N=83)
Age (years, mean ± SD)                                 
Gender (% male)                                            
Risk factors (%):
- previous cerebrovascular disease  
- previous cardiovascular disease 
- peripheral vascular disease 
- hypertension                                         
- hypercholesterolemia                                  
- diabetes mellitus                                         
- smoking                                           
Cerebrovascular symptoms (%):
    Amaurosis fugax
    TIA
    Minor stroke
Symptomatic artery (%):
    Carotid
    Vertebrobasilar
59.8 ± 12.4
53 (64%)
36 (43%)
16 (19%)
6 (7%)
61 (73%)
64 (77%)
22 (27%)
29 (35%)
8 (10%)
33 (40%)
42 (51%)
68 (82%)
15 (18%)
Table 1. Baseline characteristics of the study population
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plaques (over 29 and 40 months). Four ulcerated plaques regressed (over 3, 9, 14 and 44 
months), of which an example is shown in figure 2. 
We did not find any associations between cardiovascular risk factors and baseline plaque 
morphology and between cardiovascular risk factors and temporal change in plaque mor-
phology. There was no relation between changes in plaque morphology and the occur-
rence of TIA or ischemic stroke at baseline or follow-up (Table 4).
Discussion
This is the first MDCTA study that longitudinally evaluates the natural evolution of ca-
rotid plaque surface morphology. Our results show that plaque surface morphology re-
mains largely unchanged, and that regression and progression occur in just a minority 
of plaques after a time period of 21 ± 13 months. Most importantly, plaque ulcerations 
do not disappear; 10 out of 15 ulcerated plaques had a similar appearance after 20 ± 15 
Baseline MDCTA Follow-up MDCTA
Occlusion
No plaque
Plaque 
   Plaque surface morphology
   Smooth plaque surface
   Irregular plaque surface
   Ulcerated plaque
       Number of ulcerations
       1
       2
       3
   Plaque density *
       Soft plaque
       Mixed plaque
       Calcified plaque
   Calcifications **
       Mean number of calcifications 
       Mean calcium volume (mm3)
3 (2%)
28 (18%)
124 (80%)
86 (55%)
23 (15%)
15 (10%)
12
2
1
5 (4%)
51 (41%)
68 (55%)
4.9 ± 3.5
44.7 ± 72.1
4 (3%)
24 (15%)
127 (82%)
87 (56%)
26 (17%)
14 (9%)
11
2
1
6 (5%)
46 (36%)
75 (59%)
4.6 ± 3.2
62.8 ± 92.2
Table 2. Plaque characteristics of 155 carotid arteries on baseline and on follow-up MDCTA
*   Assessed in carotid arteries containing plaque 
** Assessed in carotid arteries containing plaques with calcification at baseline (n=102)
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months. Mean plaque density increased over time, while the number of calcifications did 
not change significantly. The increased density can be explained by the increase in vol-
ume and density of the calcifications.  
Carotid plaque ulceration is associated with fibrous cap rupture,1 which is an important 
cause of thromboembolic events.3,12 Current imaging modalities allow the visualization 
of carotid plaque ulceration, which is associated with cap rupture and other features of 
plaque instability.1 The site of ulceration probably represents part of the plaque where 
fibrous cap and part of the necrotic core has disappeared and has most probably em-
bolized.13 However, our results show that plaque ulceration on MDCTA images does not 
necessarily suggest that the plaque rupture is recent.  
Since a healing process of ruptured coronary plaques has been described in histologi-
cal studies,7,8 our finding of temporarily unchanged carotid plaque ulcerations on serial 
MDCTA imaging was unexpected. In coronary arteries a mechanism of plaque healing 
has been reported in which layers of collagen, proteoglycan-rich matrix and smooth mus-
cle cells overly the ruptured cap and contribute to increased luminal narrowing.7,8,13 One 
case report has described the concept of rupture and healing in a carotid atherosclerotic 
plaque visualized with magnetic resonance imaging (MRI).21 We therefore expected that 
Figure 1. Multiplanar reformat images (on top) and axial images (below) showing a carotid bifurcation of the 
same patient with plaque ulceration (arrows) in the proximal internal carotid artery. The time delay between 
the MDCTA scans was 11 months (a à b) and 13 months (b à c) respectively. No change in appearance of plaque 
morphology is found.
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carotid plaque ulcerations might fill and disappear. Our findings may be explained by the 
differences in vessel size and haemodynamic forces in carotid arteries compared to cor-
onary arteries, or by the possibility that ulcerations reflect the more severely ruptured 
plaques. It is uncertain which time interval should be regarded as sufficient to demon-
strate long term changes in plaque morphology. However, we consider a mean follow-up 
period of almost two years sufficient to evaluate changes, since healing of ulceration as 
assessed with MRI has been reported to occur within two months.21 
Our results are indirectly supported by some observations that also question the concept 
of healing of carotid plaque ulcerations. Whereas a histological study found plaque ulcer-
ations to be more common in symptomatic carotid arteries than in asymptomatic arteries 
(36% versus 14%, p<0.0001), the prevalence of ulceration in the ipsilateral and contralateral 
carotid artery in symptomatic patients was the same.22 Likewise, an MDCTA study report-
ed that the prevalence of complicated plaques (i.e. irregularities and ulcerations) was 
25% in symptomatic carotid arteries and 18% in asymptomatic carotid arteries.16 Whereas 
ulcerations seem to correlate with symptomatic arteries, they are also present in asymp-
tomatic arteries. This might be explained either by the fact that not every plaque rupture 
leads to thrombosis and embolization, or that the embolized particles dissolve or cause 
clinically silent infarctions. Another explanation of the incidental detection of ulcerations 
in asymptomatic arteries may be that plaque ulcerations heal very slowly or do not disap-
pear at all. The findings correspond to our own: ulcerations can persist unchanged for a 
long time in both symptomatic and asymptomatic carotid arteries. 
Plaque Morphology Baseline MDCTA Follow-up MDCTA Carotid arteries (N)
Unchanged
N=137 (88%)
No plaque
Smooth
Irregular
1 Ulceration
2 Ulcerations
3 Ulcerations
Occlusion
No plaque
Smooth
Irregular
1 Ulceration
2 Ulcerations
3 Ulcerations
Occlusion
24
81
19
8
1
1
3
Progression
N=12 (8%)
No plaque
Smooth
Smooth
Irregular
Irregular
1 Ulceration
Smooth
Irregular
1 Ulceration
Occlusion
1 Ulceration
2 Ulcerations
4
4
1
1
1
1
Regression
N=6 (4%)
1 Ulceration
2 Ulcerations
Irregular
Irregular
1 Ulceration
Smooth
3
1
2
Table 3. Changes in plaque surface morphology between baseline and follow-up MDCTA in 155 carotid arteries
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Persisting plaque ulceration 
may be a potential imag-
ing-based stroke-risk predic-
tor. The presence of plaque 
ulceration on angiography 
has been found to be associ-
ated with recurrent stroke in 
patients with a previous isch-
emic cerebral event.23 The 
question is whether persist-
ing ulcer cavities should be 
regarded merely as a scar af-
ter a previous plaque rupture 
or also as a potential source 
of thromboembolization. In-
deed, some local factors at 
the level of ulceration have 
been found to play an import-
ant role in the development 
of new thrombi. Firstly, plaque ulcerations may induce thrombus formation by disturbing 
the blood flow. In-vitro flow experiments with ultrasound showed that the flow down-
stream from ulcerated, moderate stenotic, carotid plaques was more disturbed than 
from non-ulcerated plaques.24 Similarly, an experimental slipstream visualization tech-
nique showed that the introduction of an ulceration into a stenotic carotid bifurcation 
produced observable flow disturbances.4 Further, color flow Doppler ultrasound, which 
uses detection of vortices, is useful in detecting ulcerated plaques.25 Moreover, local flow 
disturbance caused by ulcerations is likely to favor thrombo-genesis.5,6 Secondly, plaque 
ulcerations may induce thrombus formation by possessing an erosive surface. Whereas 
histological studies describe plaque healing as the deposition of a collagen matrix super-
imposing the ruptured cap,7 they have not described re-endothelialisation. Future studies 
should examine whether the surfaces of persistent ulcerations are prothrombotic.
The clinical and pathophysiological importance of the distinction between ulcerations 
and irregularities is unknown. There is no evidence that ulcerated plaques on angiograph-
ic criteria are any more likely to lead to thrombus formation than irregular plaques. Roth-
well et al.26 found that plaque-surface irregularities were highly predictive of ipsilateral 
ischemic stroke and significantly associated with macroscopic surface ulceration and 
thrombus formation. Our results show that 19 out of 23 irregular plaques on the baseline 
MDCTA remained unchanged on follow-up MDCTA. Our considerations with regard to the 
consequences of persisting ulcerations might also apply to plaque irregularities.
The strength of this serial imaging study is that it presents a way to non-invasively study 
the development of atherosclerotic plaques in human beings. Serial MDCTA provides ad-
Figure 2. Multiplanar reformat imag-
es (on top) and axial images (below) 
of a carotid bifurcation with a time 
delay between the MDCTA scans of 
9 months. The plaque ulceration (ar-
rows) disappeared over time, leav-
ing a smooth plaque surface.
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ditional information that is otherwise difficult to achieve by enabling the investigation of 
the atherosclerotic plaque in earlier stages, at various time points in the same patient, 
and in patients in whom no histological material is available. 
MRI is potentially suitable for serially studying carotid plaque rupture in more detail. Al-
though the status of the fibrous cap has been studied with MDCTA,27 no validation with 
histology is available. MRI can distinguish intact, thick fibrous caps from intact thin and 
disrupted caps in human atherosclerotic carotid arteries in vivo.28 By using MRI, Underhill 
et al. 29 evaluated the predictive value of plaque characteristics for new plaque surface 
disruption. Thin or ruptured fibrous caps have been associated with subsequent symp-
toms during follow-up.30 
Baseline Follow-up N AS à S AS à AS S à AS S à S
no plaque no plaque 24 4 11 4 5
smooth smooth 81 14 37 15 15
irregular irregular 19 5 7 2 5
1 ulceration 1 ulceration 8 1 4 3 0
2 ulcerations 2 ulcerations 1 0 1 0 0
3 ulcerations 3 ulcerations 1 1 0 0 0
occlusion occlusion 3 0 1 0 2
 Total unchanged 137 25 61 24 27
no plaque smooth 4 1 2 1 0
smooth irregular 4 1 0 3 0
smooth 1 ulceration 1 1 0 0 0
irregular occlusion 1 0 0 0 1
irregular 1 ulceration 1 1 0 0 0
1 ulceration 2 ulcerations 1 0 1 0 0
 Total progression 12 4 3 4 1
1 ulceration irregular 3 2 1 0 0
2 ulcerations 1 ulceration 1 1 0 0 0
irregular smooth 2 0 1 0 1
 Total regression 6 3 2 0 1
 Total 155 32 66 28 29
Table 4. Relation between changes in plaque morphology and symptomatology of the carotid arteries. Shown 
are the number of carotid arteries presenting with a particular plaque morphology on baseline and on follow-up 
MDCTA and the number of these arteries that became symptomatic or asymptomatic (AS = asymptomatic, S = 
symptomatic).
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Our study has some limitations. First, the relatively small study population and the low 
overall prevalence of ulcerations meant that we found a small number of ulcerations. 
Nevertheless, we found a clear trend of mainly unchanged ulcerated plaque morphology. 
The second limitation was the study design and our selection of patients with follow-up 
scans that were performed for clinical reasons. These provided a relatively small and het-
erogeneous study population that was unsuitable for evaluating the correlation between 
changes in plaque morphology and symptomatology. Temporal changes in plaque ulcer-
ation should thus be correlated with recurrent thromboembolic events by including a 
larger number of patients in a prospective, long term follow-up study. The small selected 
study population may also underlie the absence of an association between classical car-
diovascular risk factors and plaque morphology. Further, these limitations impeded the 
structural coevaluation of other important plaque characteristics. The third limitation is 
that we evaluated temporal changes at the level of the carotid artery. Since atherosclero-
sis is a systemic disease and atherosclerotic plaques are thought to be liable to systemic 
influences, we might have expected progression or regression of plaque morphology to 
be clustered in particular patients. However, we did not find such clustering. 
Conclusion
By demonstrating that ulcer cavities usually persist for a long time, the results of this 
serial MDCTA study contribute to the knowledge of the evolution of ulcerated plaques. 
Our findings suggest that the detection of plaque ulceration on MDCTA images may not 
have a direct diagnostic value as it may not represent a recent plaque rupture. However, 
persisting carotid ulcerations may remain a potential source of embolism. Further studies 
should reveal whether persisting plaque ulcerations constitute an important source of 
recurrent thromboembolism and whether they may aid future stroke-risk prediction and 
clinical decision-making in individual patients.
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Abstract 
Background and Purpose Symptomatic carotid artery plaque ulceration is associated 
with distinct plaque components such as a large lipid-rich necrotic core (LR-NC) in isch-
emic stroke patients with a ≥50% carotid stenosis. We evaluated the associations between 
carotid artery plaque ulceration and plaque characteristics in ischemic stroke patients 
with ≥50% stenosis as well as in those with a low degree stenosis (0% to 49%). 
Methods Consecutive patients (n=346) with symptoms in the anterior circulation were 
evaluated with multidetector CT angiography (MDCTA) for the presence of atheroscle-
rotic plaque, degree of stenosis, and plaque ulceration in the symptomatic carotid artery. 
Plaque volume and plaque component proportions of LR-NC, fibrous tissue, and calcifica-
tion were measured. The associations between plaque ulceration and plaque characteris-
tics were analyzed using logistic regression.
Results Atherosclerotic plaque was present in 185 patients. Plaque ulcerations were 
present in 38 (21%) patients, of which half had a low degree stenosis (0% to 49%). Plaque 
volume was significantly larger in ulcerated plaques. After adjustment for age, sex, and 
degree of stenosis, LR-NC proportion was strongly associated with plaque ulceration 
(odds ratio, 2.21; 95% CI, 1.49 to 3.27), whereas calcification proportion was inversely asso-
ciated with plaque ulceration (odds ratio, 0.60; 95% CI, 0.40 to 0.89). These associations 
remained significant in patients with a low degree stenosis (0% to 49%).
Conclusion Plaque volume, degree of stenosis, and LR-NC proportion evaluated non-in-
vasively with MDCTA are associated with carotid artery plaque ulceration, even in pa-
tients with a low degree stenosis (0% to 49%). Plaque volume and composition analysis 
with MDCTA may identify rupture prone plaques and improve risk stratification in isch-
emic stroke patients.
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Introduction
Atherosclerotic carotid plaque ulceration is an independent marker of previous plaque 
rupture and an influential predictor of ischemic stroke.1,2 Thus far, histological and non-in-
vasive imaging assessment of the relationship of carotid plaque characteristics with 
plaque surface disruption has been limited to patients with a ≥50% carotid stenosis.3,4 
In patients with severe symptomatic stenosis, carotid plaque ulceration has been asso-
ciated with the presence of fibrous cap rupture and distinct plaque components such 
as intraplaque hemorrhage, large lipid core, and less fibrous tissue.3 However,  a ≥50% 
carotid stenosis is present in only ≈10% of patients with amaurosis fugax, transient isch-
emic attack or minor ischemic stroke.5 Whereas two-third of carotid plaque ulcerations 
is observed in carotid arteries with a low degree stenosis (0% to 49%),6 little is known 
about the relation between carotid plaque characteristics with plaque ulceration in these 
patients. Also, limited data are available on the association between plaque volume and 
carotid plaque surface disruption.4
Analysis of atherosclerotic plaque volume and plaque composition using non-invasive 
imaging could be useful to identify rupture prone plaques. However, concomitant as-
sessment of carotid plaque characteristics associated with plaque rupture cannot be ad-
vocated in the general population of ischemic stroke patients without knowledge of the 
relation between plaque characteristics and plaque surface disruption.
In the present study, we analyzed the relationship between the symptomatic carotid 
plaque characteristics, comprising of plaque component proportions and plaque volume, 
with plaque ulceration in consecutive patients with amaurosis fugax, transient ischemic 
attack or ischemic stroke using multidetector CT angiography (MDCTA). The analysis in-
cluded and compared the associations of plaque characteristics with plaque ulceration in 
symptomatic carotid arteries with significant stenosis (≥50%), as well as in those with a 
low degree stenosis (0% to 49%).
Materials and Methods
Study Population
From a prospective registry of 911 consenting patients with amaurosis fugax, transient 
ischemic attack or ischemic stroke (Rankin score <4) who underwent MDCTA of the carot-
id arteries, we selected a 2-year cohort of consecutive patients (n=346) with symptoms 
in the anterior circulation. Patients were enrolled from a specialized transient ischemic 
attack/stroke outpatient clinic or the neurology ward. All patients underwent an inter-
view, neurological examination, electrocardiography, laboratory analysis, and MDCTA on 
admission. Medical history and cardiovascular risk factors as defined previously7 were 
recorded. Patients without atherosclerotic plaque (n=137), with carotid occlusion (n=20), 
and patients with an MDCTA of insufficient quality (n=4) were excluded from the analysis. 
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MDCTA Data Acquisition and Data Analysis
Imaging was performed with a 16-slice MDCT scanner (Sensation 16, Siemens, Erlangen, 
Germany) or a 64-slice MDCT scanner (Sensation 64, Siemens, Erlangen, Germany) with 
a standardized optimized contrast-enhanced protocol (120 kVp, 180 mAs, collimation 
16x0.75 mm or 64x0.6 mm, pitch≤1).8 Details of the MDCTA scan protocol have been de-
scribed previously.7,9 
MDCTA images were sent to a stand-alone workstation (Leonardo – Siemens Medical 
Solutions, Forchheim, Germany) with dedicated 3D-analysis software. The symptomatic 
carotid bifurcation was evaluated by 2 experienced investigators blinded to clinical data 
with multiplanar reformatting software, which allows reconstruction of sagittal, coronal, 
and oblique views from axial sections. Discrepancies were solved by consensus.
Symptomatic carotid arteries were evaluated for the presence of atherosclerotic plaque, 
defined as thickening of the vessel wall or the presence of calcification. Plaque ulcer-
ation was defined as extension of contrast media beyond the vascular lumen into the sur-
rounding plaque. Degree of stenosis in the symptomatic carotid artery was determined 
according to the NASCET criteria10 on multi-planar reformatting images perpendicular to 
the central lumen line. 
Plaque volume and plaque component proportions were measured with custom-made 
software, programmed in MeVisLab (MeVis Research, Bremen, Germany). Using this soft-
ware, the components of the atherosclerotic plaque within regions of interest drawn on 
axial MDCTA images can be determined from their corresponding Hounsfield values us-
ing thresholds determined previously.11 The threshold for the distinction between fibrous 
tissue and lipid-rich necrotic core (LR-NC) was set at 60 Hounsfield units. The threshold 
for distinguishing calcifications from fibrous tissue was set at 130 Hounsfield units; the 
value currently used for calcium scoring. Based on previous studies it may be assumed 
that intraplaque hemorrhage, if present, would be classified as LR-NC11 or fibrous tissue.12 
Plaque volume and plaque component volumes were automatically calculated from the 
number and dimensions of voxels for different ranges of Hounsfield unit values within 
the regions of interest (Figure 1). Plaque component proportions were calculated from 
plaque component volumes as a percentage of the plaque volume. 
Statistical Analysis
Baseline population and plaque characteristics are presented as mean±SD or number of 
patients (%). Differences were tested with χ2 tests, Fisher’s Exact tests or Mann-Whitney 
tests when appropriate. For logistic regression analysis continuous data were divided by 
10 or 100, as indicated in the relevant tables. 
The correlation between degree of stenosis and plaque volume was evaluated by cal-
culation of the Spearman rank correlation coefficient. The associations between carotid 
plaque ulceration and degree of stenosis, plaque volume, and plaque component propor-
tions were evaluated using logistic regression analysis. Two models were constructed. In 
model I, plaque characteristics were adjusted for age and sex. In model II, adjustments 
were made for age, sex, and degree of stenosis. Finally, in a stratified analysis the asso-
ciations between carotid plaque ulceration and plaque characteristics were evaluated in 
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patients with low (0% to 49%), and with significant (≥50%) carotid stenosis, with adjust-
ment for age, sex, and degree of stenosis. P-values ≤0.05 were considered statistically 
significant. All analyses were performed using SPSS 15.0 statistical package for Windows 
(SPSS Inc, Chicago, IL).
Results 
Patients Characteristics 
From the 346 evaluated patients, 185 patients with atherosclerotic plaque were includ-
ed in all further analyses. Baseline characteristics of patients with and without athero-
sclerotic plaque ulceration in the symptomatic carotid artery are illustrated in Table 1. 
Atherosclerotic plaque ulceration in the symptomatic carotid artery was present in 38 
(21%) patients. The prevalence of cardiovascular risk factors was not significantly different 
between the 2 groups. 
Plaque Characteristics on MDCTA
Atherosclerotic plaque characteristics of patients with and without atherosclerotic 
plaque ulceration in the symptomatic carotid artery are illustrated in Table 2. Degree of 
stenosis was significantly higher in patients with plaque ulceration. In patients with ca-
rotid artery ulcerations, 19 had 0% to 49% stenosis, whereas the remaining 19 patients had 
≥50% stenosis (Figure 2). 
Plaque volume of ulcerated plaques was significantly larger as compared with nonulcer-
ated plaques. A moderate correlation was observed between degree of stenosis and 
Figure 1. Two succeeding axi-
al MDCTA images illustrating an 
ulcerated plaque in the internal 
carotid artery (left). The plaque 
composition is visible in the im-
age overlay (right), with LR-NC 
(yellow), fibrous tissue (green), 
calcifications (white), and the con-
trast-filled lumen and plaque ulcer-
ation (red with blue border-zone).
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plaque volume (rs=0.57; P=0.01). Ulcerated plaques contained a significantly larger LR-NC 
volume, fibrous tissue volume, and LR-NC proportion. Fibrous tissue proportion was sig-
nificantly lower in ulcerated plaques as compared with non-ulcerated plaques.
Patients with 
Plaque Ulceration
(n=38; 21%)
Patients without 
Plaque Ulceration
(n=147; 79%) P-value
Age (yr) 67±10 67±11 0.74
Male 28 (74%) 93 (63%) 0.26
Hypercholesterolemia 28 (74%) 124 (84%) 0.15
Hypertension 27 (71%) 120 (82%) 0.15
Diabetes mellitus 4 (11%) 30 (20%) 0.24
Smoking 17 (45%) 45 (31%) 0.10
Peripheral arterial disease 4 (11%) 15 (10%) 1.00
Previous ischemic stroke 7 (18%) 19 (13%) 0.43
Previous TIA 8 (21%) 27 (18%) 0.82
Previous intracerebral hematoma 2 (5%) 2 (1%) 0.19
History of ischemic heart disease 7 (18%) 42 (29%) 0.30
Table 1. Characteristics of patients with and without symptomatic carotid artery plaque ulceration
Data are number (percentage), or mean±SD. 
Patients with  
Plaque Ulceration
(n=38; 21%)
Patients without 
Plaque Ulceration
(n=147; 79%) P-value
Degree of Stenosis 44±29% 18±27% <0.001
Plaque volume 1320±708 mm3 765±588 mm3 <0.001
LR-NC volume 416±283 mm3 168±197 mm3 <0.001
Fibrous volume 736±333 mm3 468±306 mm3 <0.001
Calcification volume 163±178 mm3 129±180 mm3 0.196
LR-NC proportion 29±10% 18±10% <0.001
Fibrous proportion 60±11% 67±13% 0.001
Calcification proportion 10±9% 15±14% 0.152
Table 2. Plaque characteristics of patients with and without symptomatic carotid artery plaque ulceration
Data are means±SD.
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Plaque Characteristics 
associated with Plaque 
Ulceration on MDCTA
Results of multivariable analyses 
relating plaque characteristics and 
plaque ulcerations are provided in 
Table 3 and 4. After adjustment for 
age and sex (model I), degree of 
stenosis, plaque volume, and the LR-
NC proportion were associated with 
plaque ulceration, whereas fibrous 
proportion was inversely associated 
with plaque ulceration. After adjust-
ment for age, sex, and degree of ste-
nosis (model II), plaque volume and 
the LR-NC proportion remained significantly associated with plaque ulceration, whereas 
the calcification proportion was inversely associated with plaque ulceration. 
In a stratified analysis of patients with a low degree stenosis of 0% to 49% (n=144), the LR-
NC proportion remained strongly associated with plaque ulceration, whereas the calcifi-
cation proportion remained inversely associated with plaque ulceration. In patients with 
significant stenosis of ≥50% (n=41), plaque volume was associated with plaque ulceration, 
whereas a trend towards a significant association between the LR-NC proportion and 
plaque ulceration was observed.
Figure 2. Bar graph illustrating the degree of 
stenosis of the symptomatic carotid artery 
in patients with atherosclerotic plaque ulcer-
ations (n=38).
Model I Model II
OR (95% CI) P-value OR (95% CI) P-value
Degree of Stenosis (/10%) 1.33 (1.18-1.50) <0.001 n.a. n.a.
Plaque volume (/100mm3) 1.14 (1.07-1.21) <0.001 1.09 (1.02-1.16) 0.01
LR-NC proportion (/10%) 2.58 (1.77-3.78) <0.001 2.21 (1.49-3.27) <0.001
Fibrous proportion (/10%) 0.64 (0.48-0.87) 0.004 0.85 (0.60-1.20) 0.35
Calcification proportion (/10%) 0.75 (0.54-1.04) 0.08 0.60 (0.40-0.89) 0.01
Table 3. Multivariable analysis for the associations between symptomatic carotid artery plaque ulceration and 
plaque characteristics
NA indicates not available; OR, odds ratio
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Discussion 
In the present study of patients with amaurosis fugax, transient ischemic attack or isch-
emic stroke, half of the plaque ulcerations were identified in symptomatic carotid arter-
ies with a low degree stenosis of 0% to 49%. Non-invasive carotid artery plaque analysis 
with MDCTA revealed that degree of stenosis, plaque volume, and the LR-NC propor-
tion were associated with plaque ulceration in the symptomatic carotid artery. Of these 
plaque characteristics, the LR-NC proportion was most strongly associated with plaque 
ulceration. In contrast, the calcification proportion was inversely associated with plaque 
ulceration. The observed associations remained significant in patients with a low degree 
carotid stenosis of 0% to 49%. The present study is the first to evaluate the associations 
between plaque ulceration and plaque characteristics irrespective of the degree of ste-
nosis.
Association of Atherosclerotic Plaque 
Characteristics with Ischemic Stroke 
Several studies have evaluated the relationship of carotid artery plaque characteristics 
with ischemic stroke.13-19 In general, imaging studies with magnetic resonance and CT 
have identified positive associations between fibrous cap thickness, the size of the LR-
NC, intraplaque hemorrhage and the presence of carotid plaque surface disruption with 
ischemic stroke in cross-sectional and follow-up studies.13-16 Accordingly, in ultrasound 
studies echolucent carotid plaques were associated with increased risk of cerebrovas-
cular events.17,18 Echolucent plaques are known to have higher levels of lipid and hemor-
rhage compared with echogenic plaques, which contain more calcification and fibrous 
tissue. On the contrary, proportion of carotid plaque calcification is shown to be inversely 
associated with the occurrence of ischemic stroke.16,19 However, results of histological 
analyses have been less consistent.20 A review by Golledge et al. demonstrated the lack 
of an association between histologically defined LR-NC and intraplaque hemorrhage with 
ischemic stroke.20 
The observed discrepancy may be a consequence of disparate etiology of ischemic stroke. 
Nevertheless, plaque rupture and subsequent thromboembolism are considered crucial 
Patients with 
0-49% Stenosis (n=144)
Patients with 
≥50% Stenosis (n=41)
OR (95% CI) P-value OR (95% CI) P-value
Plaque volume (/100mm3) 1.06 (0.98-1.14) 0.15 1.23 (1.04-1.46) 0.02
LR-NC proportion (/10%) 3.04 (1.70-5.45) <0.001 1.82 (0.98-3.40) 0.06
Fibrous proportion (/10%) 0.88 (0.57-1.36) 0.56 1.05 (0.53-2.08) 0.89
Calcification proportion (/10%) 0.34 (0.16-0.69) 0.003 0.68 (0.40-1.15) 0.15
Table 4. Stratified multivariable analysis for the associations between symptomatic carotid artery plaque ulcer-
ation and plaque characteristics in patients with low (0-49%) and with significant (≥50) carotid stenosis
OR indicates odds ratio
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elements in the pathophysiological cascade between the development of a heteroge-
neous plaque and thromboembolic stroke.21 As a result, in the present study we evaluat-
ed the direct associations between plaque characteristics comprising of plaque stenosis, 
plaque volume and composition with plaque ulceration in patients with ischemic stroke.
Association of Atherosclerotic Plaque Characteristics 
with Carotid Plaque Surface Disruption 
Previous research relating atherosclerotic carotid plaque characteristics with plaque sur-
face disruption has focused on stenotic plaques corresponding with luminal narrowing of 
≥50%.3,4 In a magnetic resonance study, the LR-NC proportion of carotid plaques of ≥50% 
stenosis was the strongest predictor of new surface disruption, in form of an ulceration 
or a fibrous cap rupture.4 In that particular study, the calcification proportion was inverse-
ly related with plaque surface disruption. In addition, the presence of intraplaque hem-
orrhage as assessed with magnetic resonance is significantly associated with the pres-
ence of plaque ulceration on MDCTA.22 Plaque ulceration on conventional angiography 
in symptomatic carotid arteries with ≥50% stenosis was associated with the presence of 
intraplaque hemorrhage, large lipid core and less fibrous tissue in carotid endarterecto-
my specimens.3 Similarly, ultrasonographic examination of carotid arteries demonstrated 
a relation between echolucency of stenotic plaques and plaque ulceration.23 However, 
conventional angiography and ultrasound provide no quantitative information on plaque 
volume. Therefore, only limited data are available on the relation of plaque volume with 
plaque surface disruption as assessed using magnetic resonance.4 
MDCTA allows for fast and reliable evaluation of steno-occlusive disease in extracrani-
al24 and intracranial arteries25 and is widely available.26 The technique is effective in the 
detection of carotid plaque ulceration with a sensitivity and specificity of 94% and 99% 
respectively.27 Furthermore, distinct plaque components as well as plaque volume can 
be quantified in good correlation with histology.11,12 In the present study, using MDCTA, 
the relation between plaque composition and plaque volume with plaque ulceration was 
evaluated in patients with a symptomatic carotid stenosis of ≥50% as well as in patients 
with a low degree of stenosis (0% to 49%). Interestingly, in line with previous reports,5,6 
a substantial proportion of the plaque ulcerations were located in symptomatic carotid 
arteries with a low degree of stenosis. The association between the LR-NC proportion 
with plaque ulceration was significant in ischemic stroke patients with a low degree of 
stenosis (0% to 49%), whereas a trend toward significance was observed in patients with 
a stenosis of ≥50%. The inverse association observed between the calcification propor-
tion and plaque ulceration was significant in patients with a low degree stenosis. Fur-
thermore, only a weak correlation was observed between the degree of carotid artery 
stenosis and plaque volume on MDCTA. Importantly, plaque volume was associated with 
plaque ulceration, even after adjustment for the severity of stenosis. Overall, these find-
ings demonstrate that the associations between plaque composition and volume with 
plaque ulcerations are present in ischemic stroke patients irrespective of the degree of 
the carotid plaque stenosis. In addition, an etiological explanation is provided for the 
previously observed correlation of plaque characteristics with ischemic stroke events. 
Herein, a key role is suggested for plaque ulceration in the pathophysiological cascade 
between the development of a heterogeneous plaque and thromboembolic stroke. In 
consequence, apart from degree of stenosis, assessment of carotid plaque composition 
and volume that predispose ulceration could contribute to risk stratification for plaque 
instability or stroke recurrence. 
Ca
ro
tid
 p
la
qu
e 
ul
ce
ra
tio
n
112
Study Limitations 
First, the study has a cross-sectional design. Indeed, the prognostic value of plaque com-
position analysis with MDCTA, and more specifically of the LR-NC proportion for the de-
velopment of plaque ulceration and subsequent thromboembolic ischemic stroke should 
be confirmed in longitudinal serial imaging studies. Second, in the present study, the 
presence of intraplaque hemorrhage was not evaluated as plaque composition analy-
sis software used in the current study has not been validated for differentiation of in-
traplaque hemorrhage. As a result, both LR-NC and fibrous tissue assessed with MDCTA 
may contain intraplaque hemorrhage if present in the plaque. Finally, plaque composition 
analysis can be performed on routine MDCTA scans used for carotid stenosis evaluation. 
Nevertheless, every MDCTA leads to ionizing radiation exposure. Therefore, repeated ex-
aminations should not be advocated.
Clinical and Research Implications
To our knowledge, the present study is the first to examine the associations between 
carotid plaque characteristics and carotid plaque ulceration in ischemic stroke patients 
with a ≥50% stenosis, as well as in those with a low degree stenosis of 0% to 49%. The LR-
NC proportion was identified as the strongest determinant for plaque ulceration. The as-
sociation between the LR-NC proportion and carotid plaque ulceration was independent 
of the degree of stenosis. Plaque composition analysis with MDCTA may prove useful for 
detection of rupture-prone plaques and could potentially improve risk stratification in 
ischemic stroke patients.
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Abstract
Background Little is known about the natural course of atherosclerotic plaque in the 
carotid artery bifurcation. This study investigated the growth pattern of calcifications in 
atherosclerotic carotid arteries and its determinants using serial multi-detector CT angi-
ography (MDCTA). 
Methods From a cohort of consecutive patients with TIA or ischemic stroke and a base-
line MCDTA scan of the carotid arteries, subjects were invited for a follow-up scan after 
4-6 years. Calcification volumes were scored semi-automatically on baseline and follow-up 
scans. Progression of calcification and its determinants were analyzed in two ways: 1. as 
incidence of newly detectable calcification in patients free of calcification at baseline, us-
ing logistic regression analysis; 2. as annual change in calcification volume in all patients, 
using linear regression analysis. 
Results Two-hundred-twenty-two patients (aged 61.0±9.6 years, follow-up time 4.7±0.8 
years) were included. Calcification volumes increased significantly (median 2.9 mm³ at 
baseline versus 9.4 mm³ at follow-up, p<0.001). Newly detectable calcification during fol-
low-up was found in 27 out of 67 patients without baseline calcification (40.3%) and was 
independently associated with age (OR 4.6 per 10 years increase in age, p<0.001) and hy-
pertension (OR 8.2, p=0.008). Annual calcification growth was independently associated 
with age, calcification load, glucose, hypertension, and smoking. Baseline calcification 
load was the most important risk factor for calcification growth in multivariable analysis.
Conclusion Several modifiable cardiovascular risk factors are associated with carotid cal-
cification growth, however, time and baseline calcification load remain the most impor-
tant determinants of calcification development.
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Introduction
Carotid artery atherosclerosis is one of the major causes of ischemic stroke. Atheroscle-
rotic plaque may rupture, leading to thrombus formation and embolization of atheroscle-
rotic debris or thrombus material into distally located arteries. 
Carotid calcification has been used as a surrogate marker for carotid atherosclerosis in 
studies on stroke risk prediction.1-3 Little data is published on the determinants of carot-
id calcification. A few cross-sectional studies on asymptomatic subjects demonstrated 
the relation between classical cardiovascular risk factors and the presence or volume of 
calcification.4-6 However, especially in symptomatic patients, who have a high risk of re-
current events, it might be of clinical importance to predict and influence further plaque 
development. Although currently available non-invasive imaging techniques enable the 
monitoring of carotid calcification growth in vivo, calcification development in the carot-
id arteries has never been studied longitudinally.
In this study, we therefore investigated the growth pattern of calcifications in athero-
sclerotic carotid arteries and its determinants using serial multi-detector CT angiography 
(MDCTA) imaging in patients with recent ischemic stroke or TIA.
Methods
Study population
Patients were recruited from a prospective registry of patients with amaurosis fugax, 
transient ischemic attack or minor ischemic stroke (Rankin score <4) who underwent an 
MDCTA of the carotid arteries as part of their clinical work-up.7 Follow-up scans were 
performed after 4-6 years in a subgroup. Inclusion criterion for this serial study was the 
presence of atherosclerotic plaque in one or both carotid arteries, defined as thickening 
and/or calcification of the vessel wall. Exclusion criteria were: bilateral occlusion and/or 
invasive treatment of the carotid artery, no informed consent, renal insufficiency, hyper-
thyroidism and poor image quality of the baseline scan. The flow chart in Figure 1 shows 
the selection process of patients for this serial study. Clinical measures and information 
on risk factors and medication use were obtained from first admission to the hospital 
and information on recurrent ischemic cerebrovascular events and medication use was 
obtained at the time of the follow-up scan. This study was approved by the Institutional 
Ethics Review Board. 
Scan protocol
Baseline scans were performed on a 16- or 64-slice MDCT scanner (Siemens, Sensa-
tion16/64, Erlangen, Germany) with a standardized optimized contrast-enhanced proto-
col (collimation 16 x 0,75mm or 2 x 32 x 0.6 mm, pitch 1, 120 kV). The scan ranged from 
the ascending aorta to the intracranial circulation. The follow-up scans were performed 
on a 128-slice MDCT scanner (Siemens, Flash, Erlangen, Germany) with a comparable pro-
tocol (collimation 2 x 64 x 0.6 mm, pitch 0.7, 120 kV) and a scan range of 6 cm around 
the bifurcation. To test for differences in in-plane resolution between similar kernels on 
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different scanners, we performed a point-spread-function analysis using a standard thin 
wire phantom.8 No differences were found. Eighty mL of contrast material was used, with 
a 40 mL saline bolus chaser and real time bolus tracking in the ascending aorta, using a 
threshold of 120 HU.
Image reconstructions were made with an FOV of 120 mm, matrix size of 512 x 512 mm, a 
slice thickness of 1.0 mm, an increment of 0.6 and a smooth (B30) as well as an interme-
diate (B46) reconstruction algorithm.
Analysis of calcification
Calcification measurements were done with a commercially available software package 
on a standalone workstation (Leonardo-Siemens Medical Solutions, Forchheim, Germa-
ny). To determine the presence and quantity of carotid calcification, one observer blind-
ed to the clinical history evaluated the axial images of the MDCT data sets. Calcification 
was semi-automatically scored within a range of 3 cm above to 3 cm under the carotid 
bifurcation or a range as long as possible given the scan range at follow-up. The analyzed 
range on baseline and follow-up was fixed within one patient. A threshold of 600 HU was 
chosen to enable an automatic differentiation between contrast medium in the lumen 
and calcifications in the vessel wall.9 Volume scoring results in low rescan variability10 and 
a volume score using a threshold of 600 HU has a high intra- and inter-observer repeat-
ability.9 As a default, an intermediate convolution kernel (B46) was used for reconstruc-
tion of the baseline and follow-up MDCTA.11 In cases no B46 kernel was available either at 
baseline or follow-up, the smooth B30 kernel was used to compare calcification volumes 
on both MDCTA scans.
Total cohort 
N=914
Patients with
AF/TIA/minor stroke and
carotid CTA evaluation in
period 2001-2006
Excluded
N=265
Patients not meeting
primary inclusion criteria
N=122
Patients had died
Non-participating
N=303
204 unwilling
60 renal failure
5 hyperthyreoid
3 contrast allergy
19 not traceable
12 no informed consent
Participating
N=224
Figure 1. Flow chart depicting patient selection for this follow-up study.
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Intra-observer and inter-observer reproducibility of this method were defined in a subset 
of 40 consecutive data sets and were very good (intra-class correlation coefficients of 1.0 
and coefficients of variation < 3%).
Cardiovascular risk factors
Diabetes was defined as fasting serum glucose levels over 7.9 mmol/l, nonfasting serum 
glucose levels over 11.0 mmol/l, or use of anti-diabetic medication. Hypertension was de-
fined as a mean systolic blood pressure over 140mmHg and/or a mean diastolic blood 
pressure over 90 mmHg during 2 episodes of at least 15 minutes of continuous non-inva-
sive blood pressure measurement, or on treatment with anti-hypertensive medication. 
Hypercholesterolemia was defined as fasting cholesterol over 5.0 mmol/l or on treatment 
with cholesterol lowering drugs. Subjects were categorized as current smoking versus 
non- and ever smoking. Besides these dichotomized risk factor definitions, the continu-
ous risk factors glucose (in mmol/l), systolic blood pressure and diastolic blood pressure 
(per 10 mmHg), and cholesterol level (in mmol/l) at baseline were used as determinants 
in the analyses. Information on medication use was obtained at baseline and at follow-up. 
Information on a history of coronary artery disease (defined as a history of myocardial in-
farction, angina pectoris or coronary artery bypass grafting) and on a history of ischemic 
cerebrovascular disease (defined as a clinical diagnosis of ischemic stroke or transient 
ischemic attack) was collected.
Statistical analysis
Data are presented as mean +/- SD, median +/- interquartile ranges (IQR) and percentages 
where appropriate. Differences between patient groups were analyzed using a c2-test, a 
t-test or a Mann-Whitney U test where appropriate.
The Wilcoxon-Signed Rank test was performed to test for differences in baseline calcifica-
tion volume and growth rate between calcifications in the left and right carotid arteries 
within patients. No significant differences in baseline calcification volume (median 0.4 
(IQR 0.0-13.6) versus 1.2 mm³ (IQR 0.0-14.2), p=0.89) or in calcification growth (median 
0.4 (IQR 0.0-3.0) versus 0.6 mm³/year   (IQR 0.0-3.5), p=0.62) between left and right carot-
id arteries were found. We therefore averaged calcification volumes across both carotid 
arteries within a patient. The calcification volumes of one side were taken in patients 
treated unilaterally with carotid endarterectomy or stent placement (n=21) or in patients 
with unilateral focal image artefacts (n=1).
Because calcification volumes had a highly positively skewed distribution, we used the 
natural log transformed values and added 1 mm3 to deal with patients who had an initial 
calcification volume of zero.12 The associations between the classical cardiovascular risk 
factors and baseline calcification volumes (ln (calcification volume + 1)) were studied us-
ing linear regression analysis. 
The changes in the amount of carotid calcification were assessed by subtracting the calci-
fication volumes at baseline from those at follow-up. To test for absolute progression in 
calcification volume from baseline in the whole group, a Wilcoxon-Signed Rank test was 
used. The annualized calcification growth rate was calculated by dividing the change in 
calcification volume by the actual number of months that passed between the two scans, 
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multiplied by 12. Two endpoints of progression of calcification were analysed separately 
and were defined as: 1. Incidence of detectable calcification in patients free of detectable 
calcification at baseline and 2. Annualized change in calcification volume in all patients. 
Associations between risk factors and incidence of newly detectable calcification at fol-
low-up were assessed with logistic regression analysis in a model adjusted for gender, 
age and scan interval (model I) and in a multivariable model (II) including all variables 
from model I with a P-value ≤0.05 and the strongest variable from two risk factors defini-
tions. Linear regression analysis was used to study determinants of absolute annual cal-
cification growth (ln (calcification growth +1)). Age, gender and variables with a P-value 
≤0.05 (and the strongest one from two risk factor definitions) from the age and gender 
adjusted model (model I) were fitted into the multivariable regression model (model II).
To avoid an induced (spurious) correlation between change in calcification and its base-
line value, the mean of calcification volume at baseline and follow-up was used as the 
determinant “calcification load” for the regression analyses.13
Statistical significance was assumed at a р-value of less than 0.05. All analyses were per-
formed using SPSS version 20.0 for Windows. 
All patients 
(n=222)
Men 
(n=141, 63.5%)
Women
(n=81, 36.5%)
Age (years, mean ± SD)
Diabetes Mellitus
Hypertension
Hypercholesterolemia
Smoking (current)
History of CAD
History of CVD
Scan interval (years, mean ± SD)
BL Ca volume (mm3, median, IQR)
FU Ca volume (mm3, median, IQR)
Annual Ca growth (mm3, median, IQR)
61.0 ± 9.6
26 (11.7%)
152 (68.5%)
175 (78.8%)
90 (40.5%)
30 (13.5%)
43 (19.4%)  
4.7 ± 0.8 
2.9 (0.0-19.7) 
9.4 (0.7-41.9)
1.1 (0.1-4.2)
60.9 ± 9.1
21 (14.9%)
98 (69.5%)
105 (74.5%)
54 (38.3%)
25 (17.7%)
36 (25.5%)
4.8 ± 0.9      
3.7 (0.0-25.9)  
11.5 (1.1-58.5)  
1.2 (0.1-5.5)     
61.0 ± 10.3
5 (6.2%)
54 (66.7%)
70 (86.4%) #
36 (44.4%)
5 (6.2%) #
7 (8.6%) #
4.4 ± 0.7 *
0.8 (0.0-13.6)
6.5 (0.2-32.3)
0.8 (0.0-3.4)
Values are means ± standard deviation or median with interquartile range for continuous variables and numbers 
(percentages) for dichotomous variables. CAD = coronary artery disease, CVD = cerebrovascular disease, BL = 
baseline, FU = follow-up, Ca = calcification
# Significant difference between men and women at the level p£0.05, analysed using a c2-test
* Significant difference between men and women at the level of p=0.001, analysed using a t-test
Table 1. Baseline patient characteristics
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Results
Of the 527 potential candidates, 224 patients were included in this study. The participat-
ing patients had a significantly lower prevalence of hypertension (68.8% versus 78.5%, 
p<0.05) and diabetes mellitus (11.6% versus 22.8%, p<0.001), but were more often smokers 
(40.6% versus 31.7%, p<0.05) as compared to the non-participating patients. In two cases, 
poor image quality due to streak artefacts hampered an accurate calcification scoring of 
both carotid arteries and these patients were therefore excluded. 
The clinical indication for the baseline MDCTA of the included patients was amaurosis 
fugax in 27 patients (12.2%), transient ischemic attack in 92 patients (41.4%) and ischemic 
stroke in 103 patients (46.4%). Mean age of the patients at inclusion was 61.0 ± 9.6 years 
and 64% of participants were male. No significant differences were found between men 
and woman in calcification volumes at baseline and follow-up, or in annual calcification 
growth. Average time between the two scans was 4.7 ± 0.8 years (Table 1). The majority 
of patients used from baseline or earlier: cholesterol lowering drugs (92.8%), anti-hyper-
tensive medication (69.4%), anti-diabetic therapy (11.3%) and anti-platelets or anti-coagu-
lation (99%) (at follow-up 84.7%, 73.4%, 16.2% and 96%, respectively). 
Table 2 displays the associations between risk factors and baseline calcification volume. 
Gender, age, diabetes mellitus, glucose, and current smoking were significant predictors 
in model I and all variables put into model II remained significantly associated with base-
line calcification volume in model II.
difference (95%-CI) I difference (95%-CI) II
Male gender
Age (per 10 years)
Diabetes Mellitus
Hypertension
Hypercholesterolemia
Smoking (current)
Glucose
SBP (per 10 mmHg)
DBP (per 10 mmHg)
Cholesterol
0.48 (0.06-0.89)*
0.64 (0.43-0.84)*
0.66 (0.03-1.29)*
0.25 (-0.18-0.68) 
0.45 (-0.05-0.95)
0.53 (0.10-0.96)*
0.22 (0.05-0.38)*
0.07 (-0.02-0.16)
-0.02 (-0.19-0.14)
0.11 (-0.07-0.29)
0.43 (0.02-0.84)*
0.74 (0.52-0.96)*
0.58 (0.16-1.01)*
0.23 (0.07-0.40)*
Values represent differences in baseline calcification volume (Ln (calcification volume + 1)) (mm3) per unit in-
crease of the cardiovascular risk factors with 95% confidence intervals (CI).
Model I: Adjusted for gender and age
Model II: Additionally adjusted for all significant risk factors from model I with a p-value £0.05
*P<0.05
Table 2. Cardiovascular risk factors and baseline calcification volume in the carotid artery bifurcation (n = 222)
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The calcification volumes in the whole group were significantly higher at follow-up 
(median 9.4 mm³, IQR 0.7-41.9) than at baseline (median 2.9 mm³, IQR 0.0-19.7; Z =-11.5, 
p<0.001). Median annual growth rate was 1.1 mm³ (IQR 0.1-4.2 mm³). 
Sixty-seven patients had no detectable calcification at baseline. Twenty-seven of these 
patients had newly detectable calcifications at follow-up (after 4.7±0.8 years), a cumu-
lative incidence of 40.3%. Median annual growth was 0.16 mm³ (IQR 0.06-0.66). Table 3 
displays the associations between the presence of newly detectable calcification at fol-
low-up and cardiovascular risk factors. Age, scan interval, and hypertension were sig-
nificantly associated with the occurrence of newly detectable calcification in model I. In 
model II, the same determinants remained significantly associated. 
Patients with detectable calcification at baseline (n=155) showed a median annual growth 
rate of 2.2 mm³ (IQR 0.8-6.4). Four patients demonstrated regression of calcifications, 
one patient did not show any progression at all and the other 150 patients all showed 
some progression (min 0.03, max 37.4 mm³ per year).
The results of the linear regression analyses for calcification growth in all patients (n=222) 
are displayed in Table 4. Age, calcification load, diabetes mellitus, glucose, hypertension, 
and current smoking were significant predictors for calcification growth in model I. In 
model II, these same risk factors remained significantly associated. 
OR (95%-CI) I OR (95%-CI) II 
Male Gender
Age(per 10 years)
Scan interval (per year)
Diabetes Mellitus
Hypertension
Hypercholesterolemia
Smoking (current)
Glucose (mmol/L)
SBP (per 10 mmHg)
DBP (per 10 mmHg)
Cholesterol (mmol/L)
0.43 (0.12-1.54)
4.01 (1.90-8.42)*
3.16 (1.20-8.35)*
0.97 (0.11-8.71)
7.95 (1.69-37.29)*
0.50 (0.12-2.05)
2.15 (0.49-9.41)
1.37 (0.74-2.52)
1.24 (0.93-1.67)
1.25 (0.75-2.11)
0.74 (0.43-1.28)
0.34 (0.08-1.43)
4.61 (1.85-11.49)*
3.06 (1.04-9.02)*
8.15 (1.73-38.34)*
Values represent odds ratios (newly detected calcification versus no calcification at follow-up) with 95% confi-
dence intervals (CI).
Model I: Adjusted for gender, age and scan interval
Model II: Additionally adjusted for all significant risk factors from model I with a p-value £0.05
*P<0.05
Table 3. Cardiovascular risk factors and newly detectable calcification at follow-up among patients free of cal-
cification at baseline (n = 67)
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difference (95%-CI) I difference (95%-CI) II
Male gender
Age (per 10 years)
Ca load (per 10mm³)* *
Diabetes Mellitus
Hypertension
Hypercholesterolemia
Smoking (current)
Glucose
SBP (per 10 mmHg)
DBP (per 10 mmHg)
Cholesterol
0.18 (-0.06-0.42)
0.32 (0.20-0.44)*
0.10 (0.08-0.11)*
0.54 (0.18-0.90)*
0.33 (0.08-0.57)* 
0.20 (-0.09-0.49)
0.38 (0.14-0.63)*
0.14 (0.05-0.24)*
0.05 (-0.001-0.10)
0.07 (-0.09-0.10)
0.05 (-0.06-0.15)
0.04 (-0.15-0.22)
0.24 (0.13-0.34)*
0.09 (0.07-0.11)* 
0.27 (0.08-0.46)*
-
0.30 (0.11-0.50)*
0.10 (0.02-0.17)*
Table 4. Cardiovascular risk factors and annual calcification growth among all patients (n = 222)
Values represent differences in annual calcification growth (Ln (calcification growth + 1)) (mm3) per unit in-
crease of the cardiovascular risk factors with 95% confidence intervals (CI).
** Ca load = calcification load, defined as the mean of baseline and follow-up calcification volume within pa-
tients
Model I: Adjusted for gender and age
Model II: Additionally adjusted for Ca load and all significant risk factors from model I with a p-value £0.05 
*P<0.05
Figure 2. Graph shows the 
mean annual calcification 
growth in accordance with 
baseline calcification volume 
categories. The different 
bars-and-whiskers represent: 
subjects without calcification 
at baseline (n=67); subjects 
with calcification present at 
baseline were divided into 
quartiles: first quartile (n=39); 
second quartile (n=39); third 
quartile (n=38) and fourth 
quartile (n=39).
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Age and gender accounted for only 12% of the variability in calcification growth. R2 signifi-
cantly increased by adding the risk factors glucose, hypertension and smoking (R2 = 0.22) 
or by adding calcification load (R2 = 0.44). R2 of the final model II was 0.48. Calcification 
load was therewith the most important determinant. Its influence is also depicted in Fig-
ure 2. 
During follow-up, 37 patients experienced one or more recurrent ischemic events from 
the territories of the carotid arteries. No differences in calcification volume at baseline or 
in calcification growth was found between the patients with and those without recurrent 
disease.
Discussion
Summary
In this serial MDCTA study, we investigated the in vivo growth pattern of calcification 
and its determinants in atherosclerotic carotid arteries of symptomatic patients. Calci-
fication volume significantly increased compared to the baseline volume. We found the 
cardiovascular risk factors age, serum glucose level, hypertension, and smoking to be 
associated with a fast annual calcification growth. Furthermore, calcification load was the 
most important predictor for absolute calcification growth. The development of newly 
detectable calcification was associated with age and hypertension. 
Literature context
Large cross-sectional studies in carotid arteries have shown that classical cardiovascular 
risk factors are associated with the presence and amount of carotid calcification.4-6 We 
found similar risk factors associated with calcification volume and calcification growth. 
No prospective studies investigating calcification growth in the carotid arteries are avail-
able for comparison. In contrast to calcification measures in the carotid arteries, coronary 
artery calcium score (CAC) has already proven to be a marker of risk of cardiovascular 
events and to have incremental prognostic value beyond traditional risk factors.14 Several 
large prospective serial coronary calcification studies have been performed.15-21 Our lon-
gitudinal study shows comparable findings with those from prospective coronary artery 
studies. First, in prospective coronary studies, comparable incidence rates, varying from 
5 to 12% per year, were found.16-18,22 In agreement with those studies 17,18 we found age and 
hypertension as risk factors for incidence of detectable calcification. Secondly, in this 
study calcification load was the dominant predictor of fast calcification growth. Base-
line calcification load was found to be the only independent risk factor for calcification 
growth in some coronary studies,20 and its importance was confirmed in several others. 
18,20-23 This finding can be explained by the fact that the chronic influence of risk factors 
is already reflected in the baseline calcification volume, since baseline calcium itself is 
part of the pathophysiological process under investigation. When treated as a determi-
nant and corrected for in a multivariable model, the effects of the other risk factors will 
diminish. Furthermore, in a large community-based cohort (n=2807) of subjects having 
coronary calcification at baseline, body mass index, a family history of heart attack, dia-
betes mellitus, and glucose remained significantly associated with coronary calcification 
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progression after adjustment for baseline calcification burden.18 Another study found hy-
pertension and diabetes mellitus to remain significant beside baseline calcification.21 In 
addition to hypertension and diabetes, we also found age and smoking to be related to 
fast annual calcification growth.
This study fills a gap in the literature, since no prospective data on calcification of carotid 
atherosclerotic plaques is available. However, in carotid arteries, the clinical significance 
of calcification of plaques is not as clear as in the coronary arteries. Whereas some stud-
ies suggest that degree of carotid calcification is associated with increased stroke risk,1,3,24 
others found that a relatively high calcification content of carotid plaques is associated 
with plaque stabilization.25-29 The relative proportion of calcification within plaques seems 
to be of significant importance. Future work should therefore focus on the determinants 
of relative calcification contribution within carotid plaques and on the relation between 
(relative) calcification burden and recurrent stroke. 
Limitations
Advantages of this study are its longitudinal and in vivo nature, which increases the sen-
sitivity for finding predictors of carotid calcification progression.
Whereas most longitudinal studies are performed on asymptomatic subjects, a sympto-
matic stroke population was subject of this study. Once having experienced an ischem-
ic cerebrovascular event, patients are prone to recurrent events. It is therefore impor-
tant to perform longitudinal atherosclerotic studies on symptomatic patients. However, 
methodological obstacles are introduced, since most patients already use one or several 
drugs for secondary prevention. We have to be aware of an obvious mingling of possible 
influences on plaque calcification growth: the ominous effect of the risk factors and in ad-
dition the, possibly reverse, influence of the drugs. For example in hypercholesterolemic 
patients, statin use may reduce the progression of calcification.15 In our prospective, ob-
servational study it is impossible to unravel these different influences. To completely sep-
arate possible drug effects from risk factor influences, a randomized clinical trial should 
be performed. 
Furthermore, in contrast to the 130 HU threshold used in non-contrast enhanced scans, 
we used a threshold of 600 HU to be able to automatically separate calcifications from 
the dens contrast material in the lumen. It can be questioned whether changes in calci-
fication burden are optimally caught by using this 600 HU threshold. Both an increas-
ing density of calcifications as well as circumferential expanding of the calcification dots 
might be partly underscored, therewith underestimating calcification growth and its var-
iability. This may reduce the sensitivity for finding significant associations with determi-
nants. However, the same would hold for the standard quantification methods using a 
threshold of 130 HU. Moreover, Glodny et al. found a strong, linear correlation between 
the calcification volumes derived using a threshold of 600 HU on coronary CT angiogra-
phies and the calcification volumes derived using 130 HU as a threshold or the Agatston 
score on non-contrast enhanced scans.9 
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Conclusion
In this study, we presented the determinants of calcification growth in the carotid ar-
teries, filling a gap in the literature. Although several modifiable classical cardiovascular 
risk factors are associated, age and especially calcification load are the most important 
predictors for calcification progression. These findings should be taken into account in 
the design of future studies that investigate the determinants of calcification proportion 
within carotid plaques and the relation between calcification changes and recurrent isch-
emic cerebrovascular events.
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Abstract 
Background and Purpose Serial in vivo imaging of atherosclerosis is important for un-
derstanding plaque progression and is potentially useful in predicting cardiovascular 
events and monitoring treatment efficacy. This prospective study aims to quantify tem-
poral changes in carotid atherosclerotic plaque volume and plaque composition using 
MDCTA.
Materials and Methods In 109 patients with TIA or ischemic stroke, serial MDCTA of the 
carotid arteries was performed after 5.3±0.7 years. The carotid bifurcation was semiauto-
matically registered for paired baseline-follow-up datasets. Outer vessel wall and lumen 
boundaries were defined using semi-automated segmentation tools. Plaque component 
volumes were measured using HU thresholds. Annual changes in plaque volume and 
plaque component proportions were calculated.
Results One-hundred-ninety-three carotid arteries were analyzed. Plaque volume de-
creased in 31% and increased in 69% of vessels (range -5.6-10.1%/year). Overall, plaque 
volume increased 1.2% per year (95% CI: 0.8-1.6, p£0.001). Plaque composition changed 
significantly from baseline (fibrous 66.4%, lipid 28.8%, calcifications 4.8%): fibrous tissue 
decreased by 1.5%, lipid decreased by 1.8%; calcification increased by 3.3% (p<0.001). In-
traobserver reproducibility of all volume and proportion measurements was good (ICC: 
0.78-1.00), interobserver reproducibility moderate (ICC: 0.76-0.99). 
Conclusions Changes in carotid plaque burden and plaque composition can be quantified 
using serial MDCTA. Plaque burden development is a heterogeneous and slow process.
137
chapter 4.2
Introduction
Atherosclerosis is a slowly progressing disease, subclinical for decades before suddenly 
causing clinical manifestations like coronary artery disease, ischemic cerebrovascular dis-
ease and peripheral artery disease. Increased atherosclerotic burden first causes outward 
remodeling of the artery, with compensatory expansion of the outer vessel wall boundary 
without narrowing of the lumen.1 In later stages of plaque progression the compensatory 
mechanism of outward remodeling no longer suffices, and vessel lumen becomes compro-
mised, eventually causing stenosis or occlusion. Beside the hemodynamic effects on blood 
flow and blood pressure, atherosclerotic disease is thought to induce ischemic events by 
plaque rupture, causing thrombosis and obstruction or thromboembolization into distal 
arteries. Increased lipid content, large lipid-richnecrotic cores, intraplaque hemorrhage, 
inflammation, and thin fibrous caps are the hallmarks of plaques vulnerable to rupture.2-3 
Knowledge of atherosclerotic plaque development has predominantly been derived from 
animal and histopathological studies.4 Still, little is known about progression of athero-
sclerosis in humans. Serial in vivo imaging of both vessel lumen and plaque is important 
for understanding the development of atherosclerotic plaque and its progression from 
subclinical lesions into rupture-prone plaques. Accurate monitoring of changes in athero-
sclerotic plaque burden and composition can potentially be used in risk prediction and in 
assessing efficacy of pharmaceutical treatment.
MDCTA has been validated for imaging atherosclerotic plaque in the carotid arteries in 
vivo.5-6 Plaque volume and several plaque components like calcifications, lipid and fibrous 
tissues can be accurately quantified.5, 7 MDCTA therefore provides a minimally invasive 
tool to investigate carotid plaque progression in humans. 
In this prospective study, serial CT angiography of the carotid arteries was performed in 
patients with TIA or ischemic stroke and changes in plaque burden and plaque compo-
sition were quantified using a semi-automated custom-made plaque segmentation tool. 
Methods
Study population
Patients were recruited from a cohort of 914 consecutive patients with TIA or ischemic 
stroke, who had undergone a standard clinical work-up, including multidetector CT angi-
ography of the carotid arteries.8 All patients with atherosclerotic plaque (i.e. thickening 
and/or calcification of the vessel wall) in one or both carotid arteries were invited to par-
ticipate in this serial imaging study. Exclusion criteria were: no atherosclerotic plaque(s) 
present at the level of the carotid bifurcation, bilateral occlusion and/or treatment of the 
carotid arteries, no informed consent, renal insufficiency or hyperthyroidism and bad im-
age quality of the baseline scan. Blood samples to determine renal function were taken if 
necessary. The study was approved by the Institutional Review Board. All patients gave 
written informed consent.
The serial MDCTA datasets of the first 113 patients included in this study were used for 
analysis. The MDCTA data from 4 patients were excluded because of motion artifacts or 
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low lumen contrast density. In addition, 6 arteries were excluded from the analysis be-
cause of occlusion on baseline and/or follow-up scan, 14 because of local treatment with 
carotid endarterectomy or stent placement and 5 because of (focal) poor image quality 
(perivenous artifacts or streak artifacts due to dental material) impeding correct plaque 
segmentation. In total, 193 carotid arteries from 109 patients were included in this study.
Clinical data
As a part of routine clinical work-up all patients underwent a detailed health question-
naire, a physical examination, laboratory measurements, a CT scan of the brain and mul-
tidetector CT angiography of the carotid arteries. Information was collected on age, gen-
der, medication use, hypertension, hypercholesterolemia, diabetes mellitus, smoking, 
and history of cerebrovascular or cardiovascular disease as previously described 8. During 
the visit for the follow-up MDCTA scan, a detailed health questionnaire was taken. 
Multidetector CT angiography protocol
Baseline scans were performed on a 16- or 64-slice multidetector CT scanner (Sensation 
16/64, Siemens Medical Solutions, Erlangen, Germany), with a standardized optimized 
contrast-enhanced protocol (collimation 16 x 0.75 mm (n=106) or 2 x 32 x 0.6 mm (n=3), 
pitch 1) and a scan range ranging from the ascending aorta to the intracranial arteries. 
The follow-up scans were performed on a 128-slice multidetector CT scanner (Somatom 
Definition, Siemens Medical Solutions), with a comparable protocol (collimation 2 x 64 x 
0.6 mm, pitch 0.7) and a scan range of 6 cm around the carotid bifurcation. Eighty mL of 
contrast material was used, with a saline bolus chaser of 40 mL and real-time bolus track-
ing in the ascending aorta, using a threshold of 120 HU. 
Image reconstructions for all scans were made with a FOV of 120 mm, matrix size 512 x 
512, slice thickness of 1.0 mm, increment of 0.6 mm and with both a smooth (B30/B31) 
and an intermediate (B46) filter kernel, of which the last one has been demonstrated to 
give the best soft tissue contrast.9 We performed a point-spread-function analysis using 
a standard thin wire phantom10 to test for differences in in-plane resolution between sim-
ilar kernels on different scanners, but we did not find any differences.
Registration of baseline and follow-up scan
In order to accurately compare the baseline plaque measurements with those at fol-
low-up within each patient, the carotid bifurcation on both scans were registered using a 
custom-made semi-automated registration tool (Figure 1). First lumen segmentation was 
generated by a level-set based method initialized with three seed points in the CCA, ICA 
and ECA. 11 From this lumen segmentation a central lumen line was extracted. Then 3 new 
observer-defined initialization points in, respectively, the CCA, the ICA and the ECA on the 
follow-up MDCTA marked the range to be segmented for plaque analysis. Using the bifur-
cation point (the level at which CCA lumen separates into 2 separate lumens of ICA and 
ECA) as a landmark, the absolute distances along the central lumen line from this point to 
the initialization points were calculated and copied to the central lumen lines of the base-
line MDCTA to define the corresponding vessel part of interest on the baseline scan (on 
axial sections). In this way, adjustments were made for possible differences between the 
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baseline and the follow-up scan in the curvature of the carotid arteries due to elongation 
or head position. Scan data reconstructed with a B46 kernel were used. 
Plaque analysis
Volume measurements of lumen, vessel wall and vessel wall components (further de-
fined as plaque and plaque components, respectively) were derived using a custom-made 
semi-automated plaque analysis method. The lumen segmentation used in registering 
the vessel range of interest between baseline and follow-up scan was also used here. The 
outer vessel wall was segmented based on a method using a Gentle Boost classifier which 
had been trained by manually annotated data.12-13 The lumen segmentations and outer 
vessel wall segmentations were checked and adjusted manually where appropriate. The 
plaque was derived by subtracting the lumen segmentation from the outer vessel wall 
segmentation.
After segmenting the carotid artery outer vessel wall and lumen, plaque components 
were differentiated based on Hounsfield Unit thresholds. The cut-off value between calci-
fications and fibrous tissue was set at 130 HU, as used for calcium scoring. The threshold 
used to differentiate lipid from fibrous tissue was 60 HU, a setting that was previously val-
idated with histology. 5 The volumes of the plaque and plaque components were calculat-
ed as the product of the number of pixels in the segmented areas, the pixel size and the 
slice increment. The proportion of plaque components was calculated as the ratio of the 
volume of the component to the total plaque volume, multiplied by 100. Figure 2 shows 
an example of axial slices through a carotid bifurcation at baseline and at follow-up and 
their corresponding plaque segmentations.
Figure 1. Explanation of the method 
of semiautomated registration of 
vessel wall range of interest. 3D re-
constructions of the lumen segmen-
tations of a carotid bifurcation at FU 
(A) and at BL (B). Lumen segmenta-
tion is semiautomatically generated 
after clicking 3 initialization points 
in the CCA, the ICA and the ECA, 
respectively (red dots), separately 
in both FU and BL data sets. From 
this lumen segmentation, CLLs are 
extracted (orange line). On the FU 
CTA the vessel range containing 
atherosclerotic plaque is defined by 
clicking another set of initialization 
points (blue dots). The absolute dis-
tances along the CLL between the 3 
blue points are measured and cop-
ied to the CLL of the BL CTA (yellow 
line), which define the range on ax-
ial images to be analyzed by the au-
tomated plaque segmentation tool 
(green dots). 
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Stenosis measurements were performed according to the NASCET criteria. Using 3D soft-
ware, MPRs were made and the smallest diameter was measured on axial images perpen-
dicular to the vessel axis. 
Reproducibility of semiautomated plaque measurements
Although the procedure was automated for a large part, there were some observer in-
terventions: clicking initialization points for lumen segmentation, clicking initialization 
points for defining the range for plaque segmentation, and manually adjusting the lu-
men and outer vessel wall segmentations, if necessary. To assess the intraobserver and 
interobserver variability of the complete method, a subset of 30 carotid arteries was an-
alyzed 2 times by the same observer with a delay of 3 months, and once by a second 
observer. This subset was randomly taken from the group of patients without a treated 
artery, an occluded carotid artery, or a poor image quality. The intraobserver and interob-
server variability are presented as ICC and CoV.
Data-analysis
Plaque volume and plaque component volumes and proportions were measured on both 
sides in each individual at baseline and follow-up, within the registered range of interest. 
Within each carotid artery, the changes over time of the different plaque measures were 
derived. 
The data are presented as mean ± SD. Total vessel, lumen, plaque and plaque compo-
nents are presented as absolute volumes (in mm3) on baseline and follow-up. Plaque com-
ponents are also expressed as proportions. A paired t-test was used for the analysis of 
absolute progression from baseline to follow-up.
Figure 2. Semiautomatically 
generated plaque segmenta-
tions on matched BL and FU 
axial MDCTA images just above 
the level of the carotid bifurca-
tion. The time interval between 
the scans is 5.8 years; a slight 
plaque progression with an in-
crease in calcifications is visible. 
Red = lumen, green = fibrous tis-
sue, yellow = lipid, white = calci-
fication.
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Temporal changes are expressed as absolute annual change in volume or proportion 
((change in volume or proportion / FU time in months)*12), and as a percentage (‘rela-
tive’) annual volume change from baseline (absolute annual change in volume / BL vol-
ume). A one-sample t test was used for comparison of “annual change” to 0. 
Correlations between percentage annual growth of plaque volume and baseline plaque 
characteristics were described by Pearson’s correlation coefficient.  Correlations be-
tween absolute change in plaque component proportion and baseline characteristics 
were described by Pearson’s correlation or Spearman’s correlation coefficient when ap-
propriate. To avoid an induced (spurious) correlation between absolute or percentage 
annual change in a plaque feature and its baseline value, the mean of the measure at 
baseline and follow-up was used.14
Baseline patient characteristics (n=109) Value
Age (years; mean ± SD)
Male sex (n [%])
Hypertension (n [%])
Hypercholesterolemia (n [%])
Diabetes mellitus (n [%])
Smoking (current or past; n [%])
Previous cardiovascular disease (n [%])
Previous cerebrovascular disease (n [%])
Symptoms (n [%])
    Amaurosis fugax
    Transient ischemic attack
    Minor stroke
Use of secondary preventive medication during FU (n [%])
    Cholesterol lowering
    Anti-hypertensive
    Anti-diabetic
Time delay BL – FU MDCTA (years; mean ± SD)
62.8 ± 8.5
70 (64%)
76 (70%)
90 (83%)
11 (10%)
87 (80%)
19 (17%)
25 (23)%
18 (17%)
50 (46%)
41 (38%)
98 (90%)
80 (73%)
17 (16%)
5.3 ± 0.7
Table 1. Baseline patient characteristics
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Results
Baseline characteristics
The clinical information on the 109 included patients is summarized in Table 1. The median 
time delay between the event and the baseline scan was 11 (IQR 5-21) days and the mean 
interval between the scans was 5.3 ± 0.7 years. In just a few cases, the degree of stenosis 
of the artery changed into a higher degree over time (Table 2). Baseline plaque volume 
was 1100 ± 464 mm3. The contributions of the different components at baseline were 66.4 
± 7.8%, 28.8 ± 5.4% and 4.8 ± 6.9% for fibrous tissue, lipid and calcifications, respectively 
(Table 3). Calcifications were present in 132 carotid arteries (68.4%). 
Follow-up
Baseline 0-29% 30-49% 50-69% 70-99% Total
0-29% 160 7 0 1 168
30-49% 1 13 4 0 18
50-69% 0 0 5 1 6
70-99% 0 0 0 1 1
Total 161 20 9 3 193
Table 2. Stenosis measurements at baseline and at follow-up as assessed according to the NASCET criteria
BL (± SD) FU (± SD) Mean paired diff 
(95%-CI)
P-value*
Vessel volume (mm3)
Lumen volume (mm3)
Plaque volume (mm3)
Fibrous volume (mm3)
Lipid volume (mm3)
Calcium volume(mm3)
Fibrous proportion (%)
Lipid proportion (%)
Calcium proportion (%)
2575.4 ± 993.6
1475.2 ± 620.2
1100.2 ± 464.0
712.2 ± 260.7
318.3 ± 154.1
69.7 ± 124.6
66.4 ± 7.8
28.8 ± 5.4
4.8 ± 6.9
2657.6 ± 1022.5
1506.5 ± 621.9
1151.1 ± 466.7
726.4 ± 262.9
309.0 ± 134.1
115.7 ± 152.9
64.9 ± 9.4
27.0 ± 5.9
8.1 ± 8.6
82.2 (55.9 - 108.5)
31.3 (9.8 - 52.8)
50.9 (28.1 - 73.7)
14.2 (-2.4 - 30.8)
-9.3 (-21.1 - 2.6)
46.0 (37.6 - 54.4)
-1.5 (-2.3 - -0.7)
-1.8 (-2.5 - -1.1)
3.3 (2.8 - 3.9)
<0.001
0.005
<0.001
0.094
0.124
<0.001
<0.001
<0.001
<0.001
Table 3. Baseline and follow-up measurements of plaque volume and plaque components
* As evaluated with a paired t test
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Atherosclerotic plaque growth
Of 193 arteries, 60 (31%) showed decrease in plaque volume (mean difference between 
BL and FU -119 mm3, 95% CI, -115 - -86 mm3), while in 133 (69%), plaque volume increased 
(mean difference: 127 mm3, 95% CI, 109 - 146 mm3). The mean volumes and plaque com-
ponent proportions at baseline and follow-up for the entire group are summarized in 
Table 3. There was a significant overall growth in plaque volume of 51 mm3 (95% CI, 28-
74 mm3). Lumen and total vessel volume also increased significantly over time. Whereas 
the absolute values of fibrous tissue and lipid did not change significantly, their relative 
contribution to the plaque volume decreased (-1.5% and -1.8%, respectively, p<.001). The 
proportion of calcification within the plaque increased with 3.3% (p<.001). 
Annualized changes in plaque measures
Overall, the percentages annual growth of total vessel volume, lumen volume, and 
plaque volume were 0.63% per year (95% CI, 0.44-0.83), 0.55% per year (95% CI, 0.25-0.85) 
and 1.16% per year (95% CI, 0.76-1.55), respectively. Absolute annual changes in the pro-
portions of the components were a decrease of 0.26% per year for fibrous tissue (95% 
CI, -0.41% - -0.10%), a decrease of 0.37% per year for lipid (95% CI, -0.51% - -0.24%) and an 
increase of 0.64% per year for calcifications (95% CI, 0.54-0.74) (all p≤.001). 
Relation between plaque changes and 
baseline plaque characteristics
Regression analysis showed no significant correlation between percentage annual plaque 
growth and plaque volume (p=0.196). No correlations were found between percentage 
annual plaque growth and plaque component proportions at baseline. 
The change in calcium proportion was significantly correlated with baseline plaque vol-
ume (rs=0.45, p<.001) and calcium proportion (rs=0.68, p<.001). Annual increase in calcium 
proportion was larger in arteries with baseline plaque volume larger than 975 mm3 (i.e. 
larger than median of baseline plaque volume, n=96) compared to arteries with a base-
line plaque volume smaller than 975 mm3 (n=97; 0.88% versus 0.39% per year; p<.001). 
Annual increase in calcium proportion was larger in plaques with a high baseline calci-
um proportion (>3.9%, median of average calcium proportion on baseline and follow-up, 
n=96) compared with those with a low baseline calcium proportion (<3.9%, n=97; 1.00% 
versus 0.26% per year; p<.001). 
Reproducibility of the method
The ICC for all volume and proportion measures varied between 0.92 and 1.00 for in-
tra-observer reproducibility, except for lipid proportion and lipid volume, for which the 
ICC was 0.78 and 0.86, respectively. The ICC for interobserver reproducibility varied be-
tween 0.76 and 0.99. The CoVs were good for intraobserver variability, varying between 
4.6% and 11.4%, except for lipid volume, for which the CoV was 19.0%. For interobserver 
variability the CoVs were moderate and varied between 4.5% and 22.0% (Table 4).
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Discussion
To our knowledge, this is the first in vivo serial CTA study to investigate atherosclerotic 
carotid plaque progression in humans. This study demonstrates that multidetector CT 
angiography can be used to quantify atherosclerotic plaque measures in vivo and track 
changes over time in large study populations.
In 193 carotid arteries, the mean percentage annual growth in plaque volume was 1.2% 
per year, with a wide range of -5.6% to 10.1% per year. MR imaging has been proven a 
reproducible method for plaque quantification,15-18 and several serial MR imaging studies 
have been performed for tracking changes in carotid atherosclerosis. In a prospective 
MRI study, Saam et al. described a yearly increase of 2.2% in wall area in >50% stenosed 
carotid arteries.19 Boussel et al. found an annual rate of progression of carotid vessel wall 
volume of 2.3% per year in arteries with >50% stenosis.20 In these studies, however, the 
included arteries had a more severe stenosis compared to the arteries included in our 
study. In another study, a carotid total wall volume increase of 1.2% and 1.8% was found 
after 16 and 24 months respectively, in patients who were on statin treatment.15 These 
results were comparable with ours. MR imaging studies often use different measures 
(area or eccentric wall volume) for assessing plaque growth, which leads to another diffi-
culty in comparing our results to those from previous serial in vivo studies. Nevertheless, 
the growth rate of carotid plaque turns out to be remarkably small and highly variable, a 
comparable finding across studies. Statin treatment has been shown to induce reduced 
progression or even regression of plaque burden.19-25 Approximately 90% of all patients in 
our study were using statins during the follow-up period. Thirty-one percent of our pa-
tients showed plaque regression, a number similar to that found in other plaque progres-
sion studies in which the majority of patients were on statin therapy.19-20 Statin treatment 
might therefore be a reason for the small mean growth in plaque volume.
We did not find any local baseline plaque characteristics significantly associated with 
plaque volume growth. In contrast, Saam et al. found that a normalized wall index >0.64, 
as a measure of large plaque burden, was associated with a reduced rate of progression 
in mean wall area.19
In this study we found a change in plaque composition over time: calcification propor-
tion increased, which coincides with a decrease in fibrous and lipid proportion. Larger 
plaques had a faster increase in calcium proportion compared to smaller plaques and the 
more calcified plaques showed a significantly larger annual increase in calcium proportion 
than the less calcified plaques. Calcified carotid plaques are thought to be more stable 
compared with noncalcified plaques.26-28 The results of this longitudinal study therefore 
suggest that when plaques progress, they finally get a more stable profile. This might 
also be an effect of the secondary preventive medication that is used by the majority of 
the patients. A few studies reported on the change in composition towards a more stable 
plaque phenotype in statin-treated patients, by demonstrating a decrease in lipid con-
tent29-30 and a trend towards more calcium.30 However, these results should be confirmed 
in larger randomized trials investigating the influence of statin use on plaque composi-
tion. 
Glagov et al. were the first to report on outward vascular remodeling, showing an in-
crease in total vessel area as an adaptive mechanism to preserve lumen area in response 
to increasing atherosclerotic disease burden. Luminal narrowing does not occur until the 
atherosclerotic lesion occupied >40% of the internal elastic lamina area.1 In our study, in-
Se
ria
l i
m
ag
in
g 
of
 c
ar
ot
id
 a
th
er
os
cl
er
ot
ic
 p
la
qu
e
146
cluding only arteries with mild atherosclerotic disease, we also found an overall increase in 
total vessel volume following an increase in plaque volume. The changes in plaque burden 
over time appeared to be too small for lumen to become compromised. This might also 
explain why a change in degree of stenosis was demonstrated in only a minority of vessels.
One of the major challenges in serial imaging studies on atherosclerotic plaques is the 
reproducibility of quantitative measures. In our study, we used volume measurements, 
which have been shown to be more precise than area measurements.17 Several studies 
have investigated factors influencing measurement errors. Differences in head position-
ing is one such factor that can cause the 3D position of the carotid bifurcation to change 
significantly,31 thereby causing difficulties in matching corresponding axial cross-section-
al images across different time points. So far, registration of carotid arteries has been 
performed manually by using fiducial landmarks, such as the carotid bifurcation point. 
In this study, we matched the range of interest in the carotid artery semi-automatically 
using the distance along the central vessel lumen line, accounting for possible variation 
in carotid position over time. Further improvement would be achieved if analyses could 
be performed in slices perpendicular to the central line of the artery. 
(Semi-) automated measurement of plaque volumes might improve the reproducibility. 
When we compare our results, using a semiautomated plaque segmentation method, 
with the inter-observer reproducibility found in a previous study in which plaque segmen-
tation was done manually, interobserver reproducibility improved; CoV for plaque volume 
was 15% compared to 23-34% found with the manual segmentation method. De Weert et 
al. demonstrated that their moderate interobserver reproducibility was partly due to the 
difficulty of defining the exact plaque range; consensus about the segmentation range 
improved the reproducibility.7 Therefore, taking a fixed range around the bifurcation to 
be segmented may further improve interobserver and intraobserver reproducibility of 
the semiautomated method. Nevertheless, the annual changes in plaque measures are 
relatively small compared to the current intraobserver variability and, although signifi-
cant for the whole group, these would not be meaningful for the individual patient.
Our study has some limitations. First, in contrast to MR imaging, MDCTA is not capable 
of visualizing fibrous cap rupture or intraplaque hemorrhage. Both plaque features are 
highly associated with plaque rupture and ischemic events.32-36 Intraplaque hemorrhage 
has also been associated with an accelerated plaque growth.35 We have not been able 
to analyze the influence of this important plaque characteristic on plaque development. 
On the other hand, HU-based differentiation of plaque components enable serial and au-
tomated plaque composition measurements in MDCTA data. Calcifications and changes 
herein can be accurately measured using MDCTA. Compared with MR imaging datasets, 
in which multiple sequences are necessary to obtain all plaque information, MDCTA data 
are more robust and allow minimal observer intervention in the steps towards registra-
tion and lumen and vessel wall segmentation. The high availability and the quick proce-
dure are advances of MDCTA that make it a promising tool for serial plaque imaging. With 
the present CT scanners and precautionary measures, the risks of the potential harmful 
radiation exposure and intravenous contrast material can be reduced to a minimum. 
Secondly, we reported on plaque volume, whereas with MDCTA, we are not able to dis-
tinguish atherosclerotic plaque itself from the underlying media. In serial studies this is of 
minor importance, because the outcome measure of interest -the difference over time- 
will merely consist of changes in the plaque itself as the range of interest is registered 
across BL and FU scans. 
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No evidence exists for a linear pattern of atherosclerotic plaque growth, and the annual 
change rate is therefore an artificial measure. However,  this study corrects for differenc-
es in follow up time and it creates a measure that can be compared across groups and 
studies.
Further, this study is performed in TIA and stroke patients who were all on secondary pre-
ventive medication. Given the known effects of statins on plaque progression, our results 
can not be extrapolated to the asymptomatic population. 
Conclusions
The present study shows that MDCTA enables quantification of carotid plaque progres-
sion and plaque composition changes in vivo in large patient groups. Carotid atheroscle-
rotic plaque progression seems to be a slow and heterogeneous process. It is unknown 
yet whether monitoring plaque progression might have a future clinical value in risk pre-
diction. Further research should therefore focus on the associations between tempo-
ral plaque changes found with serial imaging and (recurrent) ischemic cerebrovascular 
events. 
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This thesis focused on the role of multidetector CT angiography (MDCTA) in providing 
carotid atherosclerotic plaque characteristics that can be used as imaging biomarkers for 
atherosclerotic disease burden and plaque vulnerability in vivo. The final aim is to con-
tribute to the knowledge of the pathophysiology of atherosclerotic plaque development 
and its change into a clinical significant lesion, to finally enable interfere with this process. 
This thesis had three main objectives:
I. To accurately obtain (semi-)automatically derived quantitative imaging biomarkers 
of  carotid atherosclerotic plaque burden and composition with CTA.
II. To investigate the role of atherosclerotic plaque ulceration as an imaging biomarker 
for  plaque vulnerability.
III. To study carotid atherosclerotic plaque development and its determinants using  
quantitative plaque imaging in a serial CTA study. 
In this part of the thesis, I will describe the main findings of our studies and their interpre-
tation, thereby discussing some methodological considerations and deliberating on the 
future use of CT derived atherosclerotic imaging biomarkers.
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I.  Quantitative imaging biomarkers of carotid  
 atherosclerosis using CTA
Quantitative imaging of biomarkers requires validated, highly standardized and 
reproducible methods, and correlation of the imaging biomarkers to biological 
effects and clinical endpoints.1
Technical aspects
Technical aspects, as contrast density, kVp setting, window-level setting and convolution 
kernel, highly influence quantitative measurements on MDCTA scans. Our research group 
previously optimized the MDCTA scan parameters and contrast injection protocol in or-
der to reduce artefacts, optimally distinguish lumen from arterial wall/atherosclerotic 
plaque and differentiate calcifications and the non-calcified components of the plaque.2-4 
In Chapter 2.1 I reflect on all these issues concerning the use of MDCTA-based imaging 
biomarkers for atherosclerotic disease in the carotid artery. Based on these issues an 
optimized, standardized scan protocol was developed for comparable CT scanners with 
similar post-processing techniques, which is a principal requirement for the implementa-
tion of quantitative imaging biomarkers.
Validation and reproducibility of measures of plaque burden and composition
In Chapter 2.1 we reviewed on previous work that investigated CTA derived biomarkers of 
atherosclerotic disease in the carotid arteries.
The assessment of different plaque components with CTA relies upon their differences 
in linear attenuation coefficient, expressed as Hounsfield Units (HU). This differentiation 
highly depends on CT scan parameters. Reconstruction algorithms and kVp have been 
optimized in a previous study, that showed that an intermediate reconstruction kernel 
allows optimal plaque interpretation.4
Using this optimized scan acquisition protocol ex vivo and in vivo validation studies were 
performed with carotid endarterectomy (CEA) specimens as histological standard. From 
these studies, 60 HU was derived as the optimal cut-off point for differentiation between 
lipid and fibrous tissue within the plaque,4 with a sensitivity and specificity of 100%.5 Calci-
fications are detected on CT images as high density structures, with HU>130, equivalent 
to coronary calcium scoring in electron beam CT. 
The next step was the validation of the quantitative measurements of the different plaque 
components derived using the optimal threshold values found. Area measurements be-
tween ex vivo MDCTA images and histology correlated well for total plaque area, calcified 
areas and lipid areas.4 For the in vivo validation study manually annotated outer vessel 
wall segmentations were needed. MDCTA overestimates area measurements of calcifica-
tions, however the correlation with histology was good. Correlation between MDCTA and 
histology for fibrous area measurements was good, but poor for lipid, which is probably 
due to blooming artefacts from calcification, since this correlation improved in mildly 
calcified plaques and non-calcified plaques.5 
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Interobserver variability of area measurements was moderate for calcifications and fi-
brous tissue, but poor for lipid, whereas intraobserver variabilities were good.5 The poor 
observer variability of lipid area is possibly due to inclusion of peri-articular fat in seg-
mentation of the outer vessel wall contours. Quantitative measurements could be im-
proved by volumetric measurements of plaque components. In vivo manual assessment 
of atherosclerotic plaque and plaque component volumes in carotid arteries with MDCTA 
is feasible with a moderate interobserver reproducibility and a moderate to good intraob-
server reproducibility.6 
Automated quantitative plaque measurements
A further improvement in the reproducible assessment of plaque volume and plaque vol-
ume components could be expected from semi-automated or automated analysis. Also, 
as manual annotation of vessel lumen and outer wall boundaries is very labour-intensive, 
(semi-)automated plaque segmentation is required to be able to perform larger and lon-
gitudinal studies. In order to automate plaque quantification, a post-processing algorithm 
to automatically segment the lumen and outer vessel wall, was developed, enabling the 
assessment of wall (plaque) volume. This semiautomatic plaque segmentation algorithm 
has been trained and tested on manually annotated MDCTA data.7 Considering the scarce 
availability of CEA specimens, automated segmentations have not been validated against 
histology, but were compared to manually annotated segmentations, which have been 
histologically validated, as described above.8 
In the study described in Chapter 2.2 we investigated the performance of this semi-auto-
mated plaque segmentation method in quantifying plaque volume and plaque compo-
nent volumes by comparing measurement error of the automated method using manual 
contours as a reference standard with the interobserver variability in manual annota-
tions. In this study, manual segmentation comprised manual drawing of the outer ves-
sel boundary, whereas the boundaries between lumen and plaque were automatically 
calculated and were only corrected manually in cases were calcifications bordered the 
lumen. We found the differences between the automated method and the manual ob-
servers to be comparable to the interobserver differences. It is good to realize that the 
performance of an automated tool cannot be better than that of the manual method on 
which it is trained. A certain difference  will always exist between manual and automated 
segmentation and one should therefore be careful to directly compare results from stud-
ies using manual segmentations with those using automated segmentation. The perfor-
mance of automated segmentation is highly influenced by the training set and agreement 
could be optimized by training the algorithm with the study population on which it will 
be applied. Nevertheless, an automated tool will always be more robust and reproducible 
than a human being, since its results are based on statistics. We found this semi-automat-
ed method to have good intraobserver and interobserver reproducibility for plaque vol-
ume and plaque composition measurements, except for lipid, for which reproducibility 
was moderate. In quantitative plaque analysis using MRI, measurement errors for plaque 
burden measures are excellent, the most reliable measure being percentage wall volume 
(CV 3%). Measures of plaque composition in MRI studies have also been less reproducible, 
for example CV of 11.1 and 31.7 % for LRNC volume.9
One could argue whether to investigate the performance of a semi-automated segmen-
tation method for assessing temporal changes in plaque volume and plaque composition. 
Good agreement with manual segmentation on baseline does not necessarily translate 
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into a good agreement in assessing changes during follow-up, as was suggested in a se-
rial MRI plaque component quantification study.10 They argued that the (blinded) visual 
side-by-side comparison, done by human reviewers to eliminate artefacts and discern real 
changes, could improve plaque delineation as information from both scans is used. This 
was not taken into account by the computer algorithm, which could have resulted in 
a lower agreement between the manual and automated results in assessing temporal 
changes. When the segmentation on baseline and follow-up scans are performed com-
pletely independent of each other by an semi-automated algorithm, variation in temporal 
changes not representing true plaque changes, are merely due to inter-scan variability, 
an issue discussed in the third part ‘Serial carotid plaque imaging and determinants of 
atherosclerotic plaque changes’. 
Apart from plaque analysis based on plaque segmentation, we also performed a serial 
study on the development of calcifications in the carotid arteries, using calcification as a 
surrogate marker of atherosclerosis, equivalent to calcium scoring in coronary arteries. 
Calcification measurements can be automatically performed with commercially available 
software packages. Calcium volume scoring has a low rescan variability and a high intra- 
and interobserver repeatability.11, 12 When using 600 HU as a threshold, we also found very 
good intra- and interobserver reproducibility for the assessment of calcification volumes 
in the carotid arteries on MDCTA. 
Semi-automated quantitative plaque imaging for serial studies
In conclusion, quantitative measurements of carotid plaque burden and plaque com-
ponents assessed with MDCTA are validated against histology and can be derived in a 
reproducible way. Though not perfect, we thought the segmentation results from our 
automated method to be a good starting point for additional manual editing if necessary. 
We used this strategy in the serial studies investigating temporal changes in plaque and 
plaque composition in a larger patient cohort (Chapters 4.2 and 4.3).
II.  Carotid atherosclerotic plaque ulceration
Atherosclerotic carotid plaque ulceration is considered to be a marker of previous plaque 
rupture.13, 14 Carotid atherosclerotic plaque ulceration has primarily been described on an-
giography and is defined as extension of contrast material beyond the vascular lumen 
into the surrounding plaque.13 MDCTA has been found to be effective in plaque ulceration 
detection, with a high sensitivity and specificity,15 and is able to identify and classify ul-
cerations with a good interobserver agreement.16 The work in this thesis focussed on the 
potential of MDCTA assessed plaque ulceration as a (qualitative) imaging biomarker of 
plaque rupture in clinical studies.
Plaque ulceration and non-lacunar ischemic stroke
Large deep and non-lacunar ischemic strokes are thought to be caused by thrombo-em-
bolism from extracranial arteries or the heart.17 Atherosclerotic carotid plaque rupture 
might be the trigger for thrombus formation on the plaque surface and embolization of 
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plaque material and thrombus into the intracranial circulation. We tested the hypothesis 
that if non-lacunar stroke is associated with thromboembolism, it may also be associated 
with atherosclerotic plaque ulceration in the symptomatic arteries, since plaque ulcer-
ations have been associated with plaque rupture (Chapter 3.1). Patients with ischemic 
cerebrovascular events were classified according to presumed stroke etiology. Plaque 
ulceration in the symptomatic artery was indeed associated with clinically defined non- 
lacunar stroke, independent of degree of stenosis. This relation was confirmed by an 
independent association between the presence of atherosclerotic carotid plaque ulcer-
ation and non-lacunar infarction on MDCT of the brain. These results support the un-
derlying mechanism of plaque rupture and subsequent thrombo-embolism to the brain. 
It further subscribes different pathophysiologic mechanisms between lacunar and non- 
lacunar stroke and the importance of etiologic stroke subtype assessment in stroke pa-
tients in studies evaluating the relation between atherosclerotic carotid disease and clin-
ical events or brain tissue damage. Further, it suggests that plaque ulceration can be 
an important imaging biomarker for plaque rupture in future diagnostic and therapeutic 
studies of patients with atherosclerotic carotid disease. However, as this was a cross-sec-
tional study, additional longitudinal studies should assess whether plaque ulcerations in-
crease the risk of (recurrent) stroke and whether CEA will reduce this risk. 
Serial imaging of plaque ulcerations
As ulcerations are found in symptomatic carotid arteries as well as in asymptomatic ca-
rotid plaques, questions are raised as whether plaque ulcerations are indeed the conse-
quence of plaque rupture, whether ulcerations must always be associated with a recent 
ischemic event and whether they  might form a cause of future thrombo-embolization. 
In general, little is known about the natural history of plaque ulcerations in carotid ath-
erosclerotic plaques. Therefore, I performed a study in which plaque surface morphology 
was investigated on serial CTA of TIA and stroke patients (Chapter 3.2). Plaque surface 
morphology was classified as smooth, irregular or ulcerated on both baseline and fol-
low-up MDCTA. Progression (i.e. development of irregularities or ulceration) and regres-
sion (i.e. disappearance of irregularities or ulceration) in morphology were evaluated. 
At follow-up, plaque morphology remained unchanged in most ulcerated plaques. These 
results show that carotid ulcerations persist for a long time, and that finding an ulcerated 
plaque might therefore not have a direct clinical meaning, i.e. does not necessarily cor-
relate to a recent plaque rupture. Theoretically, ulcerations may, due to disturbance of 
blood flow, remain a potential source of thromboembolism.18, 19 Its implication for (recur-
rent) cerebrovascular disease therefore remains elusive.
Plaque composition and ulcerations 
According to the vulnerable plaque theory, specific plaque features, like large lipid-rich 
necrotic cores, predispose an atherosclerotic plaque to rupture.20, 21 In order to study the 
association between plaque burden and plaque composition and plaque ulceration on CT, 
we evaluated the symptomatic arteries of ischemic stroke patients (Chapter 3.3). Plaque 
volume and the proportions of LRNC, fibrous tissue and calcifications were measured 
semi-automatically based on HU-cut off values, after manual annotation of the plaque. 
Plaque ulcerations were also present in plaques in arteries with a low degree of steno-
sis. We found plaque volume to be significantly larger in ulcerated plaques. In addition, 
LRNC proportion was strongly associated with plaque ulceration, whereas calcification 
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proportion was inversely associated with plaque ulceration. These associations remained 
significant in patients with a low degree stenosis. These results indicate that plaque vol-
ume and composition assessed with MDCTA may identify rupture prone plaques, there-
with possibly improving risk stratification in ischemic stroke patients. Comparable results 
are found in cross-sectional MRI studies, that showed that intraplaque haemorrhage and 
large LRNC are associated with thin and ruptured fibrous caps.21, 22
Plaque ulcerations assessed with CTA
In summary, we showed that ulcerated atherosclerotic plaque in the carotid artery is asso-
ciated with a thrombo-embolic clinical endpoint, i.e. ischemic non-lacunar stroke, as com-
pared to lacunar stroke. It furthermore correlates with plaque volume and plaque com-
position, indepent of degree of stenosis. Plaque ulceration assessed with MDCTA could 
therefore be useful as a marker of plaque rupture, and plaque burden and plaque compo-
sition could be used to identify plaques prone to rupture. These studies, however, had a 
cross-sectional design and the findings should be confirmed in large longitudinal studies. 
Our serial imaging study showed that the clinical importance of finding an ulcerated plaque 
remains elusive. This study comprised a small cohort, which, in combination with the rela-
tive low incidence of ulcerations and the study design, hindered us to investigate the asso-
ciation between plaque ulceration and recurrent ischemic cerebrovascular events (i.e. non-
lacunar stroke). Large clinical trials should be performed to answer the question whether 
plaque ulceration as an MDCTA biomarker of advanced carotid atherosclerotic plaque can 
improve risk prediction and the decision model for surgical intervention. 
MRI is capable of imaging smaller, disrupted fibrous caps and also thin fibrous cap.23, 24 The 
ulcerations as seen on CTA are thought to represent larger ruptures, in which part of the 
LRNC has been embolized into the intracranial circulation. CTA therefore probably under-
scores the entity of plaque rupture and MRI has the advantage to identify the plaques with 
a thin fibrous cap, with the accepted view that these plaques will progress to rupture, there-
with enabling prevention of thromboembolism. However, CT angiography nowadays is – or 
can be- part of clinical work-up of acute stroke patients in many institutions. Designating 
plaque ulceration on CTA as a risk factor for recurrent stroke would therefore provide an 
easily applicable adjustment of current treatment decision protocols. 
III.  Serial carotid plaque imaging and determinants  
 of atherosclerotic plaque changes
Knowledge of atherosclerotic plaque development has primarily been derived from 
animal and histopathological studies. Risk factors for plaque development25, 26 and as-
sociations between vulnerable plaque characteristics and clinical endpoints have been 
suggested from cross-sectional studies.27-29 Last decades, temporal changes in athero-
sclerosis in human beings has been subject of prospective longitudinal studies which are 
supposed to provide the definite prove of evidence. Quantitative measures of atheroscle-
rotic carotid plaque generated by non-invasive imaging techniques are important tools 
in serial in vivo imaging studies and can help us in understanding atherosclerotic disease 
mechanisms, therewith improving (recurrent) risk prediction and monitoring response to 
pharmaceutical interventions. 
G
en
er
al
 d
is
cu
ss
io
n
158
Serial imaging – a real challenge
In addition to the technical challenges in quantitative imaging, certain issues in serial 
quantitative imaging require attention, since they influence inter-observer variability as 
well as inter-scan variability. Ongoing technical developments during the course of a seri-
al study can either create complications or opportunities. 
Over time new scanners were introduced, which use different image reconstruction tech-
niques. In our studies we adjusted the scan protocols in order to enable a secure compar-
ison of follow-up and baseline scans. Additionally, we performed a phantom study using 
the point spread function test to assess differences between different reconstruction 
kernels on CT scanners used. Due to radiation exposure it was not possible to scan pa-
tients twice on the same or on different scanners within a short time frame in order to 
perform inter-scan variability studies. 
Further, there are potential variations that are more difficult to correct for. Variation in 
imaging quality can occur due to motion artefacts or differences in contrast availability. 
Also possible variations in the geometry of the carotid arteries, caused by patient re-
position, hamper the one-by-one comparison. Optimization and standardization of the 
acquisition protocol is important, nevertheless, a certain in-patient variability will always 
be present. 
In order to reduce the impact of possible changed vessel geometry, there is the need to 
register the images of serial CT scans. In our pilot study (Chapter 4.2) in carotid arteries 
containing atherosclerotic plaque at baseline, we used a custom-made semi-automated 
registration tool. With this tool, lumen segmentations were generated by a level-set-
based method after initialization with three seed points in de common carotid, internal 
carotid and external carotid artery, followed by extraction of a center lumen line. Three 
new observer-defined initialization points on the follow-up scan defined the craniocaudal 
plaque range to be analysed. Using the carotid bifurcation point as a landmark, the abso-
lute distances along the center lumen line to the initialization points were calculated and 
copied to the center lumen line on the baseline scan, which determined the range to be 
segmented. Lumen and outer vessel wall segmentations were manually adjusted deemed 
necessary. 
In the second serial study (Chapter 4.3), we chose to analyze plaque in a fixed range 
around the carotid bifurcation, a method that had been used in previous published serial 
MRI studies.30-33 This enabled better comparison of our results on plaque changes with 
those described in the existing literature. Further, as the carotid artery is relatively fixed 
around its bifurcation, we assumed that the least variation in vessel geometry occurs in 
this segment, which is also the part that contains most atherosclerotic plaque and will 
change most during follow-up. A drawback of this method compared to the one above 
is that changes in plaque at other levels and the plaque growth in craniocaudal direction 
are not taken into account. Manual interventions were restricted to pointing the carotid 
bifurcation slice (which has a high intra- and inter-observer reproducibility) and manu-
al adjustment of the annotations deemed necessary. The interobserver reproducibility 
would increase compared to that of the registration method described above, since one 
does not have to decide on the plaque length, as is described in a previous study on dif-
ferent manual plaque segmentation methods.6 Automated measurements are thought to 
be robust compared to manual measurements and will consistently create the same seg-
mentation given the same image data, since they are based on statistical models. Since in 
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our second serial study, the automated plaque segmentations were corrected by a single 
reader for all scans, blinded for patient number and time sequence, observer variability 
was reduced to a minimum. 
During the course of the study there was an ongoing development and improve-
ment of the (semi)-automated tool for the carotid atherosclerotic plaque segmen-
tation. Nevertheless, a significant manual intervention was needed, especially at 
the level of the bifurcation, since ellipses were automatically fitted to segment the 
outer vessel wall. Especially at the division into the intracranial and extracranial ar-
tery, the contour does not fit an ellipse, but more or less a number 8 figure. There-
with the method is really a semi-automated one and further efforts should be made 
in creating a fully automated tool to ensure availability in large-scale serial studies. 
These issues also still exist in automated quantitative plaque imaging in MRI,10 in 
which automated quantification of certain plaque components is feasible, but lu-
men and outer vessel contours still have to be drawn manually.
Atherosclerotic plaque development
Increased atherosclerotic burden first causes outward remodelling of the artery, implying 
a compensatory expansion of the outer vessel wall delaying lumen narrowing.34 Yet, little 
is known about the progression of a subclinical atherosclerotic plaque into a vulnerable 
one in human beings. I performed the first serial CTA study on carotid plaque progression 
in humans in vivo. Plaque progression is a slow and heterogeneous process. Our studies 
confirmed this by demonstrating small annual growth rates and large variations in chang-
es, ranging from plaque regression to plaque progression in a study population that was 
optimally treated for their ischemic cerebral event. Though difficult to compare to the 
findings from serial studies using other imaging modalities and techniques, our findings 
seem comparable to results described in the MRI literature, especially when comparing 
progression rates expressed as percentage annual growth.30, 32, 35 
In the serial study in which I used a variant of the CAC scoring method (Chapter 4.1), I found 
calcification volume to increase in the carotid arteries of TIA and stroke patients over time. 
In our serial studies on plaque development using the (semi-)automated quantitative 
plaque segmentation method, I found lipid volume and proportion to decrease, whereas 
calcification volume and proportion increased. The two methods to investigate calcification 
changes were not directly compared to each other in one study using the exact same region 
of interest. Nevertheless, our study results suggest that the increase in calcification volume 
is merely based on significant changes in plaque composition, rather than on an increase 
in atherosclerotic plaque burden. Existing cross-sectional literature suggest calcification of 
plaque to be associated with stabilization of the plaque.36-39 MRI studies found proportion 
LRNC and its increase to be associated with plaque surface rupture21, 40 and LRNC propor-
tion to be associated with occurrence of cerebrovascular events.41 Decrease in lipid content 
therefore also suggest plaque stabilization. Recurrent cerebrovascular event rate in our 
study population was too small to investigate the clinical impact of these temporal plaque 
changes. Future, larger longitudinal studies should confirm the relation between  temporal 
changes in plaque composition and recurrent stroke. 
CTA plaque segmentation enables complete (semi-)automated plaque segmentation be-
cause the outer vessel wall can be separated from the environment. This differentiation 
seems to be harder to automatically perform in MRI plaque analysis. Serial MRI studies 
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on plaque development merely focus on certain plaque components known to charac-
terize the vulnerable plaque. Lipid-rich necrotic core (LRCN) for example has been found 
to be the most important determinant of plaque burden progression and plaque surface 
disruption in asymptomatic patients with  50-79% carotid stenosis.40 Intraplaque hemor-
rhage (IPH) has also been shown to contribute to plaque progression and destabiliza-
tion.42-45 An important shortcoming of CTA is that it does not enable the characterization 
of IPH, as this seems the most important and promising plaque imaging biomarker.
The changes found in our serial studies and those of others are very small and often 
within the measurement variability. This is a common problem in longitudinal studies, 
independent of the imaging technique used. Temporal changes and their determinants 
can therefore only be evaluated in large study populations. 
Further, I investigated plaque changes in a symptomatic population, in which patients got 
secondary preventive therapies according to national guidelines. Therefore, these tem-
poral changes do not reflect the ‘natural evolution’ of carotid atherosclerotic plaques, 
but could rather be explained by a healing mechanism and possible treatment effects. 
Studies on CEA specimens from symptomatic arteries showed plaque stabilizing changes 
on a histological level over time after an ischemic event.46, 47 Further, the transformation 
into a more stable plaque phenotype has been proved in serial MR studies in statin-treat-
ed patients.48, 49 From the results of our studies we can conclude that these optimally 
treated patients have quite indolent plaques. Therewith there remains a need for serial 
population-based studies, to enable the investigation of the real development of subclin-
ical, but vulnerable atherosclerotic plaques. 
Risk factors for atherosclerotic plaque changes
In the study described in Chapter 4.3, I investigated the determinants of plaque growth 
and changes in plaque composition. Age and baseline plaque volume were the only (re-
spectively positive and negative) determinants for plaque growth. Especially lipid propor-
tion was associated with a decrease in plaque growth, an effect that might be ascribed 
to the effect of lipid-lowering therapy, which has been demonstrated to halt plaque pro-
gression, especially by decreasing the LRNC.32, 50 
In all our serial studies, and therefore independent of the assessment method used, hyper-
tension was an independent determinant for calcification growth, measured in volumes as 
well as in proportions, and for newly developed calcifications. This finding is similar to that 
found in serial coronary calcification studies51-53 and cross-sectional studies in carotid arter-
ies54. Hypertension was also associated with a decrease in lipid proportion and in plaque 
volume. The pathophysiologic mechanism behind this association is not yet elucidated. 
Serial CTA plaque imaging in symptomatic patients
In summary, we showed the feasibility of CTA to investigate temporal changes in plaque 
burden and plaque composition. In our symptomatic cohort, plaque changes were small, 
but a significant composition change into a more stable plaque profile could be demonstrat-
ed. These effects may probably largely be ascribed to the pharmaceutical influences of the 
preventive treatment these patients are on. As this study was not a controlled, randomized 
trial, it provides a suboptimal setting to unravel the determinants of plaque development. 
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Methodological considerations
The ultimate goal of research in the field of atherosclerosis would be to decrease stroke 
incidence by preventive measures in the general population. Longitudinal popula-
tion-based imaging studies would increase our knowledge about atherosclerotic plaque 
progression and help improve risk assessment. However, since CTA is a semi-invasive 
technique - requiring intravenous contrast material and radiation exposure - it is not suit-
able for a screening setting in healthy individuals. On the other hand, especially symp-
tomatic persons are at increased risk for recurrent ischemic events and it is therefore also 
important to investigate carotid plaque development in this group. In most of the studies 
in this thesis we therefore focused on a cohort of TIA and stroke patients. We choose 
patients who already had undergone a CTA in the setting of a clinical work-up because of 
their ischemic cerebrovascular event. 
A drawback of this study design however is the fact that all patients received secondary 
preventive therapies and measures. Although this situation does reflect the real situation 
of stroke patients from the time they first present with a TIA or stroke, it makes it impos-
sible to unravel the effects of risk factors and the potential opposite effects of the treat-
ment. A randomized clinical trial would help to increase insight into the role of different 
risk factors and the effect of certain therapies. To investigate the natural evolution of ath-
erosclerosis, which appears to be very slow, a long-lasting, longitudinal population-based 
cohort remains preferred. 
A very difficult issue in performing serial imaging in order to measure changes in plaque 
burden and composition, is the variation in imaging quality caused by patient reposition, 
movement artefacts, and changes in contrast availability in the carotid artery. This intro-
duces measurement errors that might be larger than the temporal changes we are look-
ing for. We dealed with this issue by optimizing and standardizing the acquisition proto-
col, improving registration of serial scans and the use of automated plaque segmentation 
tools. Nevertheless, the semi-automated plaque segmentation tools still need significant 
manual interventions and inter/intra-observer variabilities are considerable, especially 
seen the small temporal changes. Therefore serial plaque imaging is only useful in large 
patient groups in a research setting and should not be used on an individual basis. This 
simultaneously hampers the introduction of current quantitative plaque imaging tools in 
clinical practice. 
Future directions
CTA as imaging technique to provide imaging biomarkers of atherosclerosis has advan-
tages, but also some shortcomings. Although we showed that it enables quantification 
of the plaque components lipid, calcifications as well as fibrous tissue, it seems unable 
to assess other potential plaque features like intraplaque hemorrhage and fibrous cap 
thickness and rupture. Further, with the need of intravenous contrast material and radia-
tion, it is not completely non-invasive and harmless. Moreover, even with semi-automat-
ed plaque segmentation tools, the CTA based plaque imaging remained very laborious. 
For these reasons it is less suitable for prospective serial imaging studies in asymptomatic 
patients. Serial MRI studies are probably more promising in studying the transformation 
of subclinical plaques into rupture prone plaques in asymptomatic patient populations. 
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Further effort should be put in investigating the potential role of other plaque character-
istics, like intraplaque hemorrhage, in this process. 
Nonetheless, CTA does have potential in further optimizing clinical decision making strat-
egies. In comparison to MRI, it is a quick, largely available method and radiation dose can 
be reduced to a minimum nowadays. In the last years, amongst others, the MR CLEAN tri-
al provided evidence for the usefulness of intraarterial thrombectomy in acute ischemic 
stroke patients with thrombo-embolic occlusions of the proximal intracranial arteries.55 
These studies strongly contributed to the general acceptance of CTA as first diagnostic 
tool in ischemic stroke patients. This strategy provides CT-based imaging data, including 
CTA of extracranial and intracranial arteries, CT of the brain and CT perfusion. This setting 
could be used to further investigate the role of CT imaging biomarkers, like plaque ulcer-
ations, in the pathophysiology of (recurrent) thrombo-embolic stroke.
Plaque ulceration is a potential, clinically useful imaging biomarker, as it is highly feasible 
to assess plaque ulceration on clinical available CTA of the carotid arteries with a high 
reproducibility and little extra effort. It seems to have a correlation with plaque rupture 
and cerebrovascular events as found in cross-sectional studies. This should be confirmed 
in larger, longitudinal studies and its performance in identifying patients at risk for recur-
rent stroke should be further investigated. 
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Summary and Conclusions
Chapter 1 introduces the background and purpose of this thesis. Atherosclerotic disease 
of the carotid arteries is an important cause of ischemic stroke. Current clinical practice 
provides diagnostic and treatment options for individuals presenting with symptoms. 
The currently used treatment decision model is based on the severity of atherosclerotic 
disease expressed as degree of carotid artery stenosis. As the incidence of ischemic cere-
brovascular events (i.e. cerebral infarction, TIA, amourosis fugax or retinal infarction) re-
mains high in the aging population, research in the field of atherosclerosis concentrates 
on improving risk prediction and stroke prevention. Common purpose of atherosclerosis 
research is to increase our knowledge of the transformation of subclinical, early stage 
atherosclerotic disease into advanced atherosclerotic plaques that are vulnerable to 
rupture and may cause subsequent thrombo-embolization. Non-invasive imaging tools 
create a window to the carotid artery and allow the evaluation of the pathophysiology 
of atherosclerosis in vivo. Imaging biomarkers of early and advanced atherosclerotic dis-
ease can be assessed and serial assessment of quantitative imaging biomarkers enables 
the study of plaque development and its determinants and could be used to monitor 
treatment effects. 
The work in this thesis focuses on quantitative imaging biomarkers of carotid athero-
sclerotic plaque using CTA, and the investigation of plaque development and its determi-
nants based on these CTA-based biomarkers in a serial imaging study in a symptomatic 
patient population. Furthermore, the role of ulcerated plaque surface, evaluated with 
CTA, as a qualitative imaging biomarker in clinical studies is explored.
In Chapter 2, the focus is on quantification of CTA derived biomarkers of plaque burden 
and plaque components. Chapter 2.1 reviews the CTA technique used to evaluate carotid 
atherosclerotic disease in a quantitative way. Technical aspects and CT scan acquisition 
parameters are crucial for the accurate assessment of lumen, plaque and plaque compo-
nents, and scan protocols should be optimized and standardized. Quantitative plaque 
measurements have been validated against histology in ex vivo and in vivo studies and 
can be assessed with a moderate to good interobserver and intraobserver reproducibili-
ty. (Semi-)automated algorithms to segment carotid atherosclerotic plaque and to quan-
tify plaque volume and plaque component volumes have been developed to improve 
reproducibility and to enable large-scale application in large serial studies.
Chapter 2.2 presents the results of the performance study of an automated plaque seg-
mentation algorithm in quantifying plaque volume and plaque component volumes. The 
differences between the automated method and the manual observers, accepted as the 
reference standard, were comparable to the interobserver differences in manual anno-
tations. Further, comparable risk factor associations were found for plaque burden and 
plaque composition with the automated method as compared to manual segmentations. 
These results suggest that the automated method is applicable in large cohort studies. 
Chapter 3 is dedicated to plaque ulceration on CTA as a qualitative biomarker of plaque 
rupture. Atherosclerotic carotid plaque ulceration is considered to be a marker of previ-
ous plaque rupture. In Chapter 3.1 we showed that plaque ulceration in the symptomatic 
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artery was associated with clinically defined non-lacunar stroke as compared to lacunar 
stroke, independent of degree of stenosis and cardiovascular risk factors. This relation 
was confirmed by an independent association between the presence of atherosclerotic 
carotid plaque ulceration and non-lacunar infarction on MDCT of the brain. These results 
support the underlying hypothesis on the pathophysiologic mechanism of plaque rupture 
and subsequent thrombo-embolism to the brain in non-lacunar stroke. 
In Chapter 3.2 I present a clinical, retrospective serial study on the evolution of athero-
sclerotic plaque surface morphology. Though histopathological studies suggest healing 
of plaque ulcerations and ruptures, I showed that plaque ulcerations persist  in TIA and 
stroke patients after their ischemic cerebrovascular event. This implicates that the pres-
ence of an ulcerated plaque not necessarily suggests a recent plaque rupture. The clin-
ical significance of plaque ulcerations for (recurrent) thrombo-embolic events remains 
unresolved. As plaque ulceration could theoretically provoke thrombo-embolization, its 
risk for recurrent events should be investigated in large, prospective longitudinal studies. 
According to the vulnerable plaque concept, certain plaque characteristics are thought 
to predispose the plaque to rupture. We investigated the relation between MDCT derived 
plaque volume and plaque component measures and plaque ulceration in a cross-sec-
tional CT study of the symptomatic arteries of TIA and stroke patients (Chapter 3.3). 
Plaque volume and LRNC proportion were significantly associated with plaque ulcer-
ation, whereas calcification proportion was inversely associated with plaque ulceration. 
These associations remained significant in patients with a low degree of carotid stenosis. 
This indicates that MDCTA derived plaque volume and composition may identify rupture 
prone plaques, and eventually improve stroke risk stratification.
In Chapter 4, I present the results of the first serial CTA study on quantitative plaque 
imaging. In order to improve our insight in atherosclerotic plaque development in the 
carotid arteries, we studied plaque changes in a clinical cohort of TIA and ischemic stroke 
patients, who underwent  a follow-up CTA with a mean delay of five years after the base-
line scan they initially had undergone in the context of their clinical work-up. 
Chapter 4.1 describes the study in which we used carotid calcification as a proxy for ath-
erosclerosis burden and investigated the determinants for calcification development 
and growth. Besides the modifiable classical cardiovascular risk factors, age and baseline 
calcification load were important determinants for calcification progression. This can be 
explained by the fact that chronic influences of risk factors are reflected in the baseline 
calcification, which is part of the pathophysiologic process under investigation. Although 
carotid calcification has been related to increased risk for cerebrovascular events, evi-
dence is being accumulated for calcification of plaque, and so relative calcification contri-
bution, to be associated with plaque stabilization.
Being able to quantify the relative contribution of plaque components might therefore 
be of interest. In Chapter 4.2 we proved the feasibility of assessing temporal changes in 
plaque burden and plaque components using a semi-automated plaque segmentation 
algorithm on the serial CTA data. Plaque changes were small and heterogeneous. Nev-
ertheless, we found a significant change in plaque composition towards a more stable 
plaque profile, i.e. a decreasing lipid proportion and increasing calcification proportion.  
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In Chapter 4.3 we aimed to investigate the determinants of these temporal plaque chang-
es. Baseline lipid proportion was associated with a decreased plaque progression. This 
finding is probably caused by lipid-lowering therapy, used by most of the study partic-
ipants, which has been shown to halt plaque progression by decreasing the LRNC. An-
other seemingly important determinant for plaque stabilization is hypertension. The 
pathophysiologic mechanism behind this, however, remains unresolved. As our study 
was observational instead of experimental, it was impossible to unravel the chronic influ-
ences of risk factors from the therapy effects of the secondary preventive pharmaceuti-
cal treatment that the patients were on.
In the general discussion, in Chapter 5, the main findings as well as methodological con-
siderations, possible clinical implications and directions for future research are discussed. 
In conclusion, we demonstrated the –though still restricted- feasibility of semi-automat-
ed quantitative serial carotid plaque imaging using CTA. We studied the plaque devel-
opment in carotid atherosclerotic plaques in symptomatic patients, treated according 
to national guidelines with secondary preventive therapies, and found it to be a quite 
indolent process. In interpreting our findings, we have to be aware that plaque evolu-
tion is subject to a very complex combination of biochemical and biomechanical factors 
during lifetime, which is then also influenced by therapeutic interventions. Therefore, 
large, prospective longitudinal studies are necessary to study the determinants of plaque 
development in asymptomatic patients, whereas randomized clinical trials are needed to 
unravel the therapy effects in high risk patients. Further, this thesis provides additional 
evidence for the potential of carotid plaque ulceration on CTA as a clinically applicable 
imaging biomarker. Prospective, longitudinal studies should further investigate its role in 
(recurrent) stroke risk prediction.
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Samenvatting en Conclusies
Hoofdstuk 1 introduceert de achtergrond en het doel van dit proefschrift. Atherosclerose 
van de halsslagaders vormt een van de belangrijkste oorzaken van herseninfarcten. In de 
huidige klinische praktijk zijn de diagnostische middelen en behandelingsopties gericht 
op individuen die zich presenteren met symptomen. Het klinische beslissingsmodel dat 
thans in gebruik is, is uitsluitend gebaseerd op de mate van vernauwing van de halsslag-
ader. Aangezien de incidentie van herseninfarcten hoog blijft in onze vergrijzende popu-
latie, richt het onderzoek op het gebied van atherosclerose zich op het verbeteren van 
de risico-inschatting en het voorkomen van beroerte. Het gemeenschappelijk doel in dit 
onderzoeksveld is het vergroten van onze kennis over de transformatie van subklinische 
ziekte naar de atherosclerotische plaques die een vergrote kans hebben om te scheu-
ren (plaque ruptuur) en vervolgens voor embolisatie van plaque deeltjes of bloedstolsels 
kunnen zorgen. Niet-invasieve beeldvormende technieken bieden de mogelijkheid om de 
pathofysiologie van atherosclerose in vivo te bestuderen en leveren biomarkers van zo-
wel vroege als gevorderde atherosclerotische ziekte. Seriële, kwantitatieve beoordeling 
van dergelijke biomarkers maakt het mogelijk om de ontwikkeling van atherosclerotische 
plaques en de determinanten ervan te onderzoeken en kan gebruikt worden om de effec-
ten van behandeling te vervolgen.
Het werk in dit proefschrift richt zich op de kwantitatieve biomarkers van atheroscleroti-
sche plaque in de halsslagaders, verkregen met behulp van CT angiografie (CTA), en het 
onderzoek naar de ontwikkeling van plaque en determinanten daarvan met behulp van 
deze biomarkers in een seriële CTA studie in een symptomatische patiëntenpopulatie. 
Verder wordt de rol van op CTA vastgestelde plaque ulceratie als kwalitatieve biomarker 
onderzocht in klinische studies.
In Hoofdstuk  2 ligt de focus op de kwantificering van middels CTA verkregen biomarkers 
van plaque hoeveelheid en plaque samenstelling. Hoofdstuk 2.1 betreft een review over 
de CTA techniek die wordt gebruikt om atherosclerose in de halsslagaders op een kwan-
titatieve manier te evalueren. Technische aspecten en CT scan acquisitieparameters zijn 
cruciaal voor de nauwkeurige beoordeling van lumen, plaque en plaquecomponenten 
en scanprotocollen moeten worden geoptimaliseerd en gestandaardiseerd. Kwantitatie-
ve plaquemetingen werden reeds gevalideerd in ex vivo en in vivo studies en kunnen 
worden verkregen met een matige tot goede interobserver en intraobserver reprodu-
ceerbaarheid. We hebben (semi-)geautomatiseerde algoritmen ontwikkeld voor het seg-
menteren van atherosclerotische plaque in de halsslagader en het kwantificeren van vo-
lumina van plaque en plaquecomponent om zo de reproduceerbaarheid te verbeteren en 
grootschalige toepassing in seriële, grote cohortstudies mogelijk te maken.
Hoofdstuk 2.2 presenteert de resultaten van het prestatievermogen van een geautoma-
tiseerd plaque segmentatie algoritme om volumina van plaque en plaque componenten 
te kwantificeren. De verschillen tussen de geautomatiseerde methode en de handmatige 
segmentatie, welke als referentiestandaard wordt beschouwd, waren vergelijkbaar met 
de interobserver verschillen tussen handmatig uitgevoerde annotaties. Verder werden 
vergelijkbare associaties gevonden voor risicofactoren voor plaque hoeveelheid en pla-
que samenstelling bij gebruik van de geautomatiseerde methode in vergelijking met de 
handmatige segmentaties. Op deze manier werd de semi-geautomatiseerde methode in-
direct gevalideerd voor gebruik in grotere studiecohorten.
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Hoofdstuk 3 is gewijd aan plaque ulceratie op CTA als een kwalitatieve biomarker van 
plaque ruptuur. Ulceratie in een atherosclerotische plaque wordt beschouwd als een 
marker van doorgemaakte plaque ruptuur. Hoofdstuk 3.1 beschrijft dat plaque ulcera-
tie in de symptomatische halsslagader wordt geassocieerd met klinisch gedefinieerde 
niet-lacunaire beroerte wanneer vergeleken wordt met lacunaire beroerte. Deze asso-
ciatie bleek onafhankelijk van de mate van stenose en cardiovasculaire risicofactoren. 
Deze relatie werd bevestigd door een onafhankelijke associatie tussen de aanwezigheid 
van atherosclerotische plaque ulceratie en niet-lacunair infarct op de CT van de hersenen. 
Deze resultaten ondersteunen de hypothese over het pathofysiologische mechanisme 
van ruptureren van plaques en daaropvolgende trombo-embolisatie naar de hersenen bij 
niet-lacunaire beroerte.
In hoofdstuk 3.2 presenteer ik een klinische retrospectieve seriële studie over de evolutie 
van de oppervlakte morfologie van atherosclerotische plaques. Hoewel histopathologi-
sche studies suggereren dat plaque ulceraties zouden genezen, laat ik zien dat plaque 
ulceraties na het optreden van een TIA of infarct lang en onveranderd kunnen blijven 
bestaan. Dit impliceert dat de aanwezigheid van een plaque ulceratie niet noodzakelijker-
wijs betekent dat er een recente ruptuur is opgetreden. De klinische betekenis van het 
bestaan van plaque ulceraties voor het (opnieuw) optreden van trombo-embolieën blijft 
onopgelost. Aangezien een bestaande plaque ulceratie in theorie ook trombo-embolieën 
kan veroorzaken, moet het risico op recidiverende herseninfarcten in grote prospectieve 
longitudinale studies worden onderzocht.
Volgens het ‘vulnerable plaque’ concept zorgen bepaalde plaquekenmerken ervoor dat 
een plaque makkelijker scheurt. We onderzochten daarom de relatie tussen plaque volu-
me en plaque componenten en plaque ulceratie in een cross-sectionele CT studie van de 
symptomatische slagaders in patiënten met een TIA of beroerte (hoofdstuk 3.3). Plaque 
volume en de lipide-rijke necrotische kern (LRNC) waren significant geassocieerd met 
plaque ulceratie, terwijl de proportie kalk omgekeerd geassocieerd was met plaque ulce-
ratie. Deze associaties bleven significant in vaten met een lage stenosegraad. Dit geeft 
aan dat plaquevolume en -compositie op CT mogelijk plaque ulceraties zouden kunnen 
voorspellen en daarmee uiteindelijk het risico op een herseninfarct beter kan worden 
ingeschat. 
In Hoofdstuk 4 presenteer ik de resultaten van de eerste seriële CTA-studie over kwanti-
tatieve beeldvorming van plaques in de halsslagaders. Om onze kennis te verbeteren van 
atherosclerotische plaqueontwikkeling in de halsslagaders, bestudeerden wij veranderin-
gen in atherosclerotische plaque in een klinisch cohort van patiënten die een TIA of een 
herseninfarct doormaakten. Zij kregen een follow-up CTA gemiddelde vijf jaar na de CTA 
die zij hadden ondergaan in het kader van de klinische beoordeling ten tijde van hun TIA 
of herseninfarct.
Hoofdstuk 4.1 beschrijft de studie waarin we verkalkingen in de carotiden hebben ge-
bruikt als indirecte mate voor de hoeveelheid atherosclerotische plaque, en de groei van 
deze verkalkingen, evenals de determinanten daarvan, hebben onderzocht. Naast de be-
kende klassieke cardiovasculaire risicofactoren waren met name leeftijd en de baseline 
kalk load belangrijke determinanten voor toename van de verkalkingen. Dit kan worden 
verklaard door het feit dat chronische invloeden van risicofactoren weerspiegeld zijn in 
de baseline kalk load, wat eigenlijk deel uitmaakt van het pathofysiologische proces dat 
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wordt onderzocht. Hoewel verkalkingen in de halsslagaders worden gerelateerd aan een 
verhoogd risico op herseninfarcten, is er een toenemende bewijslast dat het proces van 
verkalking van de plaque, en daarmee de relatieve bijdrage ervan, wordt geassocieerd 
met stabilisatie van de plaque. 
Het meten van de relatieve bijdrage van plaque componenten zou daarom van belang 
kunnen zijn. In hoofdstuk 4.2 laten we zien dat het haalbaar is om temporele veranderin-
gen in plaque hoeveelheid en plaque componenten te beoordelen met behulp van een 
semi-geautomatiseerd plaque segmentatie algoritme in seriële CTA data. De geconsta-
teerde plaque veranderingen waren klein en heterogeen. Niettemin vonden we een signi-
ficante verandering in plaquesamenstelling in de richting van een stabieler plaque profiel, 
d.w.z. een afnemende vet component en een toenemende kalk component.
In hoofdstuk 4.3 onderzoeken we de determinanten van deze temporale plaqueverande-
ringen. De baseline vet component was geassocieerd met een verminderde plaque groei. 
Deze bevinding is waarschijnlijk toe te schrijven aan cholesterol-verlagende therapie, 
dat werd gebruikt door de meeste deelnemers aan de studie. In andere studies heeft 
men laten zien dat cholesterol-verlagende middelen een remmende invloed hebben op 
de plaque door het doen afnemen van de vet component in de plaque. Een andere be-
langrijke determinant voor plaque stabilisatie bleek hypertensie. Het pathofysiologische 
mechanisme hierachter blijft echter onduidelijk. Aangezien onze studie niet een gerando-
miseerde, gecontroleerde klinische studie betrof, was het onmogelijk om de chronische 
effecten van risicofactoren te onderscheiden van de potentiële therapie-effecten van de 
secundaire preventieve behandeling die onze patiënten krijgen. 
In de algemene discussie, in Hoofdstuk 5, worden de belangrijkste bevindingen uit onze 
studies, evenals de methodologische overwegingen, potentiële klinische implicaties en 
richtingen voor toekomstig onderzoek besproken. 
Concluderend, dit proefschrift omvat de eerste studies waarin de bruikbaarheid van CTA 
en een semi-geautomatiseerd plaque segmentatie algoritme voor kwantitatieve seriële 
plaque imaging wordt geëvalueerd. We bestudeerden de plaqueontwikkeling in atheros-
clerotische plaques in halsslagaders van symptomatische patiënten, die worden behan-
deld volgens nationale richtlijnen met secundaire preventieve therapieën, waarbij bleek 
dat dit een behoorlijk indolent proces betreft. Bij het interpreteren van dergelijke seriële 
data, moeten we ons ervan bewust zijn dat plaque evolutie onderworpen is aan een zeer 
complexe combinatie van biochemische en biomechanische factoren gedurende een ge-
heel mensenleven, waarbij er vervolgens ook therapeutische effecten doorheen spelen. 
Om die reden zijn grote, prospectieve, longitudinale studies nodig om de determinanten 
van plaqueontwikkeling bij asymptomatische patiënten te onderzoeken, en zijn gecon-
troleerde, gerandomiseerde klinische studies nodig om de therapie-effecten bij symp-
tomatische patiënten te ontrafelen. Verder voorziet dit proefschrift in extra bewijslast 
voor de potentie van op CTA gedetecteerde plaque ulceratie als een klinisch toepasbare 
imaging biomarker. De rol van plaque ulceraties in het risico op nieuwe herseninfarcten, 
en daarmee in een eventuele verbetering van risico voorspelling, moet verder worden 
onderzocht in prospectieve, longitudinale studies.
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Dankwoord
Eindelijk… de eindstreep in zicht!
Regelmatig heb ik de afgelopen jaren de vraag gekregen of ik –als ik de tijd zou kun-
nen terugdraaien- opnieuw mijn opleiding zou onderbreken voor een promotietraject. 
Bepaalde dingen zou ik zeker anders aanpakken, maar ik kan – nu de proefdruk voor mijn 
neus ligt – met opgeheven schouders zeggen dat ik op vele fronten een leerzame erva-
ring rijker ben. 
In de jaren dat ik heb gewerkt aan mijn promotieonderzoek, hebben velen op een of 
andere manier bijgedragen aan dit werk. Een aantal mensen wil ik in het bijzonder be-
danken.
Beste prof. dr. van der Lugt, beste Aad, jouw visie op CTA van de carotiden was de basis 
en drijfveer voor dit onderzoek. Dank voor je enthousiaste begeleiding en prettige sa-
menwerking. Jouw helikopter view, positivisme en relativerende kracht hebben mij ge-
holpen, met name met de laatste loodjes!
Beste prof. dr. Dippel, beste Diederik, bedankt dat je mijn promotor wilde zijn. Jouw me-
thodologische input en opbouwende tekstuele commentaar op mijn stukken waren erg 
waardevol, dank daarvoor. 
Beste prof. dr. Krestin, dank voor de kans die ik heb gekregen om mijn opleiding tot radio-
loog te onderbreken voor deze promotie. Dit traject heeft langer geduurd dan gepland; 
ik wil u bedanken voor het geduld en het vertrouwen dat u heeft gehad op een goede 
afloop.
Beste Winnifred en Tadek, mijn opleiders, bedankt voor jullie begrip voor ‘mijn dubbele 
agenda’ en jullie steun daarbij. Winnifred, het vrijmaken van enige tijd tijdens mijn oplei-
ding was het zetje dat ik nodig had om mijn proefschrift af te kunnen ronden. 
Beste commissieleden, dank voor het beoordelen van mijn proefschrift en het zitting ne-
men in de promotie-commissie. Prof. dr. ing. Niessen, beste Wiro, dank voor de tijd die je 
hebt gestoken in het sparren over en het optimaliseren van de door jouw afdeling ont-
wikkelde segmentatie-tools en je commentaar op mijn artikelen.
Verder wil ik bedanken: mijn kamergenoten en collega-researchers uit het Hs- (en later 
Na-)gebouw, de CT laboranten, collega’s van het secretariaat en van de trial bureaus van 
de afdelingen Radiologie en Neurologie, collega’s van de Biomedical Imaging Group, stu-
denten die bij mij een onderzoeksproject hebben verricht, en mede-auteurs. Dank voor 
jullie hulp, praktische ondersteuning, input, afleiding en gezelligheid.  
Ook wil ik alle patiënten die hebben deelgenomen aan mijn onderzoek bedanken. Zonder 
hen was dit proefschrift niet tot stand gekomen.  
Lieve Neel en Kim, mijn paranimfen, wat ben ik blij dat ik jullie samen opnieuw bij zo’n 
bijzondere gelegenheid aan mijn zijde heb staan.. Dank voor jullie enthousiasme en steun!
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Lieve vrienden en familie, dank voor jullie interesse in mijn werk. Vaak had ik het er liever 
niet over, om er niet aan herinnerd te worden, dus vooral ook dank voor de nodige aflei-
ding. Ik ben blij de goede afloop nu met jullie te mogen vieren.
Lieve schoonouders, Do en Jaap, ondanks dat jullie me voor gek verklaren met mijn ‘on-
aantrekkelijke werktijden’, staan jullie altijd voor mij en ons gezin klaar. Dat maakt moge-
lijk dat ik kan doen wat ik doe en sta waar ik nu sta. Jullie zijn schatten.
Lieve pap en mam, jullie hebben me altijd gestimuleerd om overal uit te halen wat erin zit 
en van jullie heb ik ook de instelling om verantwoording te nemen en door te pakken als 
je ergens aan begint. Zonder jullie steun was ik niet gekomen waar ik nu ben. Jullie staan 
altijd voor mij en ons gezin klaar en de afgelopen jaren, waarin het nog wel eens schortte 
aan tijd en energie, waren jullie altijd bereid om de kleintjes even onder jullie hoede te 
nemen. Duizendmaal dank!
Lieve Maeke en Jop, mijn kleine bengeltjes. Jullie hebben geen idee... Jullie zijn mede-
plichtig aan de delay in dit gehele traject, maar ik had het niet anders kunnen en willen 
doen. 
Lieve Pat, samen vormen we een team… bedankt – simpelweg voor alles!
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PhD Portfolio
Courses Year Workload 
ECTS
• Clinical Epidemiology (NIHES, Rotterdam, The Netherlands)
• Courses in the Medical Library (Erasmus MC, Rotterdam, The Neth-
erlands)
• Basiscurses Regelgeving en Organisatie voor Klinisch Onderzoekers 
(Erasmus MC, Rotterdam, The Netherlands)
• Peripheral and Intracranial Obstructive Vascular Disease (COEUR, 
Rotterdam, The Netherlands)
• Classical Methods for Data-analysis (NIHES, Rotterdam, The Nether-
lands)
• Repeated Measurements in Clinical Studies (NIHES, Rotterdam, The 
Netherlands)
• Vascular Clinical Epidemiology (COEUR, Rotterdam, The Nether-
lands)
• Cardiovascular Imaging and Diagnostics
• Regression Analysis for Clinicians (NIHES, Rotterdam, The Nether-
lands)
• Biomedical English Writing and Communication
2008
2008
2009
2009
2009
2010
2010
2010
2010
2010
5.7
0.6
0.9
1.5
5.7
1.4
1.5
1.5
1.4
3
(Inter)national conferences and presentations Year Workload 
ECTS
• Radiologendagen (NVvR, Amsterdam, The Netherlands); poster 
presentation
• Radiological Society of North America Annual Meeting (RSNA, Chica-
go, United States); poster presentation
• European Congress of Radiology (ECR, Vienna, Austria); oral presen-
tation
• Radiologendagen (NVvr; Veldhoven, The Netherlands); oral presen-
tation
• Radiological Society of North America Annual Meeting (RSNA, Chica-
go, United States); educational exhibit
• Radiologendagen (NVvR, Maastricht, The Netherlands); oral presen-
tation
• Radiological Society of North America Annual Meeting (RSNA, Chica-
go, United States); oral presentation
• European Congress of Radiology (ECR, Vienna, Austria); poster
2009
2009
2010
2010
2010
2011
2011
2012
1.0
1.8
1.5
1.0
1.8
1.0
1.8
1.0
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Other Year Workload 
ECTS
• Research Seminar: Shear Stress (COEUR, Rotterdam, The Nether-
lands)
• Research Seminar: New developments in percutaneous interven-
tions (COEUR, Rotterdam, The Netherlands)
• Research Seminar: Vascular imaging: Atherosclerosis and Biome-
chanics (COEUR, Rotterdam, The Netherlands)
2008
2009
2010
0.4
0.4
0.4
Presentations and lectures Year Workload 
ECTS
• Serial CT angiography of atherosclerotic plaque; determinants and 
prognosis of changes in volume, composition and morphology (De-
partment of Radiology, Erasmus MC)
• Serial CT angiography of the atherosclerotic carotid plaque (COEUR 
seminar, Rotterdam, The Netherlands)
2009
2010
0.4
0.4
Teaching activities Year Workload 
ECTS
• Supervising research projects of 2 medical students (L. Cremers, M. 
Bodde)
2010 0.8
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Marjon van Gils was born on the 26th of May 1980 in Ermelo, the Netherlands. 
In 1998 she started the study ‘Biomedical Health Sciences’ at the Radboud University in 
Nijmegen. For student research project she participated in a pharmacological study on 
intra-cranial medication for Parkinson disease in rats at the Radboud University, Nijme-
gen. Her second research project was on Isolated Limb Perfusion in soft tissue tumors, 
at the Department of Experimental Surgery, Erasmus Medical Center, Rotterdam. During 
this study, she realized that she preferred to perform more clinically oriented work and 
research. In the last year, she combined her study with the study of Medicine and she 
graduated in both studies in 2004 and 2006 at the Radboud University of Nijmegen. 
Upon finishing her studies, her medical career started as a resident at the Emergency 
department, and later at the department of Surgery at the Albert Schweitzer Hospital 
(Zwijndrecht and Dordrecht respectively). It was in this period that she got interested in 
Radiology. From December 2007 she worked as a resident in Radiology at Erasmus Med-
ical Center, Rotterdam. In December 2008 she was challenged to interrupt her residency 
and start the PhD research project ‘Serial Atherosclerotic Carotid Plaque Imaging with 
MDCTA’, under supervision of prof. dr. A. van der Lugt (department of Radiology) and 
prof. dr. D.W.J. Dippel (department of Neurology), the results of which are presented in 
this thesis. From May 2012 on she continued her Radiology training at Erasmus MC in Rot-
terdam and partly at Albert Schweitzer Hospital in Dordrecht, with Abdominal Radiology 
as a subspecialty. In December 2017 she finalizes her residency and will continue working 
at EMC as a fellow in Abdominal Radiology.
Marjon is married to Patrick. They live with their two children Maeke and Jop in Heinen-
oord.
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